Translational and Computational Research on Solid and Hematological Cancer

Publications 2024

Arffman M, Meriranta L, Autio M, Holte H, Jørgensen J, Brown P, Jyrkkiö S, Jerkeman M, Drott K, Fluge Ø, Björkholm M, Karjalainen-Lindsberg ML, Beiske K, Pedersen MØ, Leivonen SK, Leppä S (2024)
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas
Med, 5 (6), 583-602.e5
DOI 10.1016/j.medj.2024.03.007, PubMed 38579729

Bai B, Wise JF, Vodák D, Nakken S, Sharma A, Blaker YN, Brodtkorb M, Hilden V, Trøen G, Ren W, Lorenz S, Lawrence MS, Myklebost O, Kimby E, Pan-Hammarström Q, Steen CB, Meza-Zepeda LA, Beiske K, Smeland EB, Hovig E, Lingjærde OC, Holte H, Myklebust JH (2024)
Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma
Blood Cancer J, 14 (1), 147
DOI 10.1038/s41408-024-01124-5, PubMed 39191762

Casey NP, Kleinmanns K, Forcados C, Gelebart PF, Joaquina S, Lode M, Benard E, Kaveh F, Caulier B, Helgestad Gjerde C, García de Jalón E, Warren DJ, Lindemann K, Rokkones E, Davidson B, Myhre MR, Kvalheim G, Bjørge L, McCormack E, Inderberg EM, Wälchli S (2024)
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
J Immunother Cancer, 12 (4)
DOI 10.1136/jitc-2023-008179, PubMed 38604812

Cun HT, Bernard L, Lande KT, Lawson BC, Nesbakken AJ, Davidson B, Lindemann K, Fellman B, Sørlie T, Soliman PT, Eriksson AGZ (2024)
Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma
Gynecol Oncol, 189, 138-145
DOI 10.1016/j.ygyno.2024.07.677, PubMed 39126895

Dagher C, Bjerre Trent P, Alwaqfi R, Davidson B, Ellenson L, Zhou QC, Iasonos A, Mueller JJ, Alektiar K, Makker V, Kim S, Leitao MM, Abu-Rustum NR, Eriksson AGZ (2024)
Oncologic outcomes based on lymphovascular space invasion in node-negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: a multicenter retrospective cohort study
Int J Gynecol Cancer, 34 (10), 1485-1492
DOI 10.1136/ijgc-2024-005746, PubMed 39074932

Davidson B, Doutel D, Holth A, Nymoen DA (2024)
Correction to: Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
Virchows Arch, 484 (5), 875
DOI 10.1007/s00428-023-03567-w, PubMed 37261507

Davidson B, Holth A, Hummel C, Flatmark K, Torgunrud A (2024)
Different Frequency and Clinical Role for MTAP Loss in Pleural and Peritoneal Mesothelioma
Appl Immunohistochem Mol Morphol, 32 (6), 280-284
DOI 10.1097/PAI.0000000000001206, PubMed 38812360

Davidson B, Holth A, Lindemann K, Zahl Eriksson AG, Nilsen TA, Torgunrud A (2024)
Molecular characteristics of tubo-ovarian carcinosarcoma at different anatomic locations
Virchows Arch (in press)
DOI 10.1007/s00428-024-03821-9, PubMed 38733380

Davidson B, Skeie-Jensen T, Holth A, Hausladen S (2024)
Stathmin is an Independent Prognostic Marker of Poor Outcome in Uterine Leiomyosarcoma
Int J Gynecol Pathol (in press)
DOI 10.1097/PGP.0000000000001030, PubMed 38847524

Davidson B, Teien Lande K, Nebdal D, Nesbakken AJ, Holth A, Lindemann K, Zahl Eriksson AG, Sørlie T (2024)
Endometrial carcinomas with ambiguous histology often harbor TP53 mutations
Virchows Arch (in press)
DOI 10.1007/s00428-024-03912-7, PubMed 39235515

Hilton LK, Collinge B, Ben-Neriah S, Alduaij W, Shaalan H, Weng AP, Cruz M, Slack GW, Farinha P, Miyata-Takata T, Boyle M, Meissner B, Cook JR, Ondrejka SL, Ott G, Rosenwald A, Campo E, Amador C, Greiner TC, Raess PW, Song JY, Inghirami G, Jaffe ES, Weisenburger DD, Chan WC et al. (2024)
Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study)
Blood, 144 (5), 525-540
DOI 10.1182/blood.2024024251, PubMed 38701426

Ledermann JA, Matias-Guiu X, Amant F, Concin N, Davidson B, Fotopoulou C, González-Martin A, Gourley C, Leary A, Lorusso D, Banerjee S, Chiva L, Cibula D, Colombo N, Croce S, Eriksson AG, Falandry C, Fischerova D, Harter P, Joly F, Lazaro C, Lok C, Mahner S, Marmé F, Marth C et al. (2024)
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
Ann Oncol, 35 (3), 248-266
DOI 10.1016/j.annonc.2023.11.015, PubMed 38307807

Lund-Andersen C, Torgunrud A, Kanduri C, Dagenborg VJ, Frøysnes IS, Larsen MM, Davidson B, Larsen SG, Flatmark K (2024)
Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer
J Transl Med, 22 (1), 646
DOI 10.1186/s12967-024-05467-2, PubMed 38982444

Marttila P, Bonagas N, Chalkiadaki C, Stigsdotter H, Schelzig K, Shen J, Farhat CM, Hondema A, Albers J, Wiita E, Rasti A, Warpman Berglund U, Slipicevic A, Mortusewicz O, Helleday T (2024)
The one-carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiation
Mol Oncol, 18 (9), 2179-2195
DOI 10.1002/1878-0261.13645, PubMed 38533616

Nickless T, Davidson B, Finch S, Gold L, Dowell R (2024)
Aligned or misaligned: Are public funding models for speech-language pathology reflecting recommended evidence? An exploratory survey of Australian speech-language pathologists
Health Policy Open, 6, 100117
DOI 10.1016/j.hpopen.2024.100117, PubMed 38510780

Przybyła W, Gjersvoll Paulsen KM, Mishra CK, Nygård S, Engebretsen S, Ruud E, Trøen G, Beiske K, Baumbusch LO (2024)
Correction: Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants
PLoS One, 19 (7), e0306687
DOI 10.1371/journal.pone.0306687, PubMed 38950054

Sveen A, Johannessen B, Klokkerud SM, Kraggerud SM, Meza-Zepeda LA, Bjørnslett M, Bischof K, Myklebost O, Taskén K, Skotheim RI, Dørum A, Davidson B, Lothe RA (2024)
Evolutionary mode and timing of dissemination of high-grade serous carcinomas
JCI Insight, 9 (3)
DOI 10.1172/jci.insight.170423, PubMed 38175731

Wang J, Yang M, Ali O, Dragland JS, Bjørås M, Farkas L (2024)
Predicting regulatory mutations and their target genes by new computational integrative analysis: A study of follicular lymphoma
Comput Biol Med, 178, 108787
DOI 10.1016/j.compbiomed.2024.108787, PubMed 38901187

Yang M, Kaarbø M, Myhre V, Reims HM, Karlsen TH, Wang J, Rognes T, Halvorsen B, Fevang B, Lundin KEA, Aukrust P, Bjørås M, Jørgensen SF (2024)
Altered Genome-Wide DNA Methylation in the Duodenum of Common Variable Immunodeficiency Patients
J Clin Immunol, 44 (6), 133
DOI 10.1007/s10875-024-01726-5, PubMed 38780872

Yao Z, Jin S, Zhou F, Wang J, Wang K, Zou X (2024)
A novel multiscale framework for delineating cancer evolution from subclonal compositions
J Theor Biol, 582, 111743
DOI 10.1016/j.jtbi.2024.111743, PubMed 38307450

Publications 2023

Arjona-Sanchez A, Martinez-López A, Moreno-Montilla MT, Mulsow J, Lozano-Lominchar P, Martínez-Torres B, Rau B, Canbay E, Sommariva A, Milione M, Deraco M, Sgarbura O, Torgunrud A, Kepenekian V, Carr NJ, Hoorens A, Delhorme JB, Wernert R, Goere D, Martin-Roman L, Cosyns S, Flatmark K, Davidson B, Khellaf L, Pereira-Perez F et al. (2023)
External multicentre validation of pseudomyxoma peritonei PSOGI-Ki67 classification
Eur J Surg Oncol, 49 (8), 1481-1488
DOI 10.1016/j.ejso.2023.03.206, PubMed 36935222

Davidson B, Doutel D, Holth A, Nymoen DA (2023)
Claudin-10 is a new candidate prognostic marker in metastatic high-grade serous carcinoma
Virchows Arch, 482 (6), 975-982
DOI 10.1007/s00428-023-03541-6, PubMed 37067588

Davidson B, Skeie-Jensen T, Holth A, Lindemann K, Toralba Barrameda AM, Lie AK, Wang Y (2023)
Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma
Virchows Arch, 484 (6), 951-963
DOI 10.1007/s00428-023-03670-y, PubMed 37843640

Davidson B, Solheim O (2023)
Cancer Stem Cell Markers Are Differentially Expressed in Malignant Ovarian Germ Cell Tumors
Int J Gynecol Pathol, 42 (6), 613-619
DOI 10.1097/PGP.0000000000000947, PubMed 37186896

Dos Santos MV, Holth A, Bischof K, Davidson B (2023)
Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance
Clin Exp Metastasis, 41 (1), 69-76
DOI 10.1007/s10585-023-10251-5, PubMed 38141113

Dos Santos MV, Holth A, Lindemann K, Staff AC, Davidson B (2023)
Clinical significance of L1CAM expression in metastatic tubo-ovarian high-grade serous carcinoma
Gynecol Oncol, 176, 76-81
DOI 10.1016/j.ygyno.2023.07.004, PubMed 37478615

Doutel D, Davidson B, Nitschke Pettersen IK, Torgunrud A (2023)
Molecular characteristics of low-grade serous carcinoma in effusions
Cytopathology, 34 (2), 99-105
DOI 10.1111/cyt.13207, PubMed 36609991

Gatius S, Matias Guiu X, Davidson B (2023)
Molecular features for timely cancer diagnosis and treatment - tumors of the ovary, fallopian tube and endometrium
Virchows Arch, 484 (2), 339-351
DOI 10.1007/s00428-023-03710-7, PubMed 38099957

Green AC, Marttila P, Kiweler N, Chalkiadaki C, Wiita E, Cookson V, Lesur A, Eiden K, Bernardin F, Vallin KSA, Borhade S, Long M, Ghahe EK, Jiménez-Alonso JJ, Jemth AS, Loseva O, Mortusewicz O, Meyers M, Viry E, Johansson AI, Hodek O, Homan E, Bonagas N, Ramos L, Sandberg L et al. (2023)
Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells
Nat Metab, 5 (4), 642-659
DOI 10.1038/s42255-023-00771-5, PubMed 37012496

Kalmbach S, Grau M, Zapukhlyak M, Leich E, Jurinovic V, Hoster E, Staiger AM, Kurz KS, Weigert O, Gaitzsch E, Passerini V, Engelhard M, Herfarth K, Beiske K, Micci F, Möller P, Bernd HW, Feller AC, Klapper W, Stein H, Hansmann ML, Hartmann S, Dreyling M, Holte H, Lenz G et al. (2023)
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms
Leukemia, 37 (10), 2058-2065
DOI 10.1038/s41375-023-01995-w, PubMed 37563306

Leivonen SK, Friman T, Autio M, Vaittinen S, Jensen AW, D'Amore F, Hamilton-Dutoit SJ, Holte H, Beiske K, Kovanen PE, Räty R, Leppä S (2023)
Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas
Haematologica, 108 (11), 3044-3057
DOI 10.3324/haematol.2023.282831, PubMed 37259566

Ludvigsen M, Campbell AJ, Enemark MB, Hybel TE, Karjalainen-Lindsberg ML, Beiske K, Bjerre M, Pedersen LM, Holte H, Leppä S, Jørgensen JM, Honoré B (2023)
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
Blood Cancer J, 13 (1), 161
DOI 10.1038/s41408-023-00931-6, PubMed 37884514

Panagopoulos I, Andersen K, Brunetti M, Gorunova L, Davidson B, Lund-Iversen M, Micci F, Heim S (2023)
Genetic Pathways in Peritoneal Mesothelioma Tumorigenesis
Cancer Genomics Proteomics, 20 (4), 363-374
DOI 10.21873/cgp.20388, PubMed 37400148

Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, Rustad EH, Meyer S, Isaksen K, Chellappa S, Kushekhar K, Beiske K, Førsund MS, Spetalen S, Holte H, Østenstad B, Brodtkorb M, Kimby E, Olweus J, Taskén K, Newman AM, Lorenz S, Smeland EB, Alizadeh AA, Huse K et al. (2023)
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
Blood Adv, 7 (23), 7216-7230
DOI 10.1182/bloodadvances.2023010158, PubMed 37695745

Vermorgen S, Gelton T, Bult P, Kusters-Vandevelde HVN, Hausnerová J, Van de Vijver K, Davidson B, Stefansson IM, Kooreman LFS, Qerimi A, Huvila J, Gilks B, Shahi M, Zomer S, Bartosch C, Pijnenborg JMA, Bulten J, Ciompi F, Simons M (2023)
Endometrial Pipelle Biopsy Computer-Aided Diagnosis: A Feasibility Study
Mod Pathol, 37 (2), 100417
DOI 10.1016/j.modpat.2023.100417, PubMed 38154654

Yang M, Ali O, Bjørås M, Wang J (2023)
Identifying functional regulatory mutation blocks by integrating genome sequencing and transcriptome data
iScience, 26 (8), 107266
DOI 10.1016/j.isci.2023.107266, PubMed 37520692

Publications 2022

Ali O, Farooq A, Yang M, Jin VX, Bjørås M, Wang J (2022)
abc4pwm: affinity based clustering for position weight matrices in applications of DNA sequence analysis
BMC Bioinformatics, 23 (1), 83
DOI 10.1186/s12859-022-04615-z, PubMed 35240993

Brunetti M, Panagopoulos I, Vitelli V, Andersen K, Hveem TS, Davidson B, Eriksson AGZ, Trent PKB, Heim S, Micci F (2022)
Endometrial Carcinoma: Molecular Cytogenetics and Transcriptomic Profile
Cancers (Basel), 14 (14)
DOI 10.3390/cancers14143536, PubMed 35884597

Davidson B, Elstrand MB (2022)
Clinicopathological prognostic parameters in patients with tubo-ovarian carcinoma effusions
Cytopathology, 33 (4), 479-492
DOI 10.1111/cyt.13126, PubMed 35398934

Fang K, Wang J, Liu L, Jin VX (2022)
Mapping nucleosome and chromatin architectures: A survey of computational methods
Comput Struct Biotechnol J, 20, 3955-3962
DOI 10.1016/j.csbj.2022.07.037, PubMed 35950186

Farooq A, Trøen G, Delabie J, Wang J (2022)
Integrating whole genome sequencing, methylation, gene expression, topological associated domain information in regulatory mutation prediction: A study of follicular lymphoma
Comput Struct Biotechnol J, 20, 1726-1742
DOI 10.1016/j.csbj.2022.03.023, PubMed 35495111

Flanagan K, Kumari R, Miettinen JJ, Haney SL, Varney ML, Williams JT, Majumder MM, Suvela M, Slipicevic A, Lehmann F, Nupponen NN, Holstein SA, Heckman CA (2022)
The Peptide-Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell Death
Hemasphere, 6 (3), e687
DOI 10.1097/HS9.0000000000000687, PubMed 35243210

Gatius S, Velasco A, Varela M, Cuatrecasas M, Jares P, Setaffy L, Bonhomme B, Santon A, Lindemann K, Croce S, Davidson B, Lax S, Palacios J, Matias-Guiu X (2022)
Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study
Virchows Arch, 480 (5), 1031-1039
DOI 10.1007/s00428-022-03291-x, PubMed 35124717

Gebraad A, Ohlsbom R, Miettinen JJ, Emeh P, Pakarinen TK, Manninen M, Eskelinen A, Kuismanen K, Slipicevic A, Lehmann F, Nupponen NN, Heckman CA, Miettinen S (2022)
Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen
Cells, 11 (9)
DOI 10.3390/cells11091574, PubMed 35563880

Gilks CB, Selinger CI, Davidson B, Köbel M, Ledermann JA, Lim D, Malpica A, Mikami Y, Singh N, Srinivasan R, Vang R, Lax SF, McCluggage WG (2022)
Data Set for the Reporting of Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
Int J Gynecol Pathol, 41 (Suppl 1), S119-S142
DOI 10.1097/PGP.0000000000000908, PubMed 36305537

Kleinmanns K, Gullaksen SE, Bredholt G, Davidson B, Torkildsen CF, Grindheim S, Bjørge L, McCormack E (2022)
Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
Cancers (Basel), 14 (13)
DOI 10.3390/cancers14133092, PubMed 35804867

Martinez-Monleon A, Kryh Öberg H, Gaarder J, Berbegall AP, Javanmardi N, Djos A, Ussowicz M, Taschner-Mandl S, Ambros IM, Øra I, Sandstedt B, Beiske K, Ladenstein R, Noguera R, Ambros PF, Gordon Murkes L, Ljungman G, Kogner P, Fransson S, Martinsson T (2022)
Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup
Sci Rep, 12 (1), 12420
DOI 10.1038/s41598-022-16455-1, PubMed 35859155

Nyakas M, Fleten KG, Haugen MH, Engedal N, Sveen C, Farstad IN, Flørenes VA, Prasmickaite L, Mælandsmo GM, Seip K (2022)
AXL inhibition improves BRAF-targeted treatment in melanoma
Sci Rep, 12 (1), 5076
DOI 10.1038/s41598-022-09078-z, PubMed 35332208

Onallah H, Mannully ST, Davidson B, Reich R (2022)
Exosome Secretion and Epithelial-Mesenchymal Transition in Ovarian Cancer Are Regulated by Phospholipase D
Int J Mol Sci, 23 (21)
DOI 10.3390/ijms232113286, PubMed 36362078

Panagopoulos I, Andersen K, Gorunova L, Davidson B, Micci F, Heim S (2022)
A Novel Cryptic t(2;3)(p21;q25) Translocation Fuses the WWTR1 and PRKCE Genes in Uterine Leiomyoma With 3q- as the Sole Visible Chromosome Abnormality
Cancer Genomics Proteomics, 19 (5), 636-646
DOI 10.21873/cgp.20348, PubMed 35985686

Panagopoulos I, Andersen K, Gorunova L, Davidson B, Micci F, Heim S (2022)
Fusion of the HMGA2 and BNC2 Genes in Uterine Leiomyoma With t(9;12)(p22;q14)
In Vivo, 36 (6), 2654-2661
DOI 10.21873/invivo.13000, PubMed 36309352

Przybyła W, Gjersvoll Paulsen KM, Mishra CK, Nygård S, Engebretsen S, Ruud E, Trøen G, Beiske K, Baumbusch LO (2022)
Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants
PLoS One, 17 (8), e0273280
DOI 10.1371/journal.pone.0273280, PubMed 36037157

Sonzini G, Granados-Aparici S, Sanegre S, Diaz-Lagares A, Diaz-Martin J, de Andrea C, Eritja N, Bao-Caamano A, Costa-Fraga N, García-Ros D, Salguero-Aranda C, Davidson B, López-López R, Melero I, Navarro S, Ramon Y Cajal S, de Alava E, Matias-Guiu X, Noguera R (2022)
Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness
Front Cell Dev Biol, 10, 1052098
DOI 10.3389/fcell.2022.1052098, PubMed 36467415

Van Nyen T, Planque M, van Wagensveld L, Duarte JAG, Zaal EA, Talebi A, Rossi M, Körner PR, Rizzotto L, Moens S, De Wispelaere W, Baiden-Amissah REM, Sonke GS, Horlings HM, Eelen G, Berardi E, Swinnen JV, Berkers CR, Carmeliet P, Lambrechts D, Davidson B, Agami R, Fendt SM, Annibali D, Amant F (2022)
Serine metabolism remodeling after platinum-based chemotherapy identifies vulnerabilities in a subgroup of resistant ovarian cancers
Nat Commun, 13 (1), 4578
DOI 10.1038/s41467-022-32272-6, PubMed 35931688

Publications 2021

Andersson Y, Fleten KG, Abrahamsen TW, Reed W, Davidson B, Flatmark K (2021)
Anti-Angiogenic Treatment in Pseudomyxoma Peritonei-Still a Strong Preclinical Rationale
Cancers (Basel), 13 (11)
DOI 10.3390/cancers13112819, PubMed 34198773

Autio M, Leivonen SK, Brück O, Mustjoki S, Mészáros Jørgensen J, Karjalainen-Lindsberg ML, Beiske K, Holte H, Pellinen T, Leppä S (2021)
Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
Haematologica, 106 (3), 718-729
DOI 10.3324/haematol.2019.243626, PubMed 32079690

Bellini A, Pötschger U, Bernard V, Lapouble E, Baulande S, Ambros PF, Auger N, Beiske K, Bernkopf M, Betts DR, Bhalshankar J, Bown N, de Preter K, Clément N, Combaret V, Font de Mora J, George SL, Jiménez I, Jeison M, Marques B, Martinsson T, Mazzocco K, Morini M, Mühlethaler-Mottet A, Noguera R et al. (2021)
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
J Clin Oncol, 39 (30), 3377-3390
DOI 10.1200/JCO.21.00086, PubMed 34115544

Byrgazov K, Besse A, Kraus M, Slipicevic A, Lehmann F, Driessen C, Besse L (2021)
Novel Peptide-drug Conjugate Melflufen Efficiently Eradicates Bortezomib-resistant Multiple Myeloma Cells Including Tumor-initiating Myeloma Progenitor Cells
Hemasphere, 5 (7), e602
DOI 10.1097/HS9.0000000000000602, PubMed 34136753

Byrgazov K, Lind T, Rasmusson AJ, Andersson C, Slipicevic A, Lehmann F, Gullbo J, Melhus H, Larsson R, Fryknäs M (2021)
Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes
Bone Rep, 15, 101098
DOI 10.1016/j.bonr.2021.101098, PubMed 34150958

Davidson B, Kleinberg L, Børresen IM, Slettevoll F, Fangberget A, Hindosh D, Zahl Eriksson AG, Bjerkehagen B (2021)
Primary uterine ectomesenchymoma harboring a DICER1 mutation: case report with molecular analysis
Virchows Arch, 479 (2), 419-424
DOI 10.1007/s00428-021-03057-x, PubMed 33595736

Eriksson AGZ, Davidson B, Bjerre Trent P, Eyjólfsdóttir B, Dahl GF, Wang Y, Staff AC (2021)
Update on Sentinel Lymph Node Biopsy in Surgical Staging of Endometrial Carcinoma
J Clin Med, 10 (14)
DOI 10.3390/jcm10143094, PubMed 34300260

Flatmark K, Torgunrud A, Fleten KG, Davidson B, Juul HV, Mensali N, Lund-Andersen C, Inderberg EM (2021)
Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei
J Immunother Cancer, 9 (10)
DOI 10.1136/jitc-2021-003109, PubMed 34711663

García de Jalón E, Kleinmanns K, Fosse V, Davidson B, Bjørge L, Haug BE, McCormack E (2021)
Comparison of Five Near-Infrared Fluorescent Folate Conjugates in an Ovarian Cancer Model
Mol Imaging Biol, 25 (1), 144-155
DOI 10.1007/s11307-021-01685-y, PubMed 34888759

Gatti F, Mia S, Hammarström C, Frerker N, Fosby B, Wang J, Pietka W, Sundnes O, Hol J, Kasprzycka M, Haraldsen G (2021)
Nuclear IL-33 restrains the early conversion of fibroblasts to an extracellular matrix-secreting phenotype
Sci Rep, 11 (1), 108
DOI 10.1038/s41598-020-80509-5, PubMed 33420328

Jacobs Catane L, Moshel O, Smith Y, Davidson B, Reich R (2021)
Splice-Variant Knock-Out of TGFβ Receptors Perturbates the Proteome of Ovarian Carcinoma Cells
Int J Mol Sci, 22 (23)
DOI 10.3390/ijms222312647, PubMed 34884451

Juraleviciute M, Nsengimana J, Newton-Bishop J, Hendriks GJ, Slipicevic A (2021)
MX2 mediates establishment of interferon response profile, regulates XAF1, and can sensitize melanoma cells to targeted therapy
Cancer Med, 10 (8), 2840-2854
DOI 10.1002/cam4.3846, PubMed 33734579

Kromp F, Fischer L, Bozsaky E, Ambros IM, Dorr W, Beiske K, Ambros PF, Hanbury A, Taschner-Mandl S (2021)
Evaluation of Deep Learning Architectures for Complex Immunofluorescence Nuclear Image Segmentation
IEEE Trans Med Imaging, 40 (7), 1934-1949
DOI 10.1109/TMI.2021.3069558, PubMed 33784615

Li J, Fang K, Choppavarapu L, Yang K, Yang Y, Wang J, Cao R, Jatoi I, Jin VX (2021)
Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance
Clin Epigenetics, 13 (1), 175
DOI 10.1186/s13148-021-01167-6, PubMed 34535185

Miettinen JJ, Kumari R, Traustadottir GA, Huppunen ME, Sergeev P, Majumder MM, Schepsky A, Gudjonsson T, Lievonen J, Bazou D, Dowling P, O Gorman P, Slipicevic A, Anttila P, Silvennoinen R, Nupponen NN, Lehmann F, Heckman CA (2021)
Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen
Cancers (Basel), 13 (7)
DOI 10.3390/cancers13071527, PubMed 33810334

Muylaert RL, Davidson B, Ngabirano A, Kalema-Zikusoka G, MacGregor H, Lloyd-Smith JO, Fayaz A, Knox MA, Hayman DTS (2021)
Community health and human-animal contacts on the edges of Bwindi Impenetrable National Park, Uganda
PLoS One, 16 (11), e0254467
DOI 10.1371/journal.pone.0254467, PubMed 34818325

Ruiz de Garibay G, García de Jalón E, Stigen E, Lund KB, Popa M, Davidson B, Safont MM, Rygh CB, Espedal H, Barrett TM, Haug BE, McCormack E (2021)
Repurposing ¹⁸F-FMISO as a PET tracer for translational imaging of nitroreductase-based gene directed enzyme prodrug therapy
Theranostics, 11 (12), 6044-6057
DOI 10.7150/thno.55092, PubMed 33897898

Sanegre S, Eritja N, de Andrea C, Diaz-Martin J, Diaz-Lagares Á, Jácome MA, Salguero-Aranda C, García Ros D, Davidson B, Lopez R, Melero I, Navarro S, Ramon Y Cajal S, de Alava E, Matias-Guiu X, Noguera R (2021)
Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma
Front Cell Dev Biol, 9, 670185
DOI 10.3389/fcell.2021.670185, PubMed 34150764

Publications 2020

Ambros IM, Tonini GP, Pötschger U, Gross N, Mosseri V, Beiske K, Berbegall AP, Bénard J, Bown N, Caron H, Combaret V, Couturier J, Defferrari R, Delattre O, Jeison M, Kogner P, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Valent A, Van Roy N, Villamon E et al. (2020)
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group
J Clin Oncol, 38 (31), 3685-3697
DOI 10.1200/JCO.18.02132, PubMed 32903140

Beiske K, Ikegaki N, Shimada H (2020)
Age Inherently Links to Histology to Define Histoprognostic Classification of Peripheral Neuroblastic Tumors
J Clin Oncol, 38 (31), 3719-3720
DOI 10.1200/JCO.20.01839, PubMed 32931395

Bixel K, Vetter M, Davidson B, Berchuck A, Cohn D, Copeland L, Fowler JM, Havrilesky L, Lee PS, O'Malley DM, Salani R, Valea F, Alvarez Secord A, Backes F (2020)
Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal interval tumor reductive surgery for advanced ovarian cancer
Gynecol Oncol, 156 (3), 530-534
DOI 10.1016/j.ygyno.2019.12.016, PubMed 31937450

Broner EC, Onallah H, Re'em TT, Davidson B, Reich R (2020)
Role of the Exosome Secretion Machinery in Ovarian Carcinoma: In Vitro and In Vivo Models
J. Oncol., 2020, 4291827
DOI 10.1155/2020/4291827

Brook I, Cord L, Orestes M, Davidson B (2020)
Swallowing difficulties caused by a voice prosthesis in a laryngectomee
Eur Ann Otorhinolaryngol Head Neck Dis, 137 (5), 411-413
DOI 10.1016/j.anorl.2019.12.014, PubMed 32448709

Brunetti M, Panagopoulos I, Kostolomov I, Davidson B, Heim S, Micci F (2020)
Mutation analysis and genomic imbalances of cells found in effusion fluids from patients with ovarian cancer
Oncol Lett, 20 (3), 2273-2279
DOI 10.3892/ol.2020.11782, PubMed 32782545

Byrgazov K, Anderson C, Salzer B, Bozsaky E, Larsson R, Gullbo J, Lehner M, Lehmann F, Slipicevic A, Kager L, Fryknäs M, Taschner-Mandl S (2020)
Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide
Ther Adv Med Oncol, 12, 1758835920937891
DOI 10.1177/1758835920937891, PubMed 32774473

Byrgazov K, Kraus M, Besse A, Slipicevic A, Lehmann F, Driessen C, Besse L (2020)
Up-regulation of multidrug resistance protein MDR1/ABCB1 in carfilzomib-resistant multiple myeloma differentially affects efficacy of anti-myeloma drugs
Leuk Res, 101, 106499
DOI 10.1016/j.leukres.2020.106499, PubMed 33422770

Chehover M, Reich R, Davidson B (2020)
Expression of Wnt pathway molecules is associated with disease outcome in metastatic high-grade serous carcinoma
Virchows Arch, 477 (2), 249-258
DOI 10.1007/s00428-019-02737-z, PubMed 31900634

Davidson B (2020)
Molecular testing on serous effusions
Diagn Cytopathol, 49 (5), 640-646
DOI 10.1002/dc.24392, PubMed 32023012

Davidson B, Bock AJ, Holth A, Nymoen DA (2020)
Expression of palladin is associated with disease progression in metastatic high-grade serous carcinoma
Cytopathology, 31 (6), 572-578
DOI 10.1111/cyt.12895, PubMed 32741023

Davidson B, Bock AJ, Holth A, Nymoen DA (2020)
The phosphatase PTPN1/PTP1B is a candidate marker of better chemotherapy response in metastatic high-grade serous carcinoma
Cytopathology, 32 (2), 161-168
DOI 10.1111/cyt.12921, PubMed 33025675

Davidson B, Holth A, Dong HP (2020)
Expression of the cancer stem cell marker SSEA1 is associated with poor survival in metastatic high-grade serous carcinoma
Virchows Arch, 477 (5), 677-685
DOI 10.1007/s00428-020-02850-4, PubMed 32472195

Davidson B, Matias-Guiu X, Lax SF (2020)
The clinical, morphological, and genetic heterogeneity of endometrial stromal sarcoma
Virchows Arch, 476 (4), 489-490
DOI 10.1007/s00428-020-02762-3, PubMed 31993772

Davidson B, McFadden E, Holth A, Brunetti M, Flørenes VA (2020)
Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma
Virchows Arch, 477 (6), 857-864
DOI 10.1007/s00428-020-02842-4, PubMed 32533344

Dillard P, Köksal H, Maggadottir SM, Winge-Main A, Pollmann S, Menard M, Myhre MR, Mælandsmo GM, Flørenes VA, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2020)
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
Mol Ther, 29 (3), 1199-1213
DOI 10.1016/j.ymthe.2020.11.019, PubMed 33212301

Farooq A, Grønmyr S, Ali O, Rognes T, Scheffler K, Bjørås M, Wang J (2020)
HMST-Seq-Analyzer: A new python tool for differential methylation and hydroxymethylation analysis in various DNA methylation sequencing data
Comput Struct Biotechnol J, 18, 2877-2889
DOI 10.1016/j.csbj.2020.09.038, PubMed 33163148

Filippov-Levy N, Davidson B, Reich R (2020)
The Biological Role of the Long Non-coding RNA LINK-A in Ovarian Carcinoma
Anticancer Res, 40 (12), 6677-6684
DOI 10.21873/anticanres.14691, PubMed 33288561

Filippov-Levy N, Reich R, Davidson B (2020)
The Biological and Clinical Role of the Long Non-Coding RNA LOC642852 in Ovarian Carcinoma
Int J Mol Sci, 21 (15)
DOI 10.3390/ijms21155237, PubMed 32718068

Flem-Karlsen K, Nyakas M, Farstad IN, McFadden E, Wernhoff P, Jacobsen KD, Flørenes VA, Mælandsmo GM (2020)
Soluble AXL as a marker of disease progression and survival in melanoma
PLoS One, 15 (1), e0227187
DOI 10.1371/journal.pone.0227187, PubMed 31917795

Isaksen KT, Beiske K, Smeland EB, Jørgensen J, Brodtkorb M, Myklebust JH, Jerkeman M, Meriranta L, Karjalainen-Lindsberg ML, Leppä S, Scott DW, Holte H, Blaker YN (2020)
The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma
EJHaem, 2 (1), 104-108
DOI 10.1002/jha2.109, PubMed 35846101

Kleinmanns K, Fosse V, Davidson B, de Jalón EG, Tenstad O, Bjørge L, McCormack E (2020)
CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model
EBioMedicine, 56, 102783
DOI 10.1016/j.ebiom.2020.102783, PubMed 32454402

Kromp F, Bozsaky E, Rifatbegovic F, Fischer L, Ambros M, Berneder M, Weiss T, Lazic D, Dörr W, Hanbury A, Beiske K, Ambros PF, Ambros IM, Taschner-Mandl S (2020)
An annotated fluorescence image dataset for training nuclear segmentation methods
Sci Data, 7 (1), 262
DOI 10.1038/s41597-020-00608-w, PubMed 32782410

Leppä S, Jørgensen J, Tierens A, Meriranta L, Østlie I, de Nully Brown P, Fagerli UM, Larsen TS, Mannisto S, Munksgaard L, Maisenhölder M, Vasala K, Meyer P, Jerkeman M, Björkholm M, Fluge Ø, Jyrkkiö S, Liestøl K, Ralfkiaer E, Spetalen S, Beiske K, Karjalainen-Lindsberg ML, Holte H (2020)
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis
Blood Adv, 4 (9), 1906-1915
DOI 10.1182/bloodadvances.2020001518, PubMed 32380536

Menter T, Tzankov A, Zucca E, Kimby E, Hultdin M, Sundström C, Beiske K, Cogliatti S, Banz Y, Cathomas G, Karjalainen-Lindsberg ML, Grobholz R, Mazzucchelli L, Sander B, Hawle H, Hayoz S, Dirnhofer S (2020)
Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy
Br J Haematol, 189 (4), 707-717
DOI 10.1111/bjh.16414, PubMed 32012230

Milosevic M, Edwards J, Tsang D, Dunning J, Shackcloth M, Batchelor T, Coonar A, Hasan J, Davidson B, Marchbank A, Grumett S, Williams NR, Macbeth F, Farewell V, Treasure T (2020)
Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed
Colorectal Dis, 22 (10), 1314-1324
DOI 10.1111/codi.15113, PubMed 32388895

Panagopoulos I, Gorunova L, Johannsdottir IMR, Andersen K, Holth A, Beiske K, Heim S (2020)
Chromosome Translocation t(14;21)(q11;q22) Activates Both OLIG1 and OLIG2 in Pediatric T-cell Lymphoblastic Malignancies and May Signify Adverse Prognosis
Cancer Genomics Proteomics, 17 (1), 41-48
DOI 10.21873/cgp.20166, PubMed 31882550

Pihlstrøm HK, Ueland T, Michelsen AE, Aukrust P, Gatti F, Hammarström C, Kasprzycka M, Wang J, Haraldsen G, Mjøen G, Dahle DO, Midtvedt K, Eide IA, Hartmann A, Holdaas H (2020)
Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients
PLoS One, 15 (12), e0243759
DOI 10.1371/journal.pone.0243759, PubMed 33326471

Ree AH, Nygaard V, Boye K, Heinrich D, Dueland S, Bergheim IR, Johansen C, Beiske K, Negård A, Lund-Iversen M, Nygaard V, Hovig E, Nakken S, Nasser S, Julsrud L, Reisse CH, Ruud EA, Kristensen VN, Flørenes VA, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Russnes HG, Mælandsmo GM, Flatmark K (2020)
Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study
Acta Oncol, 59 (7), 733-740
DOI 10.1080/0284186X.2020.1742377, PubMed 32208873

Sahaf Naeini A, Farooq A, Bjørås M, Wang J (2020)
IGAP-integrative genome analysis pipeline reveals new gene regulatory model associated with nonspecific TF-DNA binding affinity
Comput Struct Biotechnol J, 18, 1270-1286
DOI 10.1016/j.csbj.2020.05.024, PubMed 32612751

Schenck A, Vera-Rodriguez M, Greggains G, Davidson B, Fedorcsák P (2020)
Spatial and temporal changes in follicle distribution in the human ovarian cortex
Reprod Biomed Online, 42 (2), 375-383
DOI 10.1016/j.rbmo.2020.10.013, PubMed 33309389

Schepsky A, Traustadottir GA, Joelsson JP, Ingthorsson S, Kricker J, Bergthorsson JT, Asbjarnarson A, Gudjonsson T, Nupponen N, Slipicevic A, Lehmann F, Gudjonsson T (2020)
Melflufen, a peptide-conjugated alkylator, is an efficient anti-neo-plastic drug in breast cancer cell lines
Cancer Med, 9 (18), 6726-6738
DOI 10.1002/cam4.3300, PubMed 32717133

Sharma A, Davidson B, Skeie-Jensen T, Wang Y (2020)
Fifteen Years’ Experience with Vulvar Verrucous Carcinoma at a Single Norwegian Academic Cancer Center
Journal of Gynecology and Women Healthcare, 2 (2), 1-4
PublikaID 489

Shen YA, Hong J, Asaka R, Asaka S, Hsu FC, Suryo Rahmanto Y, Jung JG, Chen YW, Yen TT, Tomaszewski A, Zhang C, Attarwala N, DeMarzo AM, Davidson B, Chuang CM, Chen X, Gaillard S, Le A, Shih IM, Wang TL (2020)
Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers
Cancer Res, 80 (20), 4514-4526
DOI 10.1158/0008-5472.CAN-19-3971, PubMed 32859605

Siaw JT, Javanmardi N, Van den Eynden J, Lind DE, Fransson S, Martinez-Monleon A, Djos A, Sjöberg RM, Östensson M, Carén H, Trøen G, Beiske K, Berbegall AP, Noguera R, Lai WY, Kogner P, Palmer RH, Hallberg B, Martinsson T (2020)
11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma
Cell Rep, 32 (12), 108171
DOI 10.1016/j.celrep.2020.108171, PubMed 32966799

Wise JF, Nakken S, Steen CB, Vodák D, Trøen G, Johannessen B, Lingjærde OC, Hilden V, Blaker YN, Bai B, Aasheim LB, Pasanen A, Lorenz S, Sveen A, Lothe RA, Myklebost O, Leppä S, Meza-Zepeda LA, Beiske K, Lawrence MS, Hovig E, Myklebust JH, Smeland EB, Holte H (2020)
Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series
Blood Adv, 4 (9), 1859-1866
DOI 10.1182/bloodadvances.2019001325, PubMed 32374878

Yang Y, Choppavarapu L, Fang K, Naeini AS, Nosirov B, Li J, Yang K, He Z, Zhou Y, Schiff R, Li R, Hu Y, Wang J, Jin VX (2020)
The 3D genomic landscape of differential response to EGFR/HER2 inhibition in endocrine-resistant breast cancer cells
Biochim Biophys Acta Gene Regul Mech, 1863 (11), 194631
DOI 10.1016/j.bbagrm.2020.194631, PubMed 32956836

Zhou Y, Cheng X, Yang Y, Li T, Li J, Huang TH, Wang J, Lin S, Jin VX (2020)
Modeling and analysis of Hi-C data by HiSIF identifies characteristic promoter-distal loops
Genome Med, 12 (1), 69
DOI 10.1186/s13073-020-00769-8, PubMed 32787954

Zhou Y, Gerrard DL, Wang J, Li T, Yang Y, Fritz AJ, Rajendran M, Fu X, Stein G, Schiff R, Lin S, Frietze S, Jin VX (2020)
Author Correction: Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistance
Nat Commun, 11 (1), 1967
DOI 10.1038/s41467-020-15789-6, PubMed 32313124

Publications 2019

Batmanov K, Delabie J, Wang J (2019)
BayesPI-BAR2: A New Python Package for Predicting Functional Non-coding Mutations in Cancer Patient Cohorts
Front Genet, 10, 282
DOI 10.3389/fgene.2019.00282, PubMed 31001324

Binzer-Panchal A, Hardell E, Viklund B, Ghaderi M, Bosse T, Nucci MR, Lee CH, Hollfelder N, Corcoran P, Gonzalez-Molina J, Moyano-Galceran L, Bell DA, Schoolmeester JK, Måsbäck A, Kristensen GB, Davidson B, Lehti K, Isaksson A, Carlson JW (2019)
Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes
Clin Cancer Res, 25 (7), 2155-2165
DOI 10.1158/1078-0432.CCR-18-2792, PubMed 30617134

Brunetti M, Agostini A, Staurseth J, Davidson B, Heim S, Micci F (2019)
Molecular characterization of carcinosarcomas arising in the uterus and ovaries
Oncotarget, 10 (38), 3614-3624
DOI 10.18632/oncotarget.26942, PubMed 31217897

Brunetti M, Panagopoulos I, Micci F, Davidson B (2019)
MGMT promoter methylation is a rare epigenetic change in malignant effusions
Cytopathology, 31 (1), 12-15
DOI 10.1111/cyt.12782, PubMed 31808217

Davidson B (2019)
Biomarkers of drug resistance in ovarian cancer - an update
Expert Rev Mol Diagn, 19 (6), 469-476
DOI 10.1080/14737159.2019.1618187, PubMed 31075061

Dominguez-Valentin M, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Holth A, Capella G, Davidson B, Evans DG, Martins A, Møller P, Hovig E (2019)
Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing
Sci Rep, 9 (1), 18555
DOI 10.1038/s41598-019-54517-z, PubMed 31811167

Flem-Karlsen K, McFadden E, Omar N, Haugen MH, Øy GF, Ryder T, Gullestad HP, Hermann R, Mælandsmo GM, Flørenes VA (2019)
Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Melanoma
Mol Cancer Ther, 19 (3), 895-905
DOI 10.1158/1535-7163.MCT-19-0290, PubMed 31871265

Flem-Karlsen K, Tekle C, Øyjord T, Flørenes VA, Mælandsmo GM, Fodstad Ø, Nunes-Xavier CE (2019)
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistance
Sci Rep, 9 (1), 5839
DOI 10.1038/s41598-019-42303-w, PubMed 30967582

Flørenes VA, Flem-Karlsen K, McFadden E, Bergheim IR, Nygaard V, Nygård V, Farstad IN, Øy GF, Emilsen E, Giller-Fleten K, Ree AH, Flatmark K, Gullestad HP, Hermann R, Ryder T, Wernhoff P, Mælandsmo GM (2019)
A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases
Transl Oncol, 12 (7), 951-958
DOI 10.1016/j.tranon.2019.04.001, PubMed 31096111

Frøysnes IS, Andersson Y, Larsen SG, Davidson B, Øien JT, Julsrud L, Fodstad Ø, Dueland S, Flatmark K (2019)
ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis
Eur J Surg Oncol, 47 (1), 134-138
DOI 10.1016/j.ejso.2019.04.014, PubMed 31036394

Gillen J, Mills KA, Dvorak J, Zheng B, Thai T, Salani R, Cosgrove CM, Davidson B, Thaker PH, Moore KN (2019)
Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab
Gynecol Oncol Rep, 30, 100502
DOI 10.1016/j.gore.2019.100502, PubMed 31720357

Josefsson SE, Beiske K, Blaker YN, Førsund MS, Holte H, Østenstad B, Kimby E, Köksal H, Wälchli S, Bai B, Smeland EB, Levy R, Kolstad A, Huse K, Myklebust JH (2019)
TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma
Cancer Immunol Res, 7 (3), 355-362
DOI 10.1158/2326-6066.CIR-18-0351, PubMed 30659053

Juraleviciute M, Pozniak J, Nsengimana J, Harland M, Randerson-Moor J, Wernhoff P, Bassarova A, Øy GF, Trøen G, Flørenes VA, Bishop DT, Herlyn M, Newton-Bishop J, Slipicevic A (2019)
MX 2 is a novel regulator of cell cycle in melanoma cells
Pigment Cell Melanoma Res, 33 (3), 446-457
DOI 10.1111/pcmr.12837, PubMed 31660681

Köksal H, Dillard P, Josefsson SE, Maggadottir SM, Pollmann S, Fåne A, Blaker YN, Beiske K, Huse K, Kolstad A, Holte H, Kvalheim G, Smeland EB, Myklebust JH, Inderberg EM, Wälchli S (2019)
Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma
Blood Adv, 3 (8), 1230-1243
DOI 10.1182/bloodadvances.2018029678, PubMed 30979721

Latham ADM, Davidson B, Warburton B, Yockney I, Hampton JO (2019)
Efficacy and Animal Welfare Impacts of Novel Capture Methods for Two Species of Invasive Wild Mammals in New Zealand
Animals (Basel), 10 (1)
DOI 10.3390/ani10010044, PubMed 31878314

Lund-Andersen C, Nakken S, Nygård S, Fromm B, Aasheim LB, Davidson B, Julsrud L, Abrahamsen TW, Kristensen AT, Dybdahl B, Larsen SG, Hovig E, Flatmark K (2019)
Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response
Cold Spring Harb Mol Case Stud, 5 (2)
DOI 10.1101/mcs.a003566, PubMed 30862609

Murali R, Davidson B, Fadare O, Carlson JA, Crum CP, Gilks CB, Irving JA, Malpica A, Matias-Guiu X, McCluggage WG, Mittal K, Oliva E, Parkash V, Rutgers JKL, Staats PN, Stewart CJR, Tornos C, Soslow RA (2019)
High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations
Int J Gynecol Pathol, 38 Suppl 1 (Iss 1 Suppl 1), S40-S63
DOI 10.1097/PGP.0000000000000491, PubMed 30550483

Onallah H, Davidson B, Reich R (2019)
Diverse Effects of Lysophosphatidic Acid Receptors on Ovarian Cancer Signaling Pathways
J Oncol, 2019, 7547469
DOI 10.1155/2019/7547469, PubMed 31636669

Ree AH, Nygaard V, Russnes HG, Heinrich D, Nygaard V, Johansen C, Bergheim IR, Hovig E, Beiske K, Negård A, Børresen-Dale AL, Flatmark K, Mælandsmo GM (2019)
Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain
Cancer Immunol Res, 7 (5), 701-706
DOI 10.1158/2326-6066.CIR-18-0777, PubMed 30804006

Sherman-Samis M, Onallah H, Holth A, Reich R, Davidson B (2019)
SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma
Gynecol Oncol, 153 (3), 651-660
DOI 10.1016/j.ygyno.2019.03.099, PubMed 30904337

Wohlschlaeger J, Davidson B, Worm K, Feist H, Peters J, Hager T, Schmid KW, Ostertag H (2019)
Papilloma of the Fallopian Tube: A Rare Gynecologic Neoplasm Harboring a BRAF (c.1799T>A) Mutation (V600E)
Int J Gynecol Pathol, 38 (5), 459-463
DOI 10.1097/PGP.0000000000000526, PubMed 29851866

Yu Y, Suryo Rahmanto Y, Shen YA, Ardighieri L, Davidson B, Gaillard S, Ayhan A, Shi X, Xuan J, Wang TL, Shih IM (2019)
Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer
EBioMedicine, 47, 184-194
DOI 10.1016/j.ebiom.2019.08.055, PubMed 31492560

Zhou Y, Gerrard DL, Wang J, Li T, Yang Y, Fritz AJ, Rajendran M, Fu X, Stein G, Schiff R, Lin S, Frietze S, Jin VX (2019)
Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistance
Nat Commun, 10 (1), 1522
DOI 10.1038/s41467-019-09320-9, PubMed 30944316

Publications 2018

Agostini A, Brunetti M, Davidson B, Göran Tropé C, Heim S, Panagopoulos I, Micci F (2018)
Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas
Int J Cancer, 143 (6), 1379-1387
DOI 10.1002/ijc.31418, PubMed 29633253

Agostini A, Brunetti M, Davidson B, Tropé CG, Eriksson AGZ, Heim S, Panagopoulos I, Micci F (2018)
The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas
Sci Rep, 8 (1), 11069
DOI 10.1038/s41598-018-29332-7, PubMed 30038317

Berbegall AP, Bogen D, Pötschger U, Beiske K, Bown N, Combaret V, Defferrari R, Jeison M, Mazzocco K, Varesio L, Vicha A, Ash S, Castel V, Coze C, Ladenstein R, Owens C, Papadakis V, Ruud E, Amann G, Sementa AR, Navarro S, Ambros PF, Noguera R, Ambros IM (2018)
Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
Br J Cancer, 118 (11), 1502-1512
DOI 10.1038/s41416-018-0098-6, PubMed 29755120

Brunetti M, Gorunova L, Davidson B, Heim S, Panagopoulos I, Micci F (2018)
Identification of an EPC2-PHF1 fusion transcript in low-grade endometrial stromal sarcoma
Oncotarget, 9 (27), 19203-19208
DOI 10.18632/oncotarget.24969, PubMed 29721194

Brunetti M, Holth A, Panagopoulos I, Staff AC, Micci F, Davidson B (2018)
Expression and clinical role of the dipeptidyl peptidases DPP8 and DPP9 in ovarian carcinoma
Virchows Arch, 474 (2), 177-185
DOI 10.1007/s00428-018-2487-x, PubMed 30467600

Da Broi M, Jahr G, Beiske K, Holte H, Meling TR (2018)
Efficacy of the Nordic and the MSKCC chemotherapy protocols on the overall and progression-free survival in intracranial PCNSL
Blood Cells Mol Dis, 73, 25-32
DOI 10.1016/j.bcmd.2018.08.005, PubMed 30217760

Davidson B (2018)
Circulating tumor cells and cell-free nucleic acids in patients with gynecological malignancies
Virchows Arch, 473 (4), 395-403
DOI 10.1007/s00428-018-2447-5, PubMed 30145616

Davidson B, Bjørnerem M, Holth A, Hellesylt E, Hetland Falkenthal TE, Flørenes VA (2018)
Expression, activation and clinical relevance of CHK1 and CHK2 in metastatic high-grade serous carcinoma
Gynecol Oncol, 150 (1), 136-142
DOI 10.1016/j.ygyno.2018.05.007, PubMed 29804637

Davidson B, Holth A, Wang Z, Hellsylt E, Tropé CG, Hetland Falkenthal TE, Holm R (2018)
Expression of 14-3-3 sigma and eta proteins is unrelated to survival in metastatic high-grade serous carcinoma
APMIS, 126 (4), 309-313
DOI 10.1111/apm.12816, PubMed 29464778

Davidson B, Tötsch M, Wohlschlaeger J, Hager T, Pinamonti M (2018)
The diagnostic role of BAP1 in serous effusions
Hum Pathol, 79, 122-126
DOI 10.1016/j.humpath.2018.05.012, PubMed 29802871

Filippov-Levy N, Cohen-Schussheim H, Tropé CG, Hetland Falkenthal TE, Smith Y, Davidson B, Reich R (2018)
Expression and clinical role of long non-coding RNA in high-grade serous carcinoma
Gynecol Oncol, 148 (3), 559-566
DOI 10.1016/j.ygyno.2018.01.004, PubMed 29310950

Flem Karlsen K, McFadden E, Flørenes VA, Davidson B (2018)
Soluble AXL is ubiquitously present in malignant serous effusions
Gynecol Oncol, 152 (2), 408-415
DOI 10.1016/j.ygyno.2018.11.012, PubMed 30448261

Gerrard DL, Wang Y, Gaddis M, Zhou Y, Wang J, Witt H, Lin S, Farnham PJ, Jin VX, Frietze SE (2018)
Three-dimensional analysis reveals altered chromatin interaction by enhancer inhibitors harbors TCF7L2-regulated cancer gene signature
J Cell Biochem, 120 (3), 3056-3070
DOI 10.1002/jcb.27449, PubMed 30548288

Holte H, Beiske K, Boyle M, Trøen G, Blaker YN, Myklebust J, Kvaløy S, Rosenwald A, Lingjaerde OC, Rimsza LM, Smeland EB, Scott DW, Kolstad A (2018)
The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy
Br J Haematol, 183 (2), 225-234
DOI 10.1111/bjh.15518, PubMed 30080252

Jahr G, Broi MD, Holte H, Beiske K, Meling TR (2018)
Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma
Brain Behav, 8 (3), e00928
DOI 10.1002/brb3.928, PubMed 29541540

Jahr G, Da Broi M, Holte H, Beiske K, Meling TR (2018)
The role of surgery in intracranial PCNSL
Neurosurg Rev, 41 (4), 1037-1044
DOI 10.1007/s10143-018-0946-0, PubMed 29383600

Lønning PE, Berge EO, Bjørnslett M, Minsaas L, Chrisanthar R, Høberg-Vetti H, Dulary C, Busato F, Bjørneklett S, Eriksen C, Kopperud R, Axcrona U, Davidson B, Bjørge L, Evans G, Howell A, Salvesen HB, Janszky I, Hveem K, Romundstad PR, Vatten LJ, Tost J, Dørum A, Knappskog S (2018)
White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk
Ann Intern Med, 168 (5), 326-334
DOI 10.7326/M17-0101, PubMed 29335712

Matias-Guiu X, Davidson B, Lax SF (2018)
Can the classification of low-grade endometrial stromal tumors still be improved?
Virchows Arch, 473 (6), 663-664
DOI 10.1007/s00428-018-2474-2, PubMed 30367239

Meling TR, Latysheva A, Da Broi M, Jahr G, Holte H, Beiske K, Emblem KE (2018)
Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents?
Neuroradiology, 60 (7), 703-713
DOI 10.1007/s00234-018-2038-9, PubMed 29804159

Onallah H, Catane LJ, Tropé CG, Hetland Falkenthal TE, Reich R, Davidson B (2018)
Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma
Virchows Arch, 473 (4), 463-470
DOI 10.1007/s00428-018-2418-x, PubMed 30032361

Poulsen LC, Edelmann RJ, Krüger S, Diéguez-Hurtado R, Shah A, Stav-Noraas TE, Renzi A, Szymanska M, Wang J, Ehling M, Benedito R, Kasprzycka M, Bækkevold E, Sundnes O, Midwood KS, Scott H, Collas P, Siebel CW, Adams RH, Haraldsen G, Sundlisæter E, Hol J (2018)
Inhibition of Endothelial NOTCH1 Signaling Attenuates Inflammation by Reducing Cytokine-Mediated Histone Acetylation at Inflammatory Enhancers
Arterioscler Thromb Vasc Biol, 38 (4), 854-869
DOI 10.1161/ATVBAHA.117.310388, PubMed 29449332

Smogeli E, Cvancarova M, Wang Y, Davidson B, Kristensen G, Lindemann K (2018)
Clinical Outcome of Patients With High-Risk Endometrial Carcinoma After Treatment With Chemotherapy Only
Int J Gynecol Cancer, 28 (9), 1789-1795
DOI 10.1097/IGC.0000000000001356, PubMed 30365455

Wang Z, Førsund MS, Trope CG, Nesland JM, Holm R, Slipicevic A (2018)
Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro
Cancer Med, 7 (8), 3955-3964
DOI 10.1002/cam4.1638, PubMed 29963769

Publications 2017

Agostini A, Brunetti M, Davidson B, Tropé CG, Heim S, Panagopoulos I, Micci F (2017)
Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression
Oncotarget, 8 (13), 21554-21560
DOI 10.18632/oncotarget.15795, PubMed 28423547

Andersson Y, Haavardtun SI, Davidson B, Dørum A, Fleten KG, Fodstad Ø, Flatmark K (2017)
MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancer
Oncotarget, 8 (37), 61800-61809
DOI 10.18632/oncotarget.18694, PubMed 28977905

Batmanov K, Wang J (2017)
Predicting Variation of DNA Shape Preferences in Protein-DNA Interaction in Cancer Cells with a New Biophysical Model
Genes (Basel), 8 (9)
DOI 10.3390/genes8090233, PubMed 28927002

Batmanov K, Wang W, Bjørås M, Delabie J, Wang J (2017)
Integrative whole-genome sequence analysis reveals roles of regulatory mutations in BCL6 and BCL2 in follicular lymphoma
Sci Rep, 7 (1), 7040
DOI 10.1038/s41598-017-07226-4, PubMed 28765546

Brunetti M, Agostini A, Davidson B, Tropé CG, Heim S, Panagopoulos I, Micci F (2017)
Recurrent fusion transcripts in squamous cell carcinomas of the vulva
Oncotarget, 8 (10), 16843-16850
DOI 10.18632/oncotarget.15167, PubMed 28186972

Brunetti M, Panagopoulos I, Gorunova L, Davidson B, Heim S, Micci F (2017)
RNA-sequencing identifies novel GREB1-NCOA2 fusion gene in a uterine sarcoma with the chromosomal translocation t(2;8)(p25;q13)
Genes Chromosomes Cancer, 57 (4), 176-181
DOI 10.1002/gcc.22518, PubMed 29218853

Davidson B, Hellesylt E, Holth A, Danielsen HE, Skeie-Jensen T, Katz B (2017)
Neuron navigator-2 and cyclin D2 are new candidate prognostic markers in uterine sarcoma
Virchows Arch, 471 (3), 355-362
DOI 10.1007/s00428-017-2172-5, PubMed 28643014

Davidson B, Micci F (2017)
Molecular characteristics of uterine sarcomas
Expert Rev Mol Diagn, 17 (5), 515-522
DOI 10.1080/14737159.2017.1311790, PubMed 28335657

Davidson B, Pinamonti M, Cuevas D, Holth A, Zeppa P, Hager T, Wohlschlaeger J, Tötsch M (2017)
The diagnostic role of PTEN and ARID1A in serous effusions
Virchows Arch, 472 (3), 425-432
DOI 10.1007/s00428-017-2273-1, PubMed 29170871

Frøysnes IS, Andersson Y, Larsen SG, Davidson B, Øien JT, Olsen KH, Giercksky KE, Julsrud L, Fodstad Ø, Dueland S, Flatmark K (2017)
Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial
Ann Surg Oncol, 24 (7), 1916-1922
DOI 10.1245/s10434-017-5814-6, PubMed 28224367

Gutgold N, Davidson B, Catane LJ, Holth A, Hellesylt E, Tropé CG, Dørum A, Reich R (2017)
TGFβ splicing and canonical pathway activation in high-grade serous carcinoma
Virchows Arch, 470 (6), 665-678
DOI 10.1007/s00428-017-2127-x, PubMed 28432432

Hardell E, Josefson S, Ghaderi M, Skeie-Jensen T, Westbom-Fremer S, Cheek EH, Bell D, Selling J, Schoolmeester JK, Måsbäck A, Davidson B, Carlson JW (2017)
Validation of a Mitotic Index Cutoff as a Prognostic Marker in Undifferentiated Uterine Sarcomas
Am J Surg Pathol, 41 (9), 1231-1237
DOI 10.1097/PAS.0000000000000894, PubMed 28622181

Harel-Dassa K, Yedgar S, Tropé CG, Davidson B, Reich R (2017)
Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma
Hum Pathol, 62, 115-121
DOI 10.1016/j.humpath.2016.12.023, PubMed 28087476

Josefsson SE, Huse K, Kolstad A, Beiske K, Pende D, Steen CB, Inderberg EM, Lingjærde OC, Østenstad B, Smeland EB, Levy R, Irish JM, Myklebust JH (2017)
T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling
Clin Cancer Res, 24 (4), 870-881
DOI 10.1158/1078-0432.CCR-17-2337, PubMed 29217528

Lewis N, Soslow RA, Delair DF, Park KJ, Murali R, Hollmann TJ, Davidson B, Micci F, Panagopoulos I, Hoang LN, Arias-Stella JA, Oliva E, Young RH, Hensley ML, Leitao MM, Hameed M, Benayed R, Ladanyi M, Frosina D, Jungbluth AA, Antonescu CR, Chiang S (2017)
ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity
Mod Pathol, 31 (4), 674-684
DOI 10.1038/modpathol.2017.162, PubMed 29192652

Li X, Lu J, Kan Q, Li X, Fan Q, Li Y, Huang R, Slipicevic A, Dong HP, Eide L, Wang J, Zhang H, Berge V, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2017)
Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
Sci Rep, 7 (1), 5081
DOI 10.1038/s41598-017-05086-6, PubMed 28698547

Li X, Zhong Y, Lu J, Axcrona K, Eide L, Syljuåsen RG, Peng Q, Wang J, Zhang H, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2017)
Correction: MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
Oncotarget, 8 (4), 7208-7213
DOI 10.18632/oncotarget.14800, PubMed 28179591

Małecka A, Trøen G, Tierens A, Østlie I, Małecki J, Randen U, Wang J, Berentsen S, Tjønnfjord GE, Delabie JMA (2017)
Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease
Br J Haematol, 183 (5), 838-842
DOI 10.1111/bjh.15063, PubMed 29265349

Mantaka P, Malecka A, Trøen G, Helsing P, Gjersvik P, Beiske K, Delabie J (2017)
Folliculotropic Mycosis Fungoides with Skewed T-cell Receptor CDR3 Motif: Suggestive of Lipid-antigen Selection?
Acta Derm Venereol, 97 (9), 1081-1086
DOI 10.2340/00015555-2722, PubMed 28597017

Nastic D, Shanwell E, Wallin KL, Valla M, Måsbäck A, Mateoiu C, Lidang M, Liakka A, Lappi-Blanco E, Grove A, Davidson B, Carpen O, Bertelsen BI, Bak J, Abusland AB, Selling J, Carlson JW (2017)
A Selective Biomarker Panel Increases the Reproducibility and the Accuracy in Endometrial Biopsy Diagnosis
Int J Gynecol Pathol, 36 (4), 339-347
DOI 10.1097/PGP.0000000000000334, PubMed 28244894

Olsen MB, Hildrestrand GA, Scheffler K, Vinge LE, Alfsnes K, Palibrk V, Wang J, Neurauter CG, Luna L, Johansen J, Øgaard JDS, Ohm IK, Slupphaug G, Kuśnierczyk A, Fiane AE, Brorson SH, Zhang L, Gullestad L, Louch WE, Iversen PO, Østlie I, Klungland A, Christensen G, Sjaastad I, Sætrom P et al. (2017)
NEIL3-Dependent Regulation of Cardiac Fibroblast Proliferation Prevents Myocardial Rupture
Cell Rep, 18 (1), 82-92
DOI 10.1016/j.celrep.2016.12.009, PubMed 28052262

Panagopoulos I, Gorunova L, Spetalen S, Bassarova A, Beiske K, Micci F, Heim S (2017)
Fusion of the genes ataxin 2 like, ATXN2L, and Janus kinase 2, JAK2, in cutaneous CD4 positive T-cell lymphoma
Oncotarget, 8 (61), 103775-103784
DOI 10.18632/oncotarget.21790, PubMed 29262599

Phippen NT, Secord AA, Wolf S, Samsa G, Davidson B, Abernethy AP, Cella D, Havrilesky LJ, Burger RA, Monk BJ, Leath CA (2017)
Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study
Gynecol Oncol, 147 (1), 98-103
DOI 10.1016/j.ygyno.2017.07.121, PubMed 28743369

Pihlstrøm HK, Gatti F, Hammarström C, Eide IA, Kasprzycka M, Wang J, Haraldsen G, Svensson MHS, Midtvedt K, Mjøen G, Dahle DO, Hartmann A, Holdaas H (2017)
Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study
Transpl Int, 30 (8), 827-840
DOI 10.1111/tri.12973, PubMed 28436117

Querleu D, Planchamp F, Chiva L, Fotopoulou C, Barton D, Cibula D, Aletti G, Carinelli S, Creutzberg C, Davidson B, Harter P, Lundvall L, Marth C, Morice P, Rafii A, Ray-Coquard I, Rockall A, Sessa C, van der Zee A, Vergote I, duBois A (2017)
European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery
Int J Gynecol Cancer, 27 (7), 1534-1542
DOI 10.1097/IGC.0000000000001041, PubMed 30814245

Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA et al. (2017)
Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate
ESMO Open, 2 (2), e000158
DOI 10.1136/esmoopen-2017-000158, PubMed 28761742

Smebye ML, Agostini A, Johannessen B, Thorsen J, Davidson B, Tropé CG, Heim S, Skotheim RI, Micci F (2017)
Involvement of DPP9 in gene fusions in serous ovarian carcinoma
BMC Cancer, 17 (1), 642
DOI 10.1186/s12885-017-3625-6, PubMed 28893231

Solheim O, Førsund M, Tropé CG, Kraggerud SM, Nesland JM, Davidson B (2017)
Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors
APMIS, 125 (9), 781-786
DOI 10.1111/apm.12715, PubMed 28585395

Torkildsen S, Brunetti M, Gorunova L, Spetalen S, Beiske K, Heim S, Panagopoulos I (2017)
Rearrangement of the Chromatin Organizer Special AT-rich Binding Protein 1 Gene, SATB1, Resulting from a t(3;5)(p24;q14) Chromosomal Translocation in Acute Myeloid Leukemia
Anticancer Res, 37 (2), 693-698
DOI 10.21873/anticanres.11365, PubMed 28179318

Valente R, Lykoudis P, Tamburrino D, Inama M, Passas I, Toumpanakis C, Luong TV, Davidson B, Imber C, Malagò M, Rahman SH, Shankar A, Sharma D, Caplin M, Fusai G (2017)
Major postoperative complications after pancreatic resection for P-NETS are not associated to earlier recurrence
Eur J Surg Oncol, 43 (11), 2119-2128
DOI 10.1016/j.ejso.2017.07.012, PubMed 28821361

Publications 2016

Agostini A, Brunetti M, Davidson B, Trope CG, Heim S, Panagopoulos I, Micci F (2016)
Expressions of miR-30c and let-7a are inversely correlated with HMGA2 expression in squamous cell carcinoma of the vulva
Oncotarget, 7 (51), 85058-85062
DOI 10.18632/oncotarget.13187, PubMed 27835588

Agostini A, Panagopoulos I, Davidson B, Trope CG, Heim S, Micci F (2016)
A novel truncated form of HMGA2 in tumors of the ovaries
Oncol Lett, 12 (2), 1559-1563
DOI 10.3892/ol.2016.4805, PubMed 27446471

Blaker YN, Spetalen S, Brodtkorb M, Lingjaerde OC, Beiske K, Østenstad B, Sander B, Wahlin BE, Melen CM, Myklebust JH, Holte H, Delabie J, Smeland EB (2016)
The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era
Br J Haematol, 175 (1), 102-14
DOI 10.1111/bjh.14201, PubMed 27341313

Broner EC, Tropé CG, Reich R, Davidson B (2016)
TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma
Hum Pathol, 60, 180-187
DOI 10.1016/j.humpath.2016.10.017, PubMed 27825812

Burchill SA, Beiske K, Shimada H, Ambros PF, Seeger R, Tytgat GA, Brock PR, Haber M, Park JR, Berthold F (2016)
Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group
Cancer, 123 (7), 1095-1105
DOI 10.1002/cncr.30380, PubMed 27984660

Davidson B (2016)
Recently identified drug resistance biomarkers in ovarian cancer
Expert Rev Mol Diagn, 16 (5), 569-78
DOI 10.1586/14737159.2016.1156532, PubMed 26895188

Davidson B (2016)
Malignant Nonhematological Effusion Characterization by Flow Cytometry
Acta Cytol, 60 (4), 365-371
DOI 10.1159/000447687, PubMed 27532128

Davidson B (2016)
CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells
Hum Pathol, 58, 123-127
DOI 10.1016/j.humpath.2016.08.005, PubMed 27589896

Davidson B, Kjæreng ML, Førsund M, Danielsen HE, Kristensen GB, Abeler VM (2016)
Progesterone Receptor Expression Is an Independent Prognosticator in FIGO Stage I Uterine Leiomyosarcoma
Am J Clin Pathol, 145 (4), 449-58
DOI 10.1093/ajcp/aqw030, PubMed 27149024

Davidson B, Valborg Reinertsen K, Trinh D, Reed W, Bøhler PJ (2016)
BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma
Hum Pathol, 54, 64-73
DOI 10.1016/j.humpath.2016.02.023, PubMed 27038683

Egeland EV, Flatmark K, Nesland JM, Flørenes VA, Mælandsmo GM, Boye K (2016)
Expression and clinical significance of Wee1 in colorectal cancer
Tumour Biol, 37 (9), 12133-12140
DOI 10.1007/s13277-016-5081-3, PubMed 27220319

Fleten KG, Flørenes VA, Prasmickaite L, Hill O, Sykora J, Mælandsmo GM, Engesæter B (2016)
hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma
Cell Death Discov, 2, 16081
DOI 10.1038/cddiscovery.2016.81, PubMed 28028438

Horwitz V, Davidson B, Stern D, Tropé CG, Tavor Re'em T, Reich R (2016)
Ezrin Is Associated with Disease Progression in Ovarian Carcinoma
PLoS One, 11 (9), e0162502
DOI 10.1371/journal.pone.0162502, PubMed 27622508

Jung JG, Shih IM, Park JT, Gerry E, Kim TH, Ayhan A, Handschuh K, Davidson B, Fader AN, Selleri L, Wang TL (2016)
Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1
Cancer Res, 76 (21), 6351-6361
DOI 10.1158/0008-5472.CAN-16-0980, PubMed 27590741

Lee JC, Lu TP, Changou CA, Liang CW, Huang HN, Lauria A, Huang HY, Lin CY, Chiang YC, Davidson B, Lin MC, Kuo KT (2016)
Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup
Mod Pathol, 29 (9), 1070-82
DOI 10.1038/modpathol.2016.99, PubMed 27255164

Lehtinen L, Vesterkvist P, Roering P, Korpela T, Hattara L, Kaipio K, Mpindi JP, Hynninen J, Auranen A, Davidson B, Haglund C, Iljin K, Grenman S, Siitari H, Carpen O (2016)
REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker
PLoS One, 11 (3), e0151590
DOI 10.1371/journal.pone.0151590, PubMed 26981633

Li X, Zhong Y, Lu J, Axcrona K, Eide L, Syljuåsen RG, Peng Q, Wang J, Zhang H, Goscinski MA, Kvalheim G, Nesland JM, Suo Z (2016)
MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features
Oncotarget, 7 (26), 40297-40313
DOI 10.18632/oncotarget.9610, PubMed 27248169

Micci F, Gorunova L, Agostini A, Johannessen LE, Brunetti M, Davidson B, Heim S, Panagopoulos I (2016)
Cytogenetic and molecular profile of endometrial stromal sarcoma
Genes Chromosomes Cancer, 55 (11), 834-46
DOI 10.1002/gcc.22380, PubMed 27219024

Michael CW, Davidson B (2016)
Pre-analytical issues in effusion cytology
Pleura Peritoneum, 1 (1), 45-56
DOI 10.1515/pp-2016-0001, PubMed 30911607

Myklebust JH, Brody J, Kohrt HE, Kolstad A, Czerwinski DK, Wälchli S, Green MR, Trøen G, Liestøl K, Beiske K, Houot R, Delabie J, Alizadeh AA, Irish JM, Levy R (2016)
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling
Blood, 129 (6), 759-770
DOI 10.1182/blood-2016-05-718494, PubMed 28011673

Nymoen DA, Slipicevic A, Holth A, Emilsen E, Hetland Falkenthal TE, Tropé CG, Reich R, Flørenes VA, Davidson B (2016)
MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma
Hum Pathol, 54, 74-81
DOI 10.1016/j.humpath.2016.03.010, PubMed 27063471

Querleu D, Planchamp F, Chiva L, Fotopoulou C, Barton D, Cibula D, Aletti G, Carinelli S, Creutzberg C, Davidson B, Harter P, Lundvall L, Marth C, Morice P, Rafii A, Ray-Coquard I, Rockall A, Sessa C, van der Zee A, Vergote I, du Bois A (2016)
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer Surgery
Int J Gynecol Cancer, 26 (7), 1354-63
DOI 10.1097/IGC.0000000000000767, PubMed 27648648

Ravid Y, Formanski M, Smith Y, Reich R, Davidson B (2016)
Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures
Gynecol Oncol, 140 (3), 512-7
DOI 10.1016/j.ygyno.2016.01.001, PubMed 26768834

Smebye ML, Haugom L, Davidson B, Trope CG, Heim S, Skotheim RI, Micci F (2016)
Bilateral ovarian carcinomas differ in the expression of metastasis-related genes
Oncol Lett, 13 (1), 184-190
DOI 10.3892/ol.2016.5384, PubMed 28123539

Smogeli E, Davidson B, Cvancarova M, Holth A, Katz B, Risberg B, Kristensen G, Lindemann K (2016)
L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
BMC Cancer, 16, 596
DOI 10.1186/s12885-016-2631-4, PubMed 27488577

Tambe M, Pruikkonen S, Mäki-Jouppila J, Chen P, Elgaaen BV, Straume AH, Huhtinen K, Cárpen O, Lønning PE, Davidson B, Hautaniemi S, Kallio MJ (2016)
Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells' sensitivity to paclitaxel
Oncotarget, 7 (11), 12267-85
DOI 10.18632/oncotarget.7860, PubMed 26943585

van der Putten LJ, van de Vijver K, Bartosch C, Davidson B, Gatius S, Matias-Guiu X, McCluggage WG, Toledo G, van der Wurff AA, Pijnenborg JM, Massuger LF, Bulten J (2016)
Reproducibility of measurement of myometrial invasion in endometrial carcinoma
Virchows Arch, 470 (1), 63-68
DOI 10.1007/s00428-016-2035-5, PubMed 27787595

Wang J, Wu Q, Hu XT, Tian T (2016)
An integrated approach to infer dynamic protein-gene interactions - A case study of the human P53 protein
Methods, 110, 3-13
DOI 10.1016/j.ymeth.2016.08.001, PubMed 27514497

Publications 2015

Agostini A, Panagopoulos I, Andersen HK, Johannesen LE, Davidson B, Tropé CG, Heim S, Micci F (2015)
HMGA2 expression pattern and TERT mutations in tumors of the vulva
Oncol Rep, 33 (6), 2675-80
DOI 10.3892/or.2015.3882, PubMed 25823555

Bartlett TE, Jones A, Goode EL, Fridley BL, Cunningham JM, Berns EM, Wik E, Salvesen HB, Davidson B, Trope CG, Lambrechts S, Vergote I, Widschwendter M (2015)
Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers
PLoS One, 10 (12), e0143178
DOI 10.1371/journal.pone.0143178, PubMed 26629914

Crossan C, Tsochatzis EA, Longworth L, Gurusamy K, Papastergiou V, Thalassinos E, Mantzoukis K, Rodriguez-Peralvarez M, O'Brien J, Noel-Storr A, Papatheodoridis GV, Davidson B, Burroughs AK (2015)
Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis B in the UK: systematic review and economic evaluation
J Viral Hepat, 23 (2), 139-49
DOI 10.1111/jvh.12469, PubMed 26444996

Davidson B (2015)
Prognostic factors in malignant pleural mesothelioma
Hum Pathol, 46 (6), 789-804
DOI 10.1016/j.humpath.2015.02.006, PubMed 25824607

Davidson B, Holth A, Hellesylt E, Hadar R, Katz B, Tropé CG, Reich R (2015)
HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival
Hum Pathol, 48, 95-101
DOI 10.1016/j.humpath.2015.09.027, PubMed 26640230

Davidson B, Stavnes HT, Hellesylt E, Hager T, Zeppa P, Pinamonti M, Wohlschlaeger J (2015)
MMP-7 is a highly specific negative marker for benign and malignant mesothelial cells in serous effusions
Hum Pathol, 47 (1), 104-8
DOI 10.1016/j.humpath.2015.08.020, PubMed 26520416

Eide N, Garred Ø, Beiske K, Fodstad Ø (2015)
Bilateral uveal melanomas with different gene expression detected with 7 years interval
Acta Ophthalmol, 94 (1), 99-102
DOI 10.1111/aos.12857, PubMed 26496992

Flørenes VA, Emilsen E, Dong HP, Førsund M, Holm R, Slipicevic A (2015)
Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma
Cancer Med, 4 (6), 903-13
DOI 10.1002/cam4.425, PubMed 25663244

Hjerpe A, Ascoli V, Bedrossian C, Boon M, Creaney J, Davidson B, Dejmek A, Dobra K, Fassina A, Field A, Firat P, Kamei T, Kobayashi T, Michael CW, Önder S, Segal A, Vielh P (2015)
Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
Cytojournal, 12, 26
DOI 10.4103/1742-6413.170726, PubMed 26681974

Hjerpe A, Ascoli V, Bedrossian CW, Boon ME, Creaney J, Davidson B, Dejmek A, Dobra K, Fassina A, Field A, Firat P, Kamei T, Kobayashi T, Michael CW, Önder S, Segal A, Vielh P (2015)
Guidelines for the Cytopathologic Diagnosis of Epithelioid and Mixed-Type Malignant Mesothelioma: a secondary publication
Cytopathology, 26 (3), 142-56
DOI 10.1111/cyt.12250, PubMed 26052757

Hjerpe A, Ascoli V, Bedrossian CW, Boon ME, Creaney J, Davidson B, Dejmek A, Dobra K, Fassina A, Field A, Firat P, Kamei T, Kobayashi T, Michael CW, Önder S, Segal A, Vielh P, International Mesothelioma Interest Group, International Academy of Cytology (2015)
Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
Diagn Cytopathol, 43 (7), 563-76
DOI 10.1002/dc.23271, PubMed 26100969

Hjerpe A, Ascoli V, Bedrossian CWM, Boon ME, Creaney J, Davidson B, Dejmek A, Dobra K, Fassina A, Field A, Firat P, Kamei T, Kobayashi T, Michael CW, Önder S, Segal A, Vielh P (2015)
Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
Acta Cytol, 59 (1), 2-16
DOI 10.1159/000377697, PubMed 25824655

Howell VM, Davidson B (2015)
Editorial: Advances in Epithelial Ovarian Cancer: Model Systems, Microenvironmental Influences, Therapy, and Origins
Front Oncol, 5, 205
DOI 10.3389/fonc.2015.00205, PubMed 26442217

Huang R, Wang J, Zhong Y, Liu Y, Stokke T, Trope CG, Nesland JM, Suo Z (2015)
Mitochondrial DNA Deficiency in Ovarian Cancer Cells and Cancer Stem Cell-like Properties
Anticancer Res, 35 (7), 3743-53
PubMed 26124317

Jakobsson ME, Moen A, Davidson B, Falnes PØ (2015)
Hsp70 (HSPA1) Lysine Methylation Status as a Potential Prognostic Factor in Metastatic High-Grade Serous Carcinoma
PLoS One, 10 (10), e0140168
DOI 10.1371/journal.pone.0140168, PubMed 26448330

Katz B, Tropé CG, Reich R, Davidson B (2015)
MicroRNAs in Ovarian Cancer
Hum Pathol, 46 (9), 1245-56
DOI 10.1016/j.humpath.2015.06.013, PubMed 26216350

Kolberg M, Høland M, Lind GE, Ågesen TH, Skotheim RI, Hall KS, Mandahl N, Smeland S, Mertens F, Davidson B, Lothe RA (2015)
Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours--A prognostic test after surgical resection
Mol Oncol, 9 (6), 1129-39
DOI 10.1016/j.molonc.2015.02.005, PubMed 25769404

Magnussen GI, Emilsen E, Giller Fleten K, Engesæter B, Nähse-Kumpf V, Fjær R, Slipicevic A, Flørenes VA (2015)
Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma
BMC Cancer, 15, 462
DOI 10.1186/s12885-015-1474-8, PubMed 26054341

Malik H, Khan AZ, Berry DP, Cameron IC, Pope I, Sherlock D, Helmy S, Byrne B, Thompson M, Pulfer A, Davidson B (2015)
Liver resection rate following downsizing chemotherapy with cetuximab in metastatic colorectal cancer: UK retrospective observational study
Eur J Surg Oncol, 41 (4), 499-505
DOI 10.1016/j.ejso.2015.01.032, PubMed 25703078

McCluggage WG, Judge MJ, Clarke BA, Davidson B, Gilks CB, Hollema H, Ledermann JA, Matias-Guiu X, Mikami Y, Stewart CJ, Vang R, Hirschowitz L, International Collaboration on Cancer Reporting (2015)
Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
Mod Pathol, 28 (8), 1101-22
DOI 10.1038/modpathol.2015.77, PubMed 26089092

Monclair T, Ruud E, Holmstrom H, Aagenaes I, Asplin M, Beiske K (2015)
Extra-adrenal composite phaeochromocytoma/neuroblastoma in a 15-month-old child
J. Pediatr. Surg. Case Rep., 3 (8), 348-350
DOI 10.1016/j.epsc.2015.06.014

Monclair T, Ruud E, Holmstrøm HA, Aagenæs I, Asplin Marius, Beiske K (2015)
Extra-adrenal composite phaechromocytoma/neuroblastoma in a 15-month-old child
Journal of Pediatric Surgery CASE REPORTS, 3, 348-350
PublikaID 226

Nymoen DA, Hetland Falkenthal TE, Holth A, Ow GS, Ivshina AV, Tropé CG, Kuznetsov VA, Staff AC, Davidson B (2015)
Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma
Gynecol Oncol, 139 (1), 30-9
DOI 10.1016/j.ygyno.2015.07.107, PubMed 26232338

Nymoen DA, Holth A, Hetland Falkenthal TE, Tropé CG, Davidson B (2015)
CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma
Mol Cancer, 14, 44
DOI 10.1186/s12943-015-0317-1, PubMed 25889687

Oliver D, Ledger J, Davidson B, Thompson N, Northern Nutrition Network (2015)
Developing regional nutrition team training across the North-East of England: reporting on the first nutrition team course run by the Northern Nutrition Network
Clin Nutr ESPEN, 10 (5), e194
DOI 10.1016/j.clnesp.2015.03.041, PubMed 28531510

Slipicevic A, Herlyn M (2015)
KIT in melanoma: many shades of gray
J Invest Dermatol, 135 (2), 337-338
DOI 10.1038/jid.2014.417, PubMed 25573046

Tangen JM, Tierens A, Caers J, Binsfeld M, Olstad OK, Trøseid AM, Wang J, Tjønnfjord GE, Hetland G (2015)
Immunomodulatory effects of the Agaricus blazei Murrill-based mushroom extract AndoSan in patients with multiple myeloma undergoing high dose chemotherapy and autologous stem cell transplantation: a randomized, double blinded clinical study
Biomed Res Int, 2015, 718539
DOI 10.1155/2015/718539, PubMed 25664323

Teschendorff AE, Lee SH, Jones A, Fiegl H, Kalwa M, Wagner W, Chindera K, Evans I, Dubeau L, Orjalo A, Horlings HM, Niederreiter L, Kaser A, Yang W, Goode EL, Fridley BL, Jenner RG, Berns EM, Wik E, Salvesen HB, Wisman GB, van der Zee AG, Davidson B, Trope CG, Lambrechts S et al. (2015)
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Genome Med, 7, 108
DOI 10.1186/s13073-015-0233-4, PubMed 26497652

Tjønnfjord GE, Ly BE, Johannesen TB, Tierens A, Beiske K, Heim S, Jønsson V (2015)
[Chronic lymphatic leukemia in Norway-incidence and prognosis at diagnosis time]
Tidsskr Nor Laegeforen, 135 (18), 1626
DOI 10.4045/tidsskr.15.0946, PubMed 26442726

Torkildsen S, Gorunova L, Beiske K, Tjønnfjord GE, Heim S, Panagopoulos I (2015)
Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32)
PLoS One, 10 (7), e0132736
DOI 10.1371/journal.pone.0132736, PubMed 26186352

Wang J, Batmanov K (2015)
BayesPI-BAR: a new biophysical model for characterization of regulatory sequence variations
Nucleic Acids Res, 43 (21), e147
DOI 10.1093/nar/gkv733, PubMed 26202972

Wang J, Malecka A, Trøen G, Delabie J (2015)
Comprehensive genome-wide transcription factor analysis reveals that a combination of high affinity and low affinity DNA binding is needed for human gene regulation
BMC Genomics, 16 Suppl 7 (Suppl 7), S12
DOI 10.1186/1471-2164-16-S7-S12, PubMed 26099425

Wang JB, Wu QQ, Tian TH (2015)
Integrated Study to Infer Dynamic Protein-gene Interactions in human P53 Regulatory Networks
IEEE INT C BIOINFORM, 273-276

Wang Z, Slipicevic A, Førsund M, Trope CG, Nesland JM, Holm R (2015)
Expression of CDK1(Tyr15), pCDK1(Thr161), Cyclin B1 (total) and pCyclin B1(Ser126) in vulvar squamous cell carcinoma and their relations with clinicopatological features and prognosis
PLoS One, 10 (4), e0121398
DOI 10.1371/journal.pone.0121398, PubMed 25849598

Yu Y, Gaillard S, Phillip JM, Huang TC, Pinto SM, Tessarollo NG, Zhang Z, Pandey A, Wirtz D, Ayhan A, Davidson B, Wang TL, Shih IeM (2015)
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
Cancer Cell, 28 (1), 82-96
DOI 10.1016/j.ccell.2015.05.009, PubMed 26096845

Publications 2014

Brustugun OT, Khattak AM, Trømborg AK, Beigi M, Beiske K, Lund-Iversen M, Helland Å (2014)
BRAF-mutations in non-small cell lung cancer
Lung Cancer, 84 (1), 36-8
DOI 10.1016/j.lungcan.2014.01.023, PubMed 24552757

Davidson B, Holth A, Hellesylt E, Tan TZ, Huang RY, Tropé C, Nesland JM, Thiery JP (2014)
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions
Hum Pathol, 46 (1), 1-8
DOI 10.1016/j.humpath.2014.10.004, PubMed 25455994

Davidson B, Nymoen DA, Elgaaen BV, Staff AC, Tropé CG, Kærn J, Reich R, Falkenthal TE (2014)
BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma
Virchows Arch, 464 (6), 701-7
DOI 10.1007/s00428-014-1577-7, PubMed 24756216

Davidson B, Rosenfeld YB, Holth A, Hellesylt E, Tropé CG, Reich R, Yisraeli JK (2014)
VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival
Hum Pathol, 45 (7), 1520-8
DOI 10.1016/j.humpath.2014.03.005, PubMed 24814803

Davidson B, Tropé CG (2014)
Ovarian cancer: diagnostic, biological and prognostic aspects
Womens Health (Lond), 10 (5), 519-33
DOI 10.2217/whe.14.37, PubMed 25335543

Davidson B, Tropé CG, Reich R (2014)
The clinical and diagnostic role of microRNAs in ovarian carcinoma
Gynecol Oncol, 133 (3), 640-6
DOI 10.1016/j.ygyno.2014.03.575, PubMed 24713546

Davidson B, Trope CG, Reich R (2014)
The role of the tumor stroma in ovarian cancer
Front Oncol, 4, 104
DOI 10.3389/fonc.2014.00104, PubMed 24860785

Defferrari R, Mazzocco K, Ambros IM, Ambros PF, Bedwell C, Beiske K, Bénard J, Berbegall AP, Bown N, Combaret V, Couturier J, Erminio G, Gambini C, Garaventa A, Gross N, Haupt R, Kohler J, Jeison M, Lunec J, Marques B, Martinsson T, Noguera R, Parodi S, Schleiermacher G, Tweddle DA et al. (2014)
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification
Br J Cancer, 112 (2), 290-5
DOI 10.1038/bjc.2014.557, PubMed 25356804

Fiskvik I, Beiske K, Delabie J, Yri O, Spetalen S, Karjalainen-Lindsberg ML, Leppä S, Liestøl K, Smeland EB, Holte H (2014)
Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma
Leuk Lymphoma, 56 (6), 1742-9
DOI 10.3109/10428194.2014.970550, PubMed 25284491

Laporte M, Keller HH, Payette H, Allard JP, Duerksen DR, Bernier P, Jeejeebhoy K, Gramlich L, Davidson B, Vesnaver E, Teterina A (2014)
Validity and reliability of the new Canadian Nutrition Screening Tool in the 'real-world' hospital setting
Eur J Clin Nutr, 69 (5), 558-64
DOI 10.1038/ejcn.2014.270, PubMed 25514899

Maimon A, Mogilevsky M, Shilo A, Golan-Gerstl R, Obiedat A, Ben-Hur V, Lebenthal-Loinger I, Stein I, Reich R, Beenstock J, Zehorai E, Andersen CL, Thorsen K, Ørntoft TF, Davis RJ, Davidson B, Mu D, Karni R (2014)
Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformation
Cell Rep, 7 (2), 501-513
DOI 10.1016/j.celrep.2014.03.041, PubMed 24726367

Matias-Guiu X, Davidson B (2014)
Prognostic biomarkers in endometrial and ovarian carcinoma
Virchows Arch, 464 (3), 315-31
DOI 10.1007/s00428-013-1509-y, PubMed 24504546

Micci F, Gorunova L, Gatius S, Matias-Guiu X, Davidson B, Heim S, Panagopoulos I (2014)
MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma
Cancer Lett, 347 (1), 75-8
DOI 10.1016/j.canlet.2014.01.030, PubMed 24530230

Micci F, Haugom L, Abeler VM, Davidson B, Tropé CG, Heim S (2014)
Genomic profile of ovarian carcinomas
BMC Cancer, 14, 315
DOI 10.1186/1471-2407-14-315, PubMed 24886194

Micci F, Panagopoulos I, Thorsen J, Davidson B, Tropé CG, Heim S (2014)
Low frequency of ESRRA-C11orf20 fusion gene in ovarian carcinomas
PLoS Biol, 12 (2), e1001784
DOI 10.1371/journal.pbio.1001784, PubMed 24504521

Panagopoulos I, Gorunova L, Davidson B, Heim S (2014)
Novel TNS3-MAP3K3 and ZFPM2-ELF5 fusion genes identified by RNA sequencing in multicystic mesothelioma with t(7;17)(p12;q23) and t(8;11)(q23;p13)
Cancer Lett, 357 (2), 502-9
DOI 10.1016/j.canlet.2014.12.002, PubMed 25484136

Shen B, Ma J, Wang J, Wang J (2014)
Biomedical informatics and computational biology for high-throughput data analysis
ScientificWorldJournal, 2014, 398181
DOI 10.1155/2014/398181, PubMed 24688384

Slipicevic A, Holth A, Hellesylt E, Tropé CG, Davidson B, Flørenes VA (2014)
Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions
Gynecol Oncol, 135 (1), 118-24
DOI 10.1016/j.ygyno.2014.07.102, PubMed 25093290

Slipicevic A, Somasundaram R, Sproesser K, Herlyn M (2014)
Isolation of melanoma cell subpopulations using negative selection
Methods Mol Biol, 1102, 501-12
DOI 10.1007/978-1-62703-727-3_26, PubMed 24258995

Smebye ML, Sveen A, Haugom L, Davidson B, Tropé CG, Lothe RA, Heim S, Skotheim RI, Micci F (2014)
Chromosome 19 rearrangements in ovarian carcinomas: zinc finger genes are particularly targeted
Genes Chromosomes Cancer, 53 (7), 558-67
DOI 10.1002/gcc.22166, PubMed 24634323

Tuft Stavnes H, Nymoen DA, Hetland Falkenthal TE, Kærn J, Tropé CG, Davidson B (2014)
APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival
Am J Clin Pathol, 142 (1), 51-7
DOI 10.1309/AJCPD8NBSHXRXQL7, PubMed 24926085

Vaksman O, Tropé C, Davidson B, Reich R (2014)
Exosome-derived miRNAs and ovarian carcinoma progression
Carcinogenesis, 35 (9), 2113-20
DOI 10.1093/carcin/bgu130, PubMed 24925027

Vilming Elgaaen B, Olstad OK, Haug KB, Brusletto B, Sandvik L, Staff AC, Gautvik KM, Davidson B (2014)
Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker
BMC Cancer, 14, 80
DOI 10.1186/1471-2407-14-80, PubMed 24512620

Wang J (2014)
Quality versus accuracy: result of a reanalysis of protein-binding microarrays from the DREAM5 challenge by using BayesPI2 including dinucleotide interdependence
BMC Bioinformatics, 15 (1), 289
DOI 10.1186/1471-2105-15-289, PubMed 25158938

Ward LD, Wang J, Bussemaker HJ (2014)
Characterizing a collective and dynamic component of chromatin immunoprecipitation enrichment profiles in yeast
BMC Genomics, 15 (1), 494
DOI 10.1186/1471-2164-15-494, PubMed 24947676

Webster MR, Xu M, Kinzler KA, Kaur A, Appleton J, O'Connell MP, Marchbank K, Valiga A, Dang VM, Perego M, Zhang G, Slipicevic A, Keeney F, Lehrmann E, Wood W, Becker KG, Kossenkov AV, Frederick DT, Flaherty KT, Xu X, Herlyn M, Murphy ME, Weeraratna AT (2014)
Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells
Pigment Cell Melanoma Res, 28 (2), 184-95
DOI 10.1111/pcmr.12330, PubMed 25407936

Publications 2013

Azad N, Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan A, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC (2013)
Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort
Mol Cell Proteomics, 12 (6), 1621-31
DOI 10.1074/mcp.M112.026427, PubMed 23449826

Davidson B (2013)
Hepatocyte nuclear factor-1β is not a specific marker of clear cell carcinoma in serous effusions
Cancer Cytopathol, 122 (2), 153-8
DOI 10.1002/cncy.21353, PubMed 24115587

Davidson B, Abeler VM, Førsund M, Holth A, Yang Y, Kobayashi Y, Chen L, Kristensen GB, Shih IeM, Wang TL (2013)
Gene expression signatures of primary and metastatic uterine leiomyosarcoma
Hum Pathol, 45 (4), 691-700
DOI 10.1016/j.humpath.2013.11.003, PubMed 24485798

Davidson B, Smith Y, Nesland JM, Kærn J, Reich R, Tropè CG (2013)
Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion
Hum Pathol, 44 (11), 2449-60
DOI 10.1016/j.humpath.2013.06.003, PubMed 24011953

Flatmark K, Guldvik IJ, Svensson H, Fleten KG, Flørenes VA, Reed W, Giercksky KE, Fodstad Ø, Andersson Y (2013)
Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies
Int J Cancer, 133 (6), 1497-506
DOI 10.1002/ijc.28158, PubMed 23494569

Fløisand Y, Beiske K, Tjønnfjord GE, Heldal D, Bjerkehagen B, Revheim ME, Heim S, Bruland OS, Hall KS, Tierens A, Delabie J (2013)
Malignant phyllodes tumor and acute megakaryoblastic leukemia sharing a common clonal origin
Case Rep Hematol, 2013, 934781
DOI 10.1155/2013/934781, PubMed 24455338

Hoang LN, McConechy MK, Köbel M, Han G, Rouzbahman M, Davidson B, Irving J, Ali RH, Leung S, McAlpine JN, Oliva E, Nucci MR, Soslow RA, Huntsman DG, Gilks CB, Lee CH (2013)
Histotype-genotype correlation in 36 high-grade endometrial carcinomas
Am J Surg Pathol, 37 (9), 1421-32
DOI 10.1097/PAS.0b013e31828c63ed, PubMed 24076778

Keller HH, Vesnaver E, Davidson B, Allard J, Laporte M, Bernier P, Payette H, Jeejeebhoy K, Duerksen D, Gramlich L (2013)
Providing quality nutrition care in acute care hospitals: perspectives of nutrition care personnel
J Hum Nutr Diet, 27 (2), 192-202
DOI 10.1111/jhn.12170, PubMed 24147893

Kohler JA, Rubie H, Castel V, Beiske K, Holmes K, Gambini C, Casale F, Munzer C, Erminio G, Parodi S, Navarro S, Marquez C, Peuchmaur M, Cullinane C, Brock P, Valteau-Couanet D, Garaventa A, Haupt R (2013)
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study
Eur J Cancer, 49 (17), 3671-9
DOI 10.1016/j.ejca.2013.07.002, PubMed 23907002

Magnussen GI, Hellesylt E, Nesland JM, Trope CG, Flørenes VA, Holm R (2013)
High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients
BMC Cancer, 13, 288
DOI 10.1186/1471-2407-13-288, PubMed 23767999

Micci F, Panagopoulos I, Haugom L, Dahlback HS, Pretorius ME, Davidson B, Abeler VM, Tropé CG, Danielsen HE, Heim S (2013)
Genomic aberration patterns and expression profiles of squamous cell carcinomas of the vulva
Genes Chromosomes Cancer, 52 (6), 551-63
DOI 10.1002/gcc.22053, PubMed 23404381

Panagopoulos I, Thorsen J, Gorunova L, Haugom L, Bjerkehagen B, Davidson B, Heim S, Micci F (2013)
Fusion of the ZC3H7B and BCOR genes in endometrial stromal sarcomas carrying an X;22-translocation
Genes Chromosomes Cancer, 52 (7), 610-8
DOI 10.1002/gcc.22057, PubMed 23580382

Panagopoulos I, Thorsen J, Gorunova L, Micci F, Haugom L, Davidson B, Heim S (2013)
RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22)(q32;q12)
Genes Chromosomes Cancer, 52 (8), 733-40
DOI 10.1002/gcc.22068, PubMed 23630070

Randen U, Trøen G, Tierens A, Steen C, Warsame A, Beiske K, Tjønnfjord GE, Berentsen S, Delabie J (2013)
Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma
Haematologica, 99 (3), 497-504
DOI 10.3324/haematol.2013.091702, PubMed 24143001

Stavnes HT, Holth A, Don T, Kærn J, Vaksman O, Reich R, Trope' CG, Davidson B (2013)
HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival
Gynecol Oncol, 129 (2), 358-63
DOI 10.1016/j.ygyno.2013.02.021, PubMed 23438671

Tan TZ, Miow QH, Huang RY, Wong MK, Ye J, Lau JA, Wu MC, Bin Abdul Hadi LH, Soong R, Choolani M, Davidson B, Nesland JM, Wang LZ, Matsumura N, Mandai M, Konishi I, Goh BC, Chang JT, Thiery JP, Mori S (2013)
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
EMBO Mol Med, 5 (7), 1051-66
DOI 10.1002/emmm.201201823, PubMed 23666744

Vaksman O, Davidson B, Tropé C, Reich R (2013)
Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases
Hum Pathol, 44 (12), 2677-83
DOI 10.1016/j.humpath.2013.07.009, PubMed 24060004

Vettukattil R, Hetland TE, Flørenes VA, Kærn J, Davidson B, Bathen TF (2013)
Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma
Hum Pathol, 44 (9), 1859-66
DOI 10.1016/j.humpath.2013.02.009, PubMed 23656974

Wang J, Lan X, Hsu PY, Hsu HK, Huang K, Parvin J, Huang TH, Jin VX (2013)
Genome-wide analysis uncovers high frequency, strong differential chromosomal interactions and their associated epigenetic patterns in E2-mediated gene regulation
BMC Genomics, 14, 70
DOI 10.1186/1471-2164-14-70, PubMed 23368971

Publications 2012

Ben-Hur V, Denichenko P, Siegfried Z, Maimon A, Krainer A, Davidson B, Karni R (2012)
S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1
Cell Rep, 3 (1), 103-15
DOI 10.1016/j.celrep.2012.11.020, PubMed 23273915

Brenne K, Nymoen DA, Reich R, Davidson B (2012)
PRAME (preferentially expressed antigen of melanoma) is a novel marker for differentiating serous carcinoma from malignant mesothelioma
Am J Clin Pathol, 137 (2), 240-7
DOI 10.1309/AJCPGA95KVSAUDMF, PubMed 22261449

Brusegard K, Stavnes HT, Nymoen DA, Flatmark K, Trope CG, Davidson B (2012)
Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma
Virchows Arch, 460 (2), 193-202
DOI 10.1007/s00428-011-1191-x, PubMed 22249560

Davidson B, Abeler VM, Hellesylt E, Holth A, Shih IeM, Skeie-Jensen T, Chen L, Yang Y, Wang TL (2012)
Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcoma
Gynecol Oncol, 128 (2), 349-55
DOI 10.1016/j.ygyno.2012.11.021, PubMed 23178314

Davidson B, Dong HP, Berner A, Risberg B (2012)
The diagnostic and research applications of flow cytometry in cytopathology
Diagn Cytopathol, 40 (6), 525-35
DOI 10.1002/dc.22809, PubMed 22619127

Davidson B, Holth A, Nguyen MT, Tropé CG, Wu C (2012)
Migfilin, α-parvin and β-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases
Gynecol Oncol, 128 (2), 364-70
DOI 10.1016/j.ygyno.2012.10.015, PubMed 23099104

Davidson B, Tropé CG, Reich R (2012)
Epithelial-mesenchymal transition in ovarian carcinoma
Front Oncol, 2, 33
DOI 10.3389/fonc.2012.00033, PubMed 22655269

Elstrand MB, Sandstad B, Oksefjell H, Davidson B, Tropé CG (2012)
Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective
Acta Obstet Gynecol Scand, 91 (3), 308-17
DOI 10.1111/j.1600-0412.2011.01316.x, PubMed 22050605

Engesæter B, Engebraaten O, Flørenes VA, Mælandsmo GM (2012)
Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma
PLoS One, 7 (9), e45492
DOI 10.1371/journal.pone.0045492, PubMed 23029050

Fløisand Y, Tjønnfjord G, Beiske K (2012)
[Invasive fungal infection]
Tidsskr Nor Laegeforen, 132 (23-24), 2618
DOI 10.4045/tidsskr.12.0603, PubMed 23338093

Gillet JP, Calcagno AM, Varma S, Davidson B, Bunkholt Elstrand M, Ganapathi R, Kamat AA, Sood AK, Ambudkar SV, Seiden MV, Rueda BR, Gottesman MM (2012)
Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma
Clin Cancer Res, 18 (11), 3197-206
DOI 10.1158/1078-0432.CCR-12-0056, PubMed 22492981

Hetland TE, Holth A, Kærn J, Flørenes VA, Tropé CG, Davidson B (2012)
HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases
Virchows Arch, 460 (5), 505-13
DOI 10.1007/s00428-012-1228-9, PubMed 22476403

Hetland TE, Kærn J, Skrede M, Sandstad B, Tropé C, Davidson B, Flørenes VA (2012)
Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index
Cancer Chemother Pharmacol, 69 (5), 1307-14
DOI 10.1007/s00280-012-1835-9, PubMed 22302409

Hetland TE, Nymoen DA, Emilsen E, Kærn J, Tropé CG, Flørenes VA, Davidson B (2012)
MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival
Gynecol Oncol, 126 (3), 460-5
DOI 10.1016/j.ygyno.2012.05.029, PubMed 22652154

Hetland TE, Nymoen DA, Holth A, Brusegard K, Flørenes VA, Kærn J, Tropé CG, Davidson B (2012)
Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance
Hum Pathol, 44 (5), 777-85
DOI 10.1016/j.humpath.2012.08.002, PubMed 23114921

Hsu S, Kim M, Hernandez L, Grajales V, Noonan A, Anver M, Davidson B, Annunziata CM (2012)
IKK-ε coordinates invasion and metastasis of ovarian cancer
Cancer Res, 72 (21), 5494-504
DOI 10.1158/0008-5472.CAN-11-3993, PubMed 22942254

Konstantinovsky S, Davidson B, Reich R (2012)
Ezrin and BCAR1/p130Cas mediate breast cancer growth as 3-D spheroids
Clin Exp Metastasis, 29 (6), 527-40
DOI 10.1007/s10585-012-9468-2, PubMed 22476538

Lammens T, Swerts K, Derycke L, De Craemer A, De Brouwer S, De Preter K, Van Roy N, Vandesompele J, Speleman F, Philippé J, Benoit Y, Beiske K, Bracke M, Laureys G (2012)
N-cadherin in neuroblastoma disease: expression and clinical significance
PLoS One, 7 (2), e31206
DOI 10.1371/journal.pone.0031206, PubMed 22355346

Magnussen GI, Holm R, Emilsen E, Rosnes AK, Slipicevic A, Flørenes VA (2012)
High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy
PLoS One, 7 (6), e38254
DOI 10.1371/journal.pone.0038254, PubMed 22719872

Magnussen GI, Ree Rosnes AK, Shahzidi S, Dong HP, Emilsen E, Engesæter B, Flørenes VA (2012)
Synthetic retinoid CD437 induces apoptosis and acts synergistically with TRAIL receptor-2 agonist in malignant melanoma
Biochem Biophys Res Commun, 420 (3), 516-22
DOI 10.1016/j.bbrc.2012.03.023, PubMed 22446330

Panagopoulos I, Micci F, Thorsen J, Gorunova L, Eibak AM, Bjerkehagen B, Davidson B, Heim S (2012)
Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma
PLoS One, 7 (6), e39354
DOI 10.1371/journal.pone.0039354, PubMed 22761769

Pollheimer J, Bodin J, Sundnes O, Edelmann RJ, Skånland SS, Sponheim J, Brox MJ, Sundlisaeter E, Loos T, Vatn M, Kasprzycka M, Wang J, Küchler AM, Taskén K, Haraldsen G, Hol J (2012)
Interleukin-33 drives a proinflammatory endothelial activation that selectively targets nonquiescent cells
Arterioscler Thromb Vasc Biol, 33 (2), e47-55
DOI 10.1161/ATVBAHA.112.253427, PubMed 23162017

Pradhan M, Davidson B, Abeler VM, Danielsen HE, Tropé CG, Kristensen GB, Risberg BÅ (2012)
DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium
Virchows Arch, 461 (3), 291-8
DOI 10.1007/s00428-012-1275-2, PubMed 22824999

Sebban S, Golan-Gerstl R, Karni R, Vaksman O, Davidson B, Reich R (2012)
Alternatively spliced lysyl oxidase-like 4 isoforms have a pro-metastatic role in cancer
Clin Exp Metastasis, 30 (1), 103-17
DOI 10.1007/s10585-012-9514-0, PubMed 22806361

Slipicevic A, Herlyn M (2012)
Narrowing the knowledge gaps for melanoma
Ups J Med Sci, 117 (2), 237-43
DOI 10.3109/03009734.2012.658977, PubMed 22339359

Slipicevic A, Holm R, Emilsen E, Ree Rosnes AK, Welch DR, Mælandsmo GM, Flørenes VA (2012)
Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival
BMC Cancer, 12, 73
DOI 10.1186/1471-2407-12-73, PubMed 22356677

Slipicevic A, Øy GF, Rosnes AK, Stakkestad Ø, Emilsen E, Engesæter B, Mælandsmo GM, Flørenes VA (2012)
Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis
Cancer Biol Ther, 14 (2), 146-54
DOI 10.4161/cbt.22953, PubMed 23192275

Stavnes HT, Nymoen DA, Langerød A, Holth A, Børresen Dale AL, Davidson B (2012)
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma
Virchows Arch, 462 (2), 163-73
DOI 10.1007/s00428-012-1347-3, PubMed 23242172

Suganuma R, Wang LL, Sano H, Naranjo A, London WB, Seeger RC, Hogarty MD, Gastier-Foster JM, Look AT, Park JR, Maris JM, Cohn SL, Amann G, Beiske K, Cullinane CJ, d'Amore ES, Gambini C, Jarzembowski JA, Joshi VV, Navarro S, Peuchmaur M, Shimada H (2012)
Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee
Pediatr Blood Cancer, 60 (3), 363-70
DOI 10.1002/pbc.24238, PubMed 22744966

Tjønnfjord GE, Ly BE, Johannesen TB, Tierens A, Beiske K, Heim S, Jønsson V (2012)
Chronic lymphocytic leukaemia in Norway--incidence and prognostic markers at diagnosis
Tidsskr Nor Laegeforen, 132 (18), 2056-9
DOI 10.4045/tidsskr.11.1349, PubMed 23038195

Tropé CG, Elstrand MB, Sandstad B, Davidson B, Oksefjell H (2012)
Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV?
Eur J Cancer, 48 (14), 2146-54
DOI 10.1016/j.ejca.2012.01.031, PubMed 22382201

Tropé CG, Kaern J, Davidson B (2012)
Borderline ovarian tumours
Best Pract Res Clin Obstet Gynaecol, 26 (3), 325-36
DOI 10.1016/j.bpobgyn.2011.12.006, PubMed 22321906

Vaksman O, Hetland TE, Trope' CG, Reich R, Davidson B (2012)
Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma
Hum Pathol, 43 (11), 2062-9
DOI 10.1016/j.humpath.2012.02.016, PubMed 22647351

Wang J, Tian T (2012)
Effective non-linear methods for inferring genetic regulation from time-series microarray gene expression data
Methods Mol Biol, 802, 235-46
DOI 10.1007/978-1-61779-400-1_15, PubMed 22130884

Weiss I, Trope CG, Reich R, Davidson B (2012)
Hyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure
Int J Mol Sci, 13 (10), 12925-38
DOI 10.3390/ijms131012925, PubMed 23202930

Publications 2011

Ambros IM, Brunner B, Aigner G, Bedwell C, Beiske K, Bénard J, Bown N, Combaret V, Couturier J, Defferrari R, Gross N, Jeison M, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Speleman F, Stallings R, Tonini GP, Tweddle DA, Valent A, Vicha A, Roy NV et al. (2011)
A multilocus technique for risk evaluation of patients with neuroblastoma
Clin Cancer Res, 17 (4), 792-804
DOI 10.1158/1078-0432.CCR-10-0830, PubMed 21325297

Benraiss A, Bruel-Jungerman E, Lu G, Economides AN, Davidson B, Goldman SA (2011)
Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF
Gene Ther, 19 (5), 483-93
DOI 10.1038/gt.2011.114, PubMed 21918547

Bock AJ, Dong HP, Tropé CG, Staff AC, Risberg B, Davidson B (2011)
Nucleoside transporters are widely expressed in ovarian carcinoma effusions
Cancer Chemother Pharmacol, 69 (2), 467-75
DOI 10.1007/s00280-011-1716-7, PubMed 21822668

Bock AJ, Nymoen DA, Brenne K, Kærn J, Davidson B (2011)
SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions
Hum Pathol, 43 (5), 669-74
DOI 10.1016/j.humpath.2011.06.003, PubMed 21855113

Bock AJ, Tuft Stavnes H, Kærn J, Berner A, Staff AC, Davidson B (2011)
Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status
Tumour Biol, 32 (3), 589-96
DOI 10.1007/s13277-011-0157-6, PubMed 21350924

Brenne K, Nymoen DA, Hetland TE, Trope' CG, Davidson B (2011)
Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival
Hum Pathol, 43 (4), 496-505
DOI 10.1016/j.humpath.2011.05.023, PubMed 21855111

Davidson B, Holth A, Moripen L, Trope' CG, Shih IeM (2011)
Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome
Hum Pathol, 42 (7), 991-7
DOI 10.1016/j.humpath.2010.10.013, PubMed 21315424

Davidson B, Stavnes HT, Holth A, Chen X, Yang Y, Shih IeM, Wang TL (2011)
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions
J Cell Mol Med, 15 (3), 535-44
DOI 10.1111/j.1582-4934.2010.01023.x, PubMed 20132413

Davidson B, Stavnes HT, Risberg B, Nesland JM, Wohlschlaeger J, Yang Y, Shih IeM, Wang TL (2011)
Gene expression signatures differentiate adenocarcinoma of lung and breast origin in effusions
Hum Pathol, 43 (5), 684-94
DOI 10.1016/j.humpath.2011.06.015, PubMed 21937081

Dong HP, Ree Rosnes AK, Bock AJ, Holth A, Flørenes VA, Trope' CG, Risberg B, Davidson B (2011)
Flow cytometric measurement of cellular FLICE-inhibitory protein (c-FLIP) in ovarian carcinoma effusions
Cytopathology, 22 (6), 373-82
DOI 10.1111/j.1365-2303.2011.00929.x, PubMed 22032542

Elstrand MB, Stavnes HT, Tropé CG, Davidson B (2011)
Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions
Hum Pathol, 43 (4), 529-35
DOI 10.1016/j.humpath.2011.05.022, PubMed 21864883

Engesæter BO, Sathermugathevan M, Hellenes T, Engebråten O, Holm R, Flørenes VA, Mælandsmo GM (2011)
Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells
Cancer Biol Ther, 12 (1), 47-58
DOI 10.4161/cbt.12.1.15714, PubMed 21508672

Gillet JP, Calcagno AM, Varma S, Marino M, Green LJ, Vora MI, Patel C, Orina JN, Eliseeva TA, Singal V, Padmanabhan R, Davidson B, Ganapathi R, Sood AK, Rueda BR, Ambudkar SV, Gottesman MM (2011)
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
Proc Natl Acad Sci U S A, 108 (46), 18708-13
DOI 10.1073/pnas.1111840108, PubMed 22068913

Gillet JP, Wang J, Calcagno AM, Green LJ, Varma S, Bunkholt Elstrand M, Trope CG, Ambudkar SV, Davidson B, Gottesman MM (2011)
Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions
Mol Pharm, 8 (6), 2080-8
DOI 10.1021/mp200240a, PubMed 21761824

Hetland TE, Hellesylt E, Flørenes VA, Tropé C, Davidson B, Kærn J (2011)
Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance
Hum Pathol, 42 (7), 1019-26
DOI 10.1016/j.humpath.2010.10.025, PubMed 21315408

Hjortland GO, Meza-Zepeda LA, Beiske K, Ree AH, Tveito S, Hoifodt H, Bohler PJ, Hole KH, Myklebost O, Fodstad O, Smeland S, Hovig E (2011)
Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma
BMC Cancer, 11, 455
DOI 10.1186/1471-2407-11-455, PubMed 22014070

Hoskins E, Rodriguez-Canales J, Hewitt SM, Elmasri W, Han J, Han S, Davidson B, Kohn EC (2011)
Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells
Gynecol Oncol, 122 (3), 656-62
DOI 10.1016/j.ygyno.2011.04.052, PubMed 21676452

Kim G, Davidson B, Henning R, Wang J, Yu M, Annunziata C, Hetland T, Kohn EC (2011)
Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome
Cancer, 118 (6), 1543-53
DOI 10.1002/cncr.26449, PubMed 22009736

Lan X, Adams C, Landers M, Dudas M, Krissinger D, Marnellos G, Bonneville R, Xu M, Wang J, Huang TH, Meredith G, Jin VX (2011)
High resolution detection and analysis of CpG dinucleotides methylation using MBD-Seq technology
PLoS One, 6 (7), e22226
DOI 10.1371/journal.pone.0022226, PubMed 21779396

Randen U, Yri OE, Tierens A, Heim S, Beiske K, Delabie J (2011)
Mantle cell lymphoma with features of marginal-zone lymphoma
J Hematop, 4 (1), 7-11
DOI 10.1007/s12308-011-0084-x, PubMed 25089161

Reich R, Hadar S, Davidson B (2011)
Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma
Int J Mol Sci, 12 (2), 1133-45
DOI 10.3390/ijms12021133, PubMed 21541048

Safdar N, McKinley LM, Davidson B, Broome C, Schenk J (2011)
Recommendations to replace peripheral venous catheters every 72-96 hours: is a single reference enough?
J Hosp Infect, 79 (2), 172-3
DOI 10.1016/j.jhin.2011.06.005, PubMed 21802173

Scheie D, Meling TR, Cvancarova M, Skullerud K, Mørk S, Lote K, Eide TJ, Helseth E, Beiske K (2011)
Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases
Neuro Oncol, 13 (11), 1225-33
DOI 10.1093/neuonc/nor114, PubMed 21856683

Schleiermacher G, Michon J, Ribeiro A, Pierron G, Mosseri V, Rubie H, Munzer C, Bénard J, Auger N, Combaret V, Janoueix-Lerosey I, Pearson A, Tweddle DA, Bown N, Gerrard M, Wheeler K, Noguera R, Villamon E, Cañete A, Castel V, Marques B, de Lacerda A, Tonini GP, Mazzocco K, Defferrari R et al. (2011)
Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
Br J Cancer, 105 (12), 1940-8
DOI 10.1038/bjc.2011.472, PubMed 22146831

Schmitt F, Cochand-Priollet B, Toetsch M, Davidson B, Bondi A, Vielh P (2011)
Immunocytochemistry in Europe: results of the European Federation of Cytology Societies (EFCS) inquiry
Cytopathology, 22 (4), 238-42
DOI 10.1111/j.1365-2303.2011.00885.x, PubMed 21771093

Vaksman O, Stavnes HT, Kaern J, Trope CG, Davidson B, Reich R (2011)
miRNA profiling along tumour progression in ovarian carcinoma
J Cell Mol Med, 15 (7), 1593-602
DOI 10.1111/j.1582-4934.2010.01148.x, PubMed 20716115

Venkatesh B, Davidson B, Robinson K, Pascoe R, Appleton C, Jones M (2011)
Do random estimations of vitamin D3 and parathyroid hormone reflect the 24-h profile in the critically ill?
Intensive Care Med, 38 (1), 177-9
DOI 10.1007/s00134-011-2415-x, PubMed 22113816

Wang J (2011)
Computational study of associations between histone modification and protein-DNA binding in yeast genome by integrating diverse information
BMC Genomics, 12, 172
DOI 10.1186/1471-2164-12-172, PubMed 21457549

Yuan Y, Dong HP, Nymoen DA, Nesland JM, Wu C, Davidson B (2011)
PINCH-2 expression in cancers involving serosal effusions using quantitative PCR
Cytopathology, 22 (1), 22-9
DOI 10.1111/j.1365-2303.2010.00757.x, PubMed 20500520

Publications 2010

Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, Steinberg SM, Davidson B, Kohn EC (2010)
Nuclear factor kappaB transcription factors are coexpressed and convey a poor outcome in ovarian cancer
Cancer, 116 (13), 3276-84
DOI 10.1002/cncr.25190, PubMed 20564628

Berentsen S, Randen U, Vågan AM, Hjorth-Hansen H, Vik A, Dalgaard J, Jacobsen EM, Thoresen AS, Beiske K, Tjønnfjord GE (2010)
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease
Blood, 116 (17), 3180-4
DOI 10.1182/blood-2010-06-288647, PubMed 20634373

Bock AJ, Stavnes HT, Kempf T, Tropè CG, Berner A, Davidson B, Staff AC (2010)
Expression and clinical role of growth differentiation factor-15 in ovarian carcinoma effusions
Int J Gynecol Cancer, 20 (9), 1448-55
DOI 10.1111/IGC.0b013e3181f7d6be, PubMed 21336029

Bunkholt Elstrand M, Dong HP, Ødegaard E, Holth A, Elloul S, Reich R, Tropé CG, Davidson B (2010)
Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma
Hum Pathol, 41 (6), 794-804
DOI 10.1016/j.humpath.2009.09.017, PubMed 20153512

Davidson B (2010)
The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma
Cytopathology, 22 (1), 5-21
DOI 10.1111/j.1365-2303.2010.00829.x, PubMed 21114695

Davidson B, Reich R, Trope CG, Wang TL, Shih IeM (2010)
New determinates of disease progression and outcome in metastatic ovarian carcinoma
Histol Histopathol, 25 (12), 1591-609
DOI 10.14670/HH-25.1591, PubMed 20886439

Davidson B, Stavnes HT, Førsund M, Berner A, Staff AC (2010)
CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survival
Breast, 19 (6), 493-8
DOI 10.1016/j.breast.2010.05.013, PubMed 21078485

De Brouwer S, De Preter K, Kumps C, Zabrocki P, Porcu M, Westerhout EM, Lakeman A, Vandesompele J, Hoebeeck J, Van Maerken T, De Paepe A, Laureys G, Schulte JH, Schramm A, Van Den Broecke C, Vermeulen J, Van Roy N, Beiske K, Renard M, Noguera R, Delattre O, Janoueix-Lerosey I, Kogner P, Martinsson T, Nakagawara A et al. (2010)
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification
Clin Cancer Res, 16 (17), 4353-62
DOI 10.1158/1078-0432.CCR-09-2660, PubMed 20719933

Dong HP, Holth A, Ruud MG, Emilsen E, Risberg B, Davidson B (2010)
Measurement of apoptosis in cytological specimens by flow cytometry: comparison of Annexin V, caspase cleavage and dUTP incorporation assays
Cytopathology, 22 (6), 365-72
DOI 10.1111/j.1365-2303.2010.00811.x, PubMed 21054589

Elgaaen BV, Haug KB, Wang J, Olstad OK, Fortunati D, Onsrud M, Staff AC, Sauer T, Gautvik KM (2010)
POLD2 and KSP37 (FGFBP2) correlate strongly with histology, stage and outcome in ovarian carcinomas
PLoS One, 5 (11), e13837
DOI 10.1371/journal.pone.0013837, PubMed 21079801

Elloul S, Vaksman O, Stavnes HT, Trope CG, Davidson B, Reich R (2010)
Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions
Clin Exp Metastasis, 27 (3), 161-72
DOI 10.1007/s10585-010-9315-2, PubMed 20213325

Flatmark K, Davidson B, Kristian A, Stavnes HT, Førsund M, Reed W (2010)
Exploring the peritoneal surface malignancy phenotype--a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models
Hum Pathol, 41 (8), 1109-19
DOI 10.1016/j.humpath.2009.12.013, PubMed 20338618

Hernandez L, Hsu SC, Davidson B, Birrer MJ, Kohn EC, Annunziata CM (2010)
Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer
Cancer Res, 70 (10), 4005-14
DOI 10.1158/0008-5472.CAN-09-3912, PubMed 20424119

Jinawath N, Vasoontara C, Jinawath A, Fang X, Zhao K, Yap KL, Guo T, Lee CS, Wang W, Balgley BM, Davidson B, Wang TL, Shih IeM (2010)
Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma
PLoS One, 5 (6), e11198
DOI 10.1371/journal.pone.0011198, PubMed 20585448

Micci F, Haugom L, Ahlquist T, Andersen HK, Abeler VM, Davidson B, Trope CG, Lothe RA, Heim S (2010)
Genomic aberrations in borderline ovarian tumors
J Transl Med, 8, 21
DOI 10.1186/1479-5876-8-21, PubMed 20184781

Mikalsen B, Fosby B, Wang J, Hammarström C, Bjaerke H, Lundström M, Kasprzycka M, Scott H, Line PD, Haraldsen G (2010)
Genome-wide transcription profile of endothelial cells after cardiac transplantation in the rat
Am J Transplant, 10 (7), 1534-44
DOI 10.1111/j.1600-6143.2010.03157.x, PubMed 20642680

Oy GF, Slipicevic A, Davidson B, Solberg Faye R, Maelandsmo GM, Flørenes VA (2010)
Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma
Int J Cancer, 126 (2), 350-61
DOI 10.1002/ijc.24727, PubMed 19588500

Park JT, Chen X, Tropè CG, Davidson B, Shih IeM, Wang TL (2010)
Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin
Am J Pathol, 177 (3), 1087-94
DOI 10.2353/ajpath.2010.100316, PubMed 20671266

Pradhan M, Abeler VM, Davidson B, Kildal W, Nybøen A, Tropé CG, Risberg B, Danielsen HE (2010)
DNA ploidy heterogeneity in endometrial carcinoma: comparison between curettage and hysterectomy specimens
Int J Gynecol Pathol, 29 (6), 572-8
DOI 10.1097/PGP.0b013e3181e2e8ee, PubMed 20881853

Shih IeM, Chen L, Wang CC, Gu J, Davidson B, Cope L, Kurman RJ, Xuan J, Wang TL (2010)
Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis
Am J Obstet Gynecol, 203 (6), 584.e1-22
DOI 10.1016/j.ajog.2010.08.003, PubMed 20965493

Staff AC, Bock AJ, Becker C, Kempf T, Wollert KC, Davidson B (2010)
Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer
Gynecol Oncol, 118 (3), 237-43
DOI 10.1016/j.ygyno.2010.05.032, PubMed 20576287

Tierens AM, Holte H, Warsame A, Ikonomou IM, Wang J, Chan WC, Delabie J (2010)
Low levels of monoclonal small B cells in the bone marrow of patients with diffuse large B-cell lymphoma of activated B-cell type but not of germinal center B-cell type
Haematologica, 95 (8), 1334-41
DOI 10.3324/haematol.2009.014100, PubMed 20145271

Ueda SM, Yap KL, Davidson B, Tian Y, Murthy V, Wang TL, Visvanathan K, Kuhajda FP, Bristow RE, Zhang H, Shih IeM (2010)
Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas
J Oncol, 2010, 285191
DOI 10.1155/2010/285191, PubMed 20508725

Wang J (2010)
The effect of prior assumptions over the weights in BayesPI with application to study protein-DNA interactions from ChIP-based high-throughput data
BMC Bioinformatics, 11, 412
DOI 10.1186/1471-2105-11-412, PubMed 20684785

Wang J, Tian T (2010)
Quantitative model for inferring dynamic regulation of the tumour suppressor gene p53
BMC Bioinformatics, 11, 36
DOI 10.1186/1471-2105-11-36, PubMed 20085646

Wang TL, Davidson B, Buckhaults PJ, Huang CS, Poul G (2010)
Molecular genetic markers in female reproductive cancers
J Oncol, 2010, 307460
DOI 10.1155/2010/307460, PubMed 21541207

Wang Z, Trope CG, Flørenes VA, Suo Z, Nesland JM, Holm R (2010)
Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
BMC Cancer, 10, 233
DOI 10.1186/1471-2407-10-233, PubMed 20500813

Yu GQ, Feng YJ, Miller DJ, Xuan JH, Hoffman EP, Clarke R, Davidson B, Shih IM, Wang Y (2010)
Matched Gene Selection and Committee Classifier for Molecular Classification of Heterogeneous Diseases
J. Mach. Learn. Res., 11, 2141-2167

Yuan Y, Leszczynska M, Konstantinovsky S, Tropé CG, Reich R, Davidson B (2010)
Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors
Diagn Cytopathol, 39 (8), 562-6
DOI 10.1002/dc.21424, PubMed 20730893

Publications 2009

Bassarova A, Trøen G, Fosså A, Ikonomou IM, Beiske K, Nesland JM, Delabie J (2009)
Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation
J Hematop, 2 (3), 135-41
DOI 10.1007/s12308-009-0031-2, PubMed 19669194

Beiske K, Burchill SA, Cheung IY, Hiyama E, Seeger RC, Cohn SL, Pearson AD, Matthay KK, International neuroblastoma Risk Group Task Force (2009)
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
Br J Cancer, 100 (10), 1627-37
DOI 10.1038/sj.bjc.6605029, PubMed 19401690

Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R (2009)
Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival
Hum Pathol, 40 (5), 705-13
DOI 10.1016/j.humpath.2008.09.019, PubMed 19157507

Dong HP, Holth A, Kleinberg L, Ruud MG, Elstrand MB, Tropé CG, Davidson B, Risberg B (2009)
Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters
Am J Clin Pathol, 132 (5), 756-62
DOI 10.1309/AJCPAVFA8J3KHPRS, PubMed 19846818

Elstrand MB, Kleinberg L, Kohn EC, Tropé CG, Davidson B (2009)
Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma
Int J Gynecol Pathol, 28 (3), 211-21
DOI 10.1097/PGP.0b013e31818b0f5e, PubMed 19620938

Fevang B, Eugen-Olsen J, Yndestad A, Brosstad F, Beiske K, Aukrust P, Frøland SS (2009)
Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency
Clin Immunol, 131 (3), 438-46
DOI 10.1016/j.clim.2009.01.007, PubMed 19232508

Fevang B, Yndestad A, Damås JK, Halvorsen B, Holm AM, Beiske K, Aukrust P, Frøland SS (2009)
Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation
Clin Exp Immunol, 158 (2), 237-45
DOI 10.1111/j.1365-2249.2009.04013.x, PubMed 19747210

Kleinberg L, Davidson B (2009)
Cell survival and apoptosis-related molecules in cancer cells in effusions: a comprehensive review
Diagn Cytopathol, 37 (8), 613-24
DOI 10.1002/dc.21095, PubMed 19418469

Kleinberg L, Dong HP, Holth A, Risberg B, Trope' CG, Nesland JM, Flørenes VA, Davidson B (2009)
Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma
Hum Pathol, 40 (6), 795-806
DOI 10.1016/j.humpath.2008.10.019, PubMed 19157506

Konstantinovsky S, Smith Y, Zilber S, Tuft Stavnes H, Becker AM, Nesland JM, Reich R, Davidson B (2009)
Breast carcinoma cells in primary tumors and effusions have different gene array profiles
J Oncol, 2010, 969084
DOI 10.1155/2010/969084, PubMed 19680458

Maelandsmo GM, Flørenes VA, Nguyen MT, Flatmark K, Davidson B (2009)
Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites
Tumour Biol, 30 (1), 15-25
DOI 10.1159/000199447, PubMed 19194111

Micci F, Panagopoulos I, Haugom L, Andersen HK, Tjønnfjord GE, Beiske K, Heim S (2009)
t(3;21)(q22;q22) leading to truncation of the RYK gene in atypical chronic myeloid leukemia
Cancer Lett, 277 (2), 205-11
DOI 10.1016/j.canlet.2008.12.016, PubMed 19168282

Michalsen S, Schrumpf E, Beiske K, Tierens A, Stenberg V, Tjønnfjord GE (2009)
[Large granular lymphocytic leukaemia]
Tidsskr Nor Laegeforen, 129 (11), 1098-102
DOI 10.4045/tidsskr.09.0152, PubMed 19488091

Pradhan M, Davidson B, Tropé CG, Danielsen HE, Abeler VM, Risberg B (2009)
Gross genomic alterations differ between serous borderline tumors and serous adenocarcinomas--an image cytometric DNA ploidy analysis of 307 cases with histogenetic implications
Virchows Arch, 454 (6), 677-83
DOI 10.1007/s00428-009-0778-y, PubMed 19421773

Pretorius ME, Waehre H, Abeler VM, Davidson B, Vlatkovic L, Lothe RA, Giercksky KE, Danielsen HE (2009)
Large scale genomic instability as an additive prognostic marker in early prostate cancer
Cell Oncol, 31 (4), 251-9
DOI 10.3233/CLO-2009-0463, PubMed 19633362

Shih IeM, Davidson B (2009)
Pathogenesis of ovarian cancer: clues from selected overexpressed genes
Future Oncol, 5 (10), 1641-57
DOI 10.2217/fon.09.126, PubMed 20001801

Slipicevic A, Øy GF, Askildt IC, Holth A, Hellesylt E, Flørenes VA, Davidson B (2009)
Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions
Hum Pathol, 40 (4), 527-37
DOI 10.1016/j.humpath.2008.10.003, PubMed 19121847

Tropé C, Davidson B, Paulsen T, Abeler VM, Kaern J (2009)
Diagnosis and treatment of borderline ovarian neoplasms "the state of the art"
Eur J Gynaecol Oncol, 30 (5), 471-82
PubMed 19899396

Vermeulen J, De Preter K, Naranjo A, Vercruysse L, Van Roy N, Hellemans J, Swerts K, Bravo S, Scaruffi P, Tonini GP, De Bernardi B, Noguera R, Piqueras M, Cañete A, Castel V, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Michon J, Combaret V, Fischer M, Oberthuer A, Ambros PF, Beiske K, Bénard J et al. (2009)
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
Lancet Oncol, 10 (7), 663-71
DOI 10.1016/S1470-2045(09)70154-8, PubMed 19515614

Virador VM, Davidson B, Czechowicz J, Mai A, Kassis J, Kohn EC (2009)
The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome
PLoS One, 4 (4), e5136
DOI 10.1371/journal.pone.0005136, PubMed 19352495

Wang J, Morigen (2009)
BayesPI - a new model to study protein-DNA interactions: a case study of condition-specific protein binding parameters for Yeast transcription factors
BMC Bioinformatics, 10, 345
DOI 10.1186/1471-2105-10-345, PubMed 19857274

Yuan Y, Nymoen DA, Dong HP, Bjørang O, Shih IeM, Low PS, Trope' CG, Davidson B (2009)
Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions
Hum Pathol, 40 (10), 1453-60
DOI 10.1016/j.humpath.2009.02.013, PubMed 19454358

Yuan Y, Nymoen DA, Stavnes HT, Rosnes AK, Bjørang O, Wu C, Nesland JM, Davidson B (2009)
Tenascin-X is a novel diagnostic marker of malignant mesothelioma
Am J Surg Pathol, 33 (11), 1673-82
DOI 10.1097/PAS.0b013e3181b6bde3, PubMed 19738457

Publications 2008

Choi JH, Park JT, Davidson B, Morin PJ, Shih IeM, Wang TL (2008)
Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion
Cancer Res, 68 (14), 5716-23
DOI 10.1158/0008-5472.CAN-08-0001, PubMed 18632624

Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih IeM, Zhang Y, Wood W, Becker KG, Morin PJ (2008)
MicroRNA expression and identification of putative miRNA targets in ovarian cancer
PLoS One, 3 (6), e2436
DOI 10.1371/journal.pone.0002436, PubMed 18560586

Davidson B (2008)
New diagnostic and molecular characteristics of malignant mesothelioma
Ultrastruct Pathol, 32 (6), 227-40
DOI 10.1080/01913120802454298, PubMed 19117264

Davidson B, Dong HP, Holth A, Berner A, Risberg B (2008)
The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions
Breast J, 14 (5), 476-82
DOI 10.1111/j.1524-4741.2008.00625.x, PubMed 18657145

Davidson B, Shih IeM, Wang TL (2008)
Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma
Hum Pathol, 39 (11), 1630-6
DOI 10.1016/j.humpath.2008.03.009, PubMed 18656238

Davidson B, Wang TL, Shih IeM, Berner A (2008)
Expression of the chromatin remodeling factor Rsf-1 is down-regulated in breast carcinoma effusions
Hum Pathol, 39 (4), 616-22
DOI 10.1016/j.humpath.2007.09.008, PubMed 18289639

Dong HP, Kleinberg L, Davidson B, Risberg B (2008)
Methods for simultaneous measurement of apoptosis and cell surface phenotype of epithelial cells in effusions by flow cytometry
Nat Protoc, 3 (6), 955-64
DOI 10.1038/nprot.2008.77, PubMed 18546596

Dong HP, Kleinberg L, Silins I, Flørenes VA, Tropé CG, Risberg B, Nesland JM, Davidson B (2008)
Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma
Cancer, 112 (1), 84-93
DOI 10.1002/cncr.23140, PubMed 17985388

Emblem KE, Scheie D, Due-Tonnessen P, Nedregaard B, Nome T, Hald JK, Beiske K, Meling TR, Bjornerud A (2008)
Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes
AJNR Am J Neuroradiol, 29 (9), 1664-70
DOI 10.3174/ajnr.A1182, PubMed 18583405

Fevang B, Yndestad A, Damås JK, Bjerkeli V, Ueland T, Holm AM, Beiske K, Aukrust P, Frøland SS (2008)
Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation
Clin Immunol, 130 (2), 151-61
DOI 10.1016/j.clim.2008.09.002, PubMed 18938112

Goscinski MA, Suo Z, Flørenes VA, Vlatkovic L, Nesland JM, Giercksky KE (2008)
FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions
Ultrastruct Pathol, 32 (3), 89-96
DOI 10.1080/01913120802034934, PubMed 18570153

Goscinski MA, Suo ZH, Nesland JM, Chen WT, Zakrzewska M, Wang J, Zhang S, Flørenes VA, Giercksky KE (2008)
Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China
Oncology, 75 (1-2), 49-59
DOI 10.1159/000151741, PubMed 18787344

Goscinski MA, Suo ZH, Nesland JM, Flørenes VA, Giercksky KE (2008)
Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines
APMIS, 116 (9), 823-31
DOI 10.1111/j.1600-0463.2008.01029.x, PubMed 19024603

Kleinberg L, Holth A, Trope CG, Reich R, Davidson B (2008)
Claudin upregulation in ovarian carcinoma effusions is associated with poor survival
Hum Pathol, 39 (5), 747-57
DOI 10.1016/j.humpath.2007.10.002, PubMed 18439941

Kleinberg L, Pradhan M, Tropé CG, Nesland JM, Davidson B, Risberg B (2008)
Ovarian carcinoma cells in effusions show increased S-phase fraction compared to corresponding primary tumors
Diagn Cytopathol, 36 (9), 637-44
DOI 10.1002/dc.20879, PubMed 18677760

Odlo K, Hentzen J, dit Chabert JF, Ducki S, Gani OA, Sylte I, Skrede M, Flørenes VA, Hansen TV (2008)
1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin
Bioorg Med Chem, 16 (9), 4829-38
DOI 10.1016/j.bmc.2008.03.049, PubMed 18396050

Rayhman O, Klipper E, Muller L, Davidson B, Reich R, Meidan R (2008)
Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells
Cancer Res, 68 (22), 9265-73
DOI 10.1158/0008-5472.CAN-08-2093, PubMed 19010899

Scheie D, Cvancarova M, Mørk S, Skullerud K, Andresen PA, Benestad I, Helseth E, Meling T, Beiske K (2008)
Can morphology predict 1p/19q loss in oligodendroglial tumours?
Histopathology, 53 (5), 578-87
DOI 10.1111/j.1365-2559.2008.03160.x, PubMed 18983467

Sebban S, Davidson B, Reich R (2008)
Lysyl oxidase-like 4 is alternatively spliced in an anatomic site-specific manner in tumors involving the serosal cavities
Virchows Arch, 454 (1), 71-9
DOI 10.1007/s00428-008-0694-6, PubMed 19015874

Slipicevic A, Jørgensen K, Skrede M, Rosnes AK, Trøen G, Davidson B, Flørenes VA (2008)
The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells
BMC Cancer, 8, 276
DOI 10.1186/1471-2407-8-276, PubMed 18826602

Sunde PT, Olsen I, Enersen M, Beiske K, Grinde B (2008)
Human cytomegalovirus and Epstein-Barr virus in apical and marginal periodontitis: a role in pathology?
J Med Virol, 80 (6), 1007-11
DOI 10.1002/jmv.21180, PubMed 18428124

Torlakovic EE, Slipicevic A, Flørenes VA, Chibbar R, DeCoteau JF, Bilalovic N (2008)
Fli-1 expression in malignant melanoma
Histol Histopathol, 23 (11), 1309-14
DOI 10.14670/HH-23.1309, PubMed 18785112

Wang J (2008)
Computational biology of genome expression and regulation--a review of microarray bioinformatics
J Environ Pathol Toxicol Oncol, 27 (3), 157-79
DOI 10.1615/jenvironpatholtoxicoloncol.v27.i3.10, PubMed 18652564

Ødegaard E, Davidson B, Elgaaen BV, Fagerhol MK, Engh V, Onsrud M, Staff AC (2008)
Circulating calprotectin in ovarian carcinomas and borderline tumors of the ovary
Am J Obstet Gynecol, 198 (4), 418.e1-7
DOI 10.1016/j.ajog.2007.10.792, PubMed 18241816

Ødegaard E, Davidson B, Engh V, Onsrud M, Staff AC (2008)
Assessment of endoglin and calprotectin as potential biomarkers in ovarian carcinoma and borderline tumors of the ovary
Am J Obstet Gynecol, 199 (5), 533.e1-8
DOI 10.1016/j.ajog.2008.04.004, PubMed 18533117

Publications 2007

Annunziata CM, Kleinberg L, Davidson B, Berner A, Gius D, Tchabo N, Steinberg SM, Kohn EC (2007)
BAG-4/SODD and associated antiapoptotic proteins are linked to aggressiveness of epithelial ovarian cancer
Clin Cancer Res, 13 (22 Pt 1), 6585-92
DOI 10.1158/1078-0432.CCR-07-0327, PubMed 18006758

Berentsen S, Beiske K, Tjønnfjord GE (2007)
Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy
Hematology, 12 (5), 361-70
DOI 10.1080/10245330701445392, PubMed 17891600

Davidson B (2007)
Anatomic site-related expression of cancer-associated molecules in ovarian carcinoma
Curr Cancer Drug Targets, 7 (1), 109-20
DOI 10.2174/156800907780006904, PubMed 17305482

Davidson B (2007)
Biological characteristics of cancers involving the serosal cavities
Crit Rev Oncog, 13 (3), 189-227
DOI 10.1615/critrevoncog.v13.i3.10, PubMed 18298385

Davidson B (2007)
Expression of cancer-associated molecules in malignant mesothelioma
Biomark Insights, 2, 173-84
PubMed 19662202

Davidson B, Baekelandt M, Shih IeM (2007)
MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells
Diagn Cytopathol, 35 (12), 756-60
DOI 10.1002/dc.20771, PubMed 18008338

Davidson B, Berner A, Trope' CG, Wang TL, Shih IM (2007)
Expression and clinical role of the bric-a-brac tramtrack broad complex/poxvirus and zinc protein NAC-1 in ovarian carcinoma effusions
Hum Pathol, 38 (7), 1030-1036
DOI 10.1016/j.humpath.2006.12.009, PubMed 17391728

Davidson B, Dong HP, Holth A, Berner A, Risberg B (2007)
Chemokine receptors are infrequently expressed in malignant and benign mesothelial cells
Am J Clin Pathol, 127 (5), 752-9
DOI 10.1309/LN2075V7C8K31CH8, PubMed 17439834

Davidson B, Dong HP, Holth A, Berner A, Risberg B (2007)
Flow cytometric immunophenotyping of cancer cells in effusion specimens: diagnostic and research applications
Diagn Cytopathol, 35 (9), 568-78
DOI 10.1002/dc.20707, PubMed 17703449

Davidson B, Hadar R, Schlossberg A, Sternlicht T, Slipicevic A, Skrede M, Risberg B, Flørenes VA, Kopolovic J, Reich R (2007)
Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma
Hum Pathol, 39 (1), 87-95
DOI 10.1016/j.humpath.2007.05.014, PubMed 17949781

Davidson B, Skrede M, Silins I, Shih IeM, Trope CG, Flørenes VA (2007)
Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma
Cancer, 110 (6), 1264-71
DOI 10.1002/cncr.22918, PubMed 17647260

Davidson B, Xi Z, Saatcioglu F (2007)
Kallikrein 4 is expressed in malignant mesothelioma--further evidence for the histogenetic link between mesothelial and epithelial cells
Diagn Cytopathol, 35 (2), 80-4
DOI 10.1002/dc.20588, PubMed 17230566

Dong HP, Holth A, Berner A, Davidson B, Risberg B (2007)
Flow cytometric immunphenotyping of epithelial cancer cells in effusions--technical considerations and pitfalls
Cytometry B Clin Cytom, 72 (5), 332-43
DOI 10.1002/cyto.b.20172, PubMed 17226863

Gilliam AD, Davidson B, Guest J (2007)
The carbon footprint of laparoscopic surgery: should we offset?
Surg Endosc, 22 (2), 573
DOI 10.1007/s00464-007-9722-x, PubMed 18095020

Kleinberg L, Flørenes VA, Nesland JM, Davidson B (2007)
Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions
Am J Clin Pathol, 128 (3), 389-97
DOI 10.1309/E899BG1282M5D505, PubMed 17709312

Kleinberg L, Flørenes VA, Silins I, Haug K, Trope CG, Nesland JM, Davidson B (2007)
Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma
Cancer, 109 (2), 228-38
DOI 10.1002/cncr.22426, PubMed 17167759

Kleinberg L, Holth A, Fridman E, Schwartz I, Shih IeM, Davidson B (2007)
The diagnostic role of claudins in serous effusions
Am J Clin Pathol, 127 (6), 928-37
DOI 10.1309/V025QRN3R9CJGNPX, PubMed 17509990

Kleinberg L, Lie AK, Flørenes VA, Nesland JM, Davidson B (2007)
Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma
Hum Pathol, 38 (7), 986-994
DOI 10.1016/j.humpath.2006.12.013, PubMed 17350081

Micci F, Panagopoulos I, Tjønnfjord GE, Kolstad A, Delabie J, Beiske K, Heim S (2007)
Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies
Virchows Arch, 450 (5), 559-65
DOI 10.1007/s00428-007-0407-6, PubMed 17406891

Osuji N, Beiske K, Randen U, Matutes E, Tjonnfjord G, Catovsky D, Wotherspoon A (2007)
Characteristic appearances of the bone marrow in T-cell large granular lymphocyte leukaemia
Histopathology, 50 (5), 547-54
DOI 10.1111/j.1365-2559.2007.02656.x, PubMed 17394489

Salani R, Davidson B, Fiegl M, Marth C, Müller-Holzner E, Gastl G, Huang HY, Hsiao JC, Lin HS, Wang TL, Lin BL, Shih IeM (2007)
Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions
Clin Cancer Res, 13 (19), 5805-9
DOI 10.1158/1078-0432.CCR-07-0853, PubMed 17908972

Sudbo J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Soland TM, Lippman SM (2007)
Molecular based treatment of oral cancer (Retraction of vol 39, pg 749, 2003)
Oral Oncol., 43 (4), 421
DOI 10.1016/j.oraloncology.2007.01.004

Wang J (2007)
A new framework for identifying combinatorial regulation of transcription factors: a case study of the yeast cell cycle
J Biomed Inform, 40 (6), 707-25
DOI 10.1016/j.jbi.2007.02.003, PubMed 17418646

Publications 2006

Bassarova AV, Nesland JM, Davidson B (2006)
D2-40 is not a specific marker for cells of mesothelial origin in serous effusions
Am J Surg Pathol, 30 (7), 878-82
DOI 10.1097/01.pas.0000208280.29291.34, PubMed 16819331

Berentsen S, Ulvestad E, Langholm R, Beiske K, Hjorth-Hansen H, Ghanima W, Sørbø JH, Tjønnfjord GE (2006)
Primary chronic cold agglutinin disease: a population based clinical study of 86 patients
Haematologica, 91 (4), 460-6
PubMed 16585012

Berner A, Sigstad E, Pradhan M, Grøholt KK, Davidson B (2006)
Fine-needle aspiration cytology of the thyroid gland: comparative analysis of experience at three hospitals
Diagn Cytopathol, 34 (2), 97-100
DOI 10.1002/dc.20384, PubMed 16514672

Davidson B, Espina V, Steinberg SM, Flørenes VA, Liotta LA, Kristensen GB, Tropé CG, Berner A, Kohn EC (2006)
Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling
Clin Cancer Res, 12 (3 Pt 1), 791-9
DOI 10.1158/1078-0432.CCR-05-2516, PubMed 16467090

Davidson B, Konstantinovsky S, Kleinberg L, Nguyen MT, Bassarova A, Kvalheim G, Nesland JM, Reich R (2006)
The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma
Gynecol Oncol, 102 (3), 453-61
DOI 10.1016/j.ygyno.2006.01.034, PubMed 16494928

Davidson B, Risberg B, Berner A, Bedrossian CW, Reich R (2006)
The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma
Semin Diagn Pathol, 23 (1), 35-43
DOI 10.1053/j.semdp.2006.06.003, PubMed 17044194

Davidson B, Shafat I, Risberg B, Ilan N, Trope' CG, Vlodavsky I, Reich R (2006)
Heparanase expression correlates with poor survival in metastatic ovarian carcinoma
Gynecol Oncol, 104 (2), 311-9
DOI 10.1016/j.ygyno.2006.08.045, PubMed 17030350

Davidson B, Trope' CG, Wang TL, Shih IeM (2006)
Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival
Gynecol Oncol, 103 (3), 814-9
DOI 10.1016/j.ygyno.2006.05.042, PubMed 16844205

Davidson B, Zhang Z, Kleinberg L, Li M, Flørenes VA, Wang TL, Shih IeM (2006)
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma
Clin Cancer Res, 12 (20 Pt 1), 5944-50
DOI 10.1158/1078-0432.CCR-06-1059, PubMed 17062665

Dong HP, Elstrand MB, Holth A, Silins I, Berner A, Trope CG, Davidson B, Risberg B (2006)
NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma
Am J Clin Pathol, 125 (3), 451-8
DOI 10.1309/15B66DQMFYYM78CJ, PubMed 16613351

Elloul S, Silins I, Tropé CG, Benshushan A, Davidson B, Reich R (2006)
Expression of E-cadherin transcriptional regulators in ovarian carcinoma
Virchows Arch, 449 (5), 520-8
DOI 10.1007/s00428-006-0274-6, PubMed 17024425

Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R (2006)
The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma
Gynecol Oncol, 103 (3), 831-40
DOI 10.1016/j.ygyno.2006.06.042, PubMed 16919315

Gotlieb WH, Bruchim I, Ben-Baruch G, Davidson B, Zeltser A, Andersen A, Olsen H (2006)
Doxorubicin levels in the serum and ascites of patients with ovarian cancer
Eur J Surg Oncol, 33 (2), 213-5
DOI 10.1016/j.ejso.2006.11.006, PubMed 17174514

Holm AM, Tjønnfjord G, Yndestad A, Beiske K, Müller F, Aukrust P, Frøland SS (2006)
Polyclonal expansion of large granular lymphocytes in common variable immunodeficiency - association with neutropenia
Clin Exp Immunol, 144 (3), 418-24
DOI 10.1111/j.1365-2249.2006.03086.x, PubMed 16734610

Jørgensen K, Davidson B, Flørenes VA (2006)
Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma
Mod Pathol, 19 (11), 1446-55
DOI 10.1038/modpathol.3800662, PubMed 16951673

Kleinberg L, Flørenes VA, Skrede M, Dong HP, Nielsen S, McMaster MT, Nesland JM, Shih IeM, Davidson B (2006)
Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma
Virchows Arch, 449 (1), 31-9
DOI 10.1007/s00428-005-0144-7, PubMed 16541284

Meza-Zepeda LA, Kresse SH, Barragan-Polania AH, Bjerkehagen B, Ohnstad HO, Namløs HM, Wang J, Kristiansen BE, Myklebost O (2006)
Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas
Cancer Res, 66 (18), 8984-93
DOI 10.1158/0008-5472.CAN-06-1972, PubMed 16982739

Moorman C, Sun LV, Wang J, de Wit E, Talhout W, Ward LD, Greil F, Lu XJ, White KP, Bussemaker HJ, van Steensel B (2006)
Hotspots of transcription factor colocalization in the genome of Drosophila melanogaster
Proc Natl Acad Sci U S A, 103 (32), 12027-32
DOI 10.1073/pnas.0605003103, PubMed 16880385

Nakayama K, Nakayama N, Davidson B, Katabuchi H, Kurman RJ, Velculescu VE, Shih IeM, Wang TL (2006)
Homozygous deletion of MKK4 in ovarian serous carcinoma
Cancer Biol Ther, 5 (6), 630-4
DOI 10.4161/cbt.5.6.2675, PubMed 16627982

Nakayama K, Nakayama N, Davidson B, Sheu JJ, Jinawath N, Santillan A, Salani R, Bristow RE, Morin PJ, Kurman RJ, Wang TL, Shih IeM (2006)
A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival
Proc Natl Acad Sci U S A, 103 (49), 18739-44
DOI 10.1073/pnas.0604083103, PubMed 17130457

Navarro S, Amann G, Beiske K, Cullinane CJ, d'Amore ES, Gambini C, Mosseri V, De Bernardi B, Michon J, Peuchmaur M, European Study Group 94.01 Trial and Protocol (2006)
Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol
J Clin Oncol, 24 (4), 695-9
DOI 10.1200/JCO.2004.00.8631, PubMed 16446343

Park JT, Li M, Nakayama K, Mao TL, Davidson B, Zhang Z, Kurman RJ, Eberhart CG, Shih IeM, Wang TL (2006)
Notch3 gene amplification in ovarian cancer
Cancer Res, 66 (12), 6312-8
DOI 10.1158/0008-5472.CAN-05-3610, PubMed 16778208

Rocha AS, Risberg B, Magalhães J, Trovisco V, de Castro IV, Lazarovici P, Soares P, Davidson B, Sobrinho-Simões M (2006)
The p75 neurotrophin receptor is widely expressed in conventional papillary thyroid carcinoma
Hum Pathol, 37 (5), 562-8
DOI 10.1016/j.humpath.2005.12.016, PubMed 16647954

Scheie D, Andresen PA, Cvancarova M, Bø AS, Helseth E, Skullerud K, Beiske K (2006)
Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors
Am J Surg Pathol, 30 (7), 828-37
DOI 10.1097/01.pas.0000213250.44822.2e, PubMed 16819324

Sivertsen S, Berner A, Michael CW, Bedrossian C, Davidson B (2006)
Cadherin expression in ovarian carcinoma and malignant mesothelioma cell effusions
Acta Cytol, 50 (6), 603-7
DOI 10.1159/000326027, PubMed 17152269

Sivertsen S, Hadar R, Elloul S, Vintman L, Bedrossian C, Reich R, Davidson B (2006)
Expression of Snail, Slug and Sip1 in malignant mesothelioma effusions is associated with matrix metalloproteinase, but not with cadherin expression
Lung Cancer, 54 (3), 309-17
DOI 10.1016/j.lungcan.2006.08.010, PubMed 16996643

Torlakovic E, Slipicevic A, Robinson C, DeCoteau JF, Alfsen GC, Vyberg M, Chibbar R, Flørenes VA (2006)
Pax-5 expression in nonhematopoietic tissues
Am J Clin Pathol, 126 (5), 798-804
DOI 10.1309/XEC7-JMW9-YRM7-4RNO, PubMed 17050077

Ødegaard E, Staff AC, Abeler VM, Kopolovic J, Onsrud M, Lazarovici P, Davidson B (2006)
The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma
Hum Pathol, 38 (1), 140-6
DOI 10.1016/j.humpath.2006.06.027, PubMed 16996570

Publications 2005

Agesen TH, Flørenes VA, Molenaar WM, Lind GE, Berner JM, Plaat BE, Komdeur R, Myklebost O, van den Berg E, Lothe RA (2005)
Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors
J Neuropathol Exp Neurol, 64 (1), 74-81
DOI 10.1093/jnen/64.1.74, PubMed 15715087

Beiske K, Ambros PF, Burchill SA, Cheung IY, Swerts K (2005)
Detecting minimal residual disease in neuroblastoma patients-the present state of the art
Cancer Lett, 228 (1-2), 229-40
DOI 10.1016/j.canlet.2005.02.053, PubMed 15951104

Chen YC, Davidson B, Cheng CC, Maitra A, Giuntoli RL, Hruban RH, Wang TL, Shih IeM (2005)
Identification and characterization of membralin, a novel tumor-associated gene, in ovarian carcinoma
Biochim Biophys Acta, 1730 (2), 96-102
DOI 10.1016/j.bbaexp.2005.06.008, PubMed 16084606

Chen YC, Pohl G, Wang TL, Morin PJ, Risberg B, Kristensen GB, Yu A, Davidson B, Shih IeM (2005)
Apolipoprotein E is required for cell proliferation and survival in ovarian cancer
Cancer Res, 65 (1), 331-7
PubMed 15665311

Davidson B, Abeler VM (2005)
Primary ovarian angiosarcoma presenting as malignant cells in ascites: case report and review of the literature
Diagn Cytopathol, 32 (5), 307-9
DOI 10.1002/dc.20245, PubMed 15830366

Davidson B, Elstrand MB, McMaster MT, Berner A, Kurman RJ, Risberg B, Trope CG, Shih IeM (2005)
HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma
Gynecol Oncol, 96 (1), 42-7
DOI 10.1016/j.ygyno.2004.09.049, PubMed 15589578

Davidson B, Vintman L, Nielsen S, Reich R, Berner A (2005)
Site-related expression of metastasis-associated and signaling molecules in malignant mesothelioma--a new model for the study of tumor biology and disease progression
Lung Cancer, 49 Suppl 1, S89-93
DOI 10.1016/j.lungcan.2005.03.026, PubMed 15950809

Davidson B, Xi Z, Klokk TI, Tropé CG, Dørum A, Scheistrøen M, Saatcioglu F (2005)
Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions
Am J Clin Pathol, 123 (3), 360-8
DOI 10.1309/PTBB-5BPC-KX8K-9V69, PubMed 15716231

Elloul S, Elstrand MB, Nesland JM, Tropé CG, Kvalheim G, Goldberg I, Reich R, Davidson B (2005)
Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma
Cancer, 103 (8), 1631-43
DOI 10.1002/cncr.20946, PubMed 15742334

Givant-Horwitz V, Davidson B, Reich R (2005)
Laminin-induced signaling in tumor cells
Cancer Lett, 223 (1), 1-10
DOI 10.1016/j.canlet.2004.08.030, PubMed 15890231

Jørgensen K, Skrede M, Cruciani V, Mikalsen SO, Slipicevic A, Flørenes VA (2005)
Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2
Biochem Biophys Res Commun, 329 (1), 266-74
DOI 10.1016/j.bbrc.2005.01.143, PubMed 15721302

Konstantinovsky S, Nielsen S, Vyberg M, Kvalheim G, Nesland JM, Reich R, Davidson B (2005)
Angiogenic molecule expression is downregulated in effusions from breast cancer patients
Breast Cancer Res Treat, 94 (1), 71-80
DOI 10.1007/s10549-005-7328-3, PubMed 16142438

Reich R, Vintman L, Nielsen S, Kaern J, Bedrossian C, Berner A, Davidson B (2005)
Differential expression of the 67 kilodalton laminin receptor in epithelioid malignant mesothelioma and carcinomas that spread to serosal cavities
Diagn Cytopathol, 33 (5), 332-7
DOI 10.1002/dc.20296, PubMed 16240397

Schaner ME, Davidson B, Skrede M, Reich R, Flørenes VA, Risberg B, Berner A, Goldberg I, Givant-Horwitz V, Tropè CG, Kristensen GB, Nesland JM, Børresen-Dale AL (2005)
Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients
Mol Cancer, 4, 26
DOI 10.1186/1476-4598-4-26, PubMed 16042759

Shih IeM, Sheu JJ, Santillan A, Nakayama K, Yen MJ, Bristow RE, Vang R, Parmigiani G, Kurman RJ, Trope CG, Davidson B, Wang TL (2005)
Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma
Proc Natl Acad Sci U S A, 102 (39), 14004-9
DOI 10.1073/pnas.0504195102, PubMed 16172393

Sigstad E, Dong HP, Nielsen S, Berner A, Davidson B, Risberg B (2005)
Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping
Diagn Cytopathol, 33 (5), 325-31
DOI 10.1002/dc.20282, PubMed 16240402

Slipicevic A, Holm R, Nguyen MT, Bøhler PJ, Davidson B, Flørenes VA (2005)
Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome
Am J Clin Pathol, 124 (4), 528-36
DOI 10.1309/YT58WWMTA6YR1PRV, PubMed 16146807

Stevens EV, Raffeld M, Espina V, Kristensen GB, Trope' CG, Kohn EC, Davidson B (2005)
Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma
Cancer, 103 (11), 2313-9
DOI 10.1002/cncr.21031, PubMed 15844177

Sudbø J, Samuelsson R, Risberg B, Heistein S, Nyhus C, Samuelsson M, Puntervold R, Sigstad E, Davidson B, Reith A, Berner A (2005)
Risk markers of oral cancer in clinically normal mucosa as an aid in smoking cessation counseling
J Clin Oncol, 23 (9), 1927-33 (Retracted)
DOI 10.1200/JCO.2005.03.172, PubMed 15774785

Swerts K, Ambros PF, Brouzes C, Navarro JM, Gross N, Rampling D, Schumacher-Kuckelkorn R, Sementa AR, Ladenstein R, Beiske K (2005)
Standardization of the immunocytochemical detection of neuroblastoma cells in bone marrow
J Histochem Cytochem, 53 (12), 1433-40
DOI 10.1369/jhc.5C6661.2005, PubMed 15956022

Swerts K, De Moerloose B, Dhooge C, Vandesompele J, Hoyoux C, Beiske K, Benoit Y, Laureys G, Philippé J (2005)
Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells
Clin Chem, 52 (3), 438-45
DOI 10.1373/clinchem.2005.059485, PubMed 16384890

Vintman L, Nielsen S, Berner A, Reich R, Davidson B (2005)
Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells
Cancer, 103 (11), 2427-33
DOI 10.1002/cncr.21014, PubMed 15830375

Wang J, Cheung LW, Delabie J (2005)
New probabilistic graphical models for genetic regulatory networks studies
J Biomed Inform, 38 (6), 443-55
DOI 10.1016/j.jbi.2005.04.003, PubMed 15996532

Ødegaard E, Staff AC, Kaern J, Flørenes VA, Kopolovic J, Tropé CG, Abeler VM, Reich R, Davidson B (2005)
The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma
Gynecol Oncol, 100 (3), 462-8
DOI 10.1016/j.ygyno.2005.09.022, PubMed 16216317

Publications 2004

Andersen K, Nesland JM, Holm R, Flørenes VA, Fodstad Ø, Maelandsmo GM (2004)
Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma
Mod Pathol, 17 (8), 990-7
DOI 10.1038/modpathol.3800151, PubMed 15133476

Davidson B (2004)
Malignant effusions: from diagnosis to biology
Diagn Cytopathol, 31 (4), 246-54
DOI 10.1002/dc.20133, PubMed 15452897

Davidson B, Alejandro E, Flørenes VA, Goderstad JM, Risberg B, Kristensen GB, Trope CG, Kohn EC (2004)
Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma
Cancer, 100 (10), 2139-47
DOI 10.1002/cncr.20219, PubMed 15139056

Davidson B, Goldberg I, Tell L, Vigdorchik S, Baekelandt M, Berner A, Kristensen GB, Reich R, Kopolovic J (2004)
The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions
Clin Exp Metastasis, 21 (3), 191-9
DOI 10.1023/b:clin.0000037703.37275.35, PubMed 15387369

Davidson B, Konstantinovsky S, Nielsen S, Dong HP, Berner A, Vyberg M, Reich R (2004)
Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression
Clin Cancer Res, 10 (21), 7335-46
DOI 10.1158/1078-0432.CCR-04-0183, PubMed 15534110

Davidson B, Reich R, Lazarovici P, Ann Flørenes V, Nielsen S, Nesland JM (2004)
Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma
Breast Cancer Res Treat, 83 (2), 119-28
DOI 10.1023/B:BREA.0000010704.17479.8a, PubMed 14997042

Davidson B, Reich R, Lazarovici P, Flørenes VA, Risberg B, Nielsen S, Sert B, Bedrossian C (2004)
Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma
Lung Cancer, 44 (2), 159-65
DOI 10.1016/j.lungcan.2003.11.014, PubMed 15084380

Davidson B, Suo Z, Nesland JM (2004)
Malignant mesothelioma
Ultrastruct Pathol, 28 (4), 179-80
DOI 10.1080/01913120490518051, PubMed 15693629

Davidson B, Vintman L, Zcharia E, Bedrossian C, Berner A, Nielsen S, Ilan N, Vlodavsky I, Reich R (2004)
Heparanase and basic fibroblast growth factor are co-expressed in malignant mesothelioma
Clin Exp Metastasis, 21 (5), 469-76
DOI 10.1007/s10585-004-3150-2, PubMed 15672872

Flørenes VA, Maelandsmo GM, Holm R, Reich R, Lazarovici P, Davidson B (2004)
Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome
Am J Clin Pathol, 122 (3), 412-20
DOI 10.1309/CHFH-EYAT-44WW-P7J3, PubMed 15362372

Flørenes VA, Skrede M, Jørgensen K, Nesland JM (2004)
Deacetylase inhibition in malignant melanomas: impact on cell cycle regulation and survival
Melanoma Res, 14 (3), 173-81
DOI 10.1097/01.cmr.0000129576.49313.26, PubMed 15179185

Givant-Horwitz V, Davidson B, Goderstad JM, Nesland JM, Tropé CG, Reich R (2004)
The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma
Gynecol Oncol, 93 (2), 517-23
DOI 10.1016/j.ygyno.2004.03.009, PubMed 15099972

Givant-Horwitz V, Davidson B, Reich R (2004)
Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor
Cancer Res, 64 (10), 3572-9
DOI 10.1158/0008-5472.CAN-03-3424, PubMed 15150114

Hjortland GO, Lillehammer T, Somme S, Wang J, Halvorsen T, Juell S, Hirschberg H, Fodstad Ø, Engebraaten O (2004)
Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells
Exp Cell Res, 294 (1), 130-9
DOI 10.1016/j.yexcr.2003.10.013, PubMed 14980508

Posadas EM, Davidson B, Kohn EC (2004)
Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature
Curr Opin Oncol, 16 (5), 478-84
DOI 10.1097/00001622-200409000-00012, PubMed 15314519

Sigstad E, Dong HP, Davidson B, Berner A, Tierens A, Risberg B (2004)
The role of flow cytometric immunophenotyping in improving the diagnostic accuracy in referred fine-needle aspiration specimens
Diagn Cytopathol, 31 (3), 159-63
DOI 10.1002/dc.20108, PubMed 15349984

Stevens EV, Posadas EM, Davidson B, Kohn EC (2004)
Proteomics in cancer
Ann Oncol, 15 Suppl 4, iv167-71
DOI 10.1093/annonc/mdh922, PubMed 15477302

Torlakovic EE, Bilalovic N, Nesland JM, Torlakovic G, Flørenes VA (2004)
Ets-1 transcription factor is widely expressed in benign and malignant melanocytes and its expression has no significant association with prognosis
Mod Pathol, 17 (11), 1400-6
DOI 10.1038/modpathol.3800206, PubMed 15205685

Wang J, Meza-Zepeda LA, Kresse SH, Myklebost O (2004)
M-CGH: analysing microarray-based CGH experiments
BMC Bioinformatics, 5, 74
DOI 10.1186/1471-2105-5-74, PubMed 15189572

Xi Z, Kaern J, Davidson B, Klokk TI, Risberg B, Tropé C, Saatcioglu F (2004)
Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer
Gynecol Oncol, 94 (1), 80-5
DOI 10.1016/j.ygyno.2004.03.044, PubMed 15262123

Publications 2003

Berner A, Davidson B, Sigstad E, Risberg B (2003)
Fine-needle aspiration cytology vs. core biopsy in the diagnosis of breast lesions
Diagn Cytopathol, 29 (6), 344-8
DOI 10.1002/dc.10372, PubMed 14648793

Davidson B, Givant-Horwitz V, Lazarovici P, Risberg B, Nesland JM, Trope CG, Schaefer E, Reich R (2003)
Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma
Clin Exp Metastasis, 20 (7), 621-31
DOI 10.1023/a:1027347932543, PubMed 14669793

Davidson B, Goldberg I, Berner A, Kristensen GB, Reich R (2003)
EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma
Clin Exp Metastasis, 20 (2), 161-9
DOI 10.1023/a:1022696012668, PubMed 12705637

Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Reich R (2003)
PEA3 is the second Ets family transcription factor involved in tumor progression in ovarian carcinoma
Clin Cancer Res, 9 (4), 1412-9
PubMed 12684413

Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Risberg B, Ben-Baruch G, Reich R (2003)
Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway?
Cancer Metastasis Rev, 22 (1), 103-15
DOI 10.1023/a:1022272204045, PubMed 12716042

Davidson B, Goldberg I, Reich R, Tell L, Dong HP, Trope' CG, Risberg B, Kopolovic J (2003)
AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients
Gynecol Oncol, 90 (2), 248-57
DOI 10.1016/s0090-8258(03)00321-4, PubMed 12893184

Davidson B, Reich R, Lazarovici P, Nesland JM, Skrede M, Risberg B, Tropé CG, Flørenes VA (2003)
Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma
Clin Cancer Res, 9 (6), 2248-59
PubMed 12796393

Davidson B, Risberg B, Reich R, Berner A (2003)
Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis
Clin Lab Med, 23 (3), 729-54, viii
DOI 10.1016/s0272-2712(03)00058-1, PubMed 14560537

Givant-Horwitz V, Davidson B, Lazarovici P, Schaefer E, Nesland JM, Tropé CG, Reich R (2003)
Mitogen-activated protein kinases (MAPK) as predictors of clinical outcome in serous ovarian carcinoma in effusions
Gynecol Oncol, 91 (1), 160-72
DOI 10.1016/s0090-8258(03)00434-7, PubMed 14529677

Givant-Horwitz V, Davidson B, van de Putte G, Dong HP, Goldberg I, Amir S, Kristensen GB, Reich R (2003)
Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma
Clin Exp Metastasis, 20 (7), 599-609
DOI 10.1023/a:1027340208536, PubMed 14669791

Jørgensen K, Holm R, Maelandsmo GM, Flørenes VA (2003)
Expression of activated extracellular signal-regulated kinases 1/2 in malignant melanomas: relationship with clinical outcome
Clin Cancer Res, 9 (14), 5325-31
PubMed 14614017

Maelandsmo GM, Holm R, Nesland JM, Fodstad Ø, Flørenes VA (2003)
Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma
Clin Cancer Res, 9 (9), 3383-8
PubMed 12960126

Skotheim RI, Abeler VM, Nesland JM, Fosså SD, Holm R, Wagner U, Flørenes VA, Aass N, Kallioniemi OP, Lothe RA (2003)
Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays
Neoplasia, 5 (5), 397-404
DOI 10.1016/s1476-5586(03)80042-8, PubMed 14670177

Sudbø J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Søland TM, Lippman SM (2003)
Molecular based treatment of oral cancer
Oral Oncol, 39 (8), 749-58 (Retracted)
DOI 10.1016/s1368-8375(03)00098-8, PubMed 13679198

Sudbø J, Reith A, Flørenes VA, Nesland JM, Ristimäki A, Bryne M (2003)
COX-2 expression in striated muscle under physiological conditions
Oral Dis, 9 (6), 313-6
DOI 10.1034/j.1601-0825.2003.00957.x, PubMed 14629333

Tierens A, Delabie J, Malecka A, Wang J, Gruszka-Westwood A, Catovsky D, Matutes E (2003)
Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations
Am J Pathol, 162 (2), 681-9
DOI 10.1016/S0002-9440(10)63862-X, PubMed 12547726

Wang J, Bø TH, Jonassen I, Myklebost O, Hovig E (2003)
Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data
BMC Bioinformatics, 4, 60
DOI 10.1186/1471-2105-4-60, PubMed 14651757

Wang J, Myklebost O, Hovig E (2003)
MGraph: graphical models for microarray data analysis
Bioinformatics, 19 (17), 2210-1
DOI 10.1093/bioinformatics/btg298, PubMed 14630649

Publications 2002

Davidson B, Dong HP, Berner A, Christensen J, Nielsen S, Johansen P, Bryne M, Asschenfeldt P, Risberg B (2002)
Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases
Am J Clin Pathol, 118 (1), 85-92
DOI 10.1309/M877-QABM-D9GB-FJAX, PubMed 12109861

Davidson B, Goldberg I, Givant-Horwitz V, Nesland JM, Berner A, Bryne M, Risberg B, Kopolovic J, Kristensen GB, Tropé CG, van de Putte G, Reich R (2002)
Caveolin-1 expression in ovarian carcinoma is MDR1 independent
Am J Clin Pathol, 117 (2), 225-34
DOI 10.1309/u40r-1bn4-6kj3-bdg3, PubMed 11863219

Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM, Reich R (2002)
The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma
Mol Cell Endocrinol, 187 (1-2), 39-45
DOI 10.1016/s0303-7207(01)00709-2, PubMed 11988310

Davidson B, Reich R, Kopolovic J, Berner A, Nesland JM, Kristensen GB, Tropé CG, Bryne M, Risberg B, van de Putte G, Goldberg I (2002)
Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions
Clin Exp Metastasis, 19 (2), 135-44
DOI 10.1023/a:1014582911680, PubMed 11964077

Davidson B, Reich R, Risberg B, Nesland JM (2002)
The biological role and regulation of matrix metalloproteinases (MMP) in cancer
Arkh Patol, 64 (3), 47-53
PubMed 15338725

Karbova E, Davidson B, Metodiev K, Tropé CG, Nesland JM (2002)
Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma
Int J Surg Pathol, 10 (3), 175-80
DOI 10.1177/106689690201000302, PubMed 12232570

Meza-Zepeda LA, Forus A, Lygren B, Dahlberg AB, Godager LH, South AP, Marenholz I, Lioumi M, Flørenes VA, Maelandsmo GM, Serra M, Mischke D, Nizetic D, Ragoussis J, Tarkkanen M, Nesland JM, Knuutila S, Myklebost O (2002)
Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21
Oncogene, 21 (14), 2261-9
DOI 10.1038/sj.onc.1205339, PubMed 11948409

Ree AH, Bratland A, Kroes RA, Aasheim HC, Flørenes VA, Moskal JR, Fodstad O, Bruland OS, Maelandsmo GM (2002)
Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases
Anticancer Res, 22 (4), 1949-57
PubMed 12174869

Risberg B, Karlsson K, Abeler V, Lagrelius A, Davidson B, Karlsson MG (2002)
Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications
Int J Gynecol Pathol, 21 (2), 155-60
DOI 10.1097/00004347-200204000-00008, PubMed 11917225

Ustün M, Berner A, Davidson B, Risberg B (2002)
Fine-needle aspiration cytology of lobular carcinoma in situ
Diagn Cytopathol, 27 (1), 22-6
DOI 10.1002/dc.10128, PubMed 12112810

Ustün M, Risberg B, Davidson B, Berner A (2002)
Cystic change in metastatic lymph nodes: a common diagnostic pitfall in fine-needle aspiration cytology
Diagn Cytopathol, 27 (6), 387-92
DOI 10.1002/dc.10201, PubMed 12451573

Wang J, Delabie J, Aasheim H, Smeland E, Myklebost O (2002)
Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study
BMC Bioinformatics, 3, 36
DOI 10.1186/1471-2105-3-36, PubMed 12445336

Wang J, Nygaard V, Smith-Sørensen B, Hovig E, Myklebost O (2002)
MArray: analysing single, replicated or reversed microarray experiments
Bioinformatics, 18 (8), 1139-40
DOI 10.1093/bioinformatics/18.8.1139, PubMed 12176840

Publications 2001

Amitay R, Nass D, Meitar D, Goldberg I, Davidson B, Trakhtenbrot L, Brok-Simoni F, Ben-Ze'ev A, Rechavi G, Kaufmann Y (2001)
Reduced expression of plakoglobin correlates with adverse outcome in patients with neuroblastoma
Am J Pathol, 159 (1), 43-9
DOI 10.1016/S0002-9440(10)61671-9, PubMed 11438452

Beiner ME, Gotlieb WH, Davidson B, Kopolovic J, Ben-Baruch G (2001)
Infertility treatment after conservative management of borderline ovarian tumors
Cancer, 92 (2), 320-5
DOI 10.1002/1097-0142(20010715)92:2<320::aid-cncr1325>3.0.co;2-g, PubMed 11466685

Davidson B (2001)
Ovarian carcinoma and serous effusions. Changing views regarding tumor progression and review of current literature
Anal Cell Pathol, 23 (3-4), 107-28
DOI 10.1155/2001/418547, PubMed 12082292

Davidson B, Goldberg I, Berner A, Nesland JM, Givant-Horwitz V, Bryne M, Risberg B, Kristensen GB, Tropé CG, Kopolovic J, Reich R (2001)
Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions
Am J Clin Pathol, 115 (4), 517-24
DOI 10.1309/B1YX-L8DB-TGY1-7905, PubMed 11293899

Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R (2001)
Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients
Clin Cancer Res, 7 (11), 3457-64
PubMed 11705863

Davidson B, Nesland JM, Goldberg I, Kopolovic J, Gotlieb WH, Bryne M, Ben-Baruch G, Berner A, Reich R (2001)
Caveolin-1 expression in advanced-stage ovarian carcinoma--a clinicopathologic study
Gynecol Oncol, 81 (2), 166-71
DOI 10.1006/gyno.2001.6156, PubMed 11330944

Davidson B, Nielsen S, Christensen J, Asschenfeldt P, Berner A, Risberg B, Johansen P (2001)
The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells
Am J Surg Pathol, 25 (11), 1405-12
DOI 10.1097/00000478-200111000-00008, PubMed 11684957

Davidson B, Reich R, Berner A, Givant-Horwitz V, Goldberg I, Risberg B, Kristensen GB, Trope CG, Bryne M, Kopolovic J, Nesland JM (2001)
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels
Eur J Cancer, 37 (16), 2040-9
DOI 10.1016/s0959-8049(01)00235-0, PubMed 11597382

Davidson B, Reich R, Goldberg I, Gotlieb WH, Kopolovic J, Berner A, Ben-Baruch G, Bryne M, Nesland JM (2001)
Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma
Clin Cancer Res, 7 (3), 551-7
PubMed 11297247

Davidson B, Risberg B, Berner A, Nesland JM, Tropé CG, Kristensen GB, Bryne M, Goscinski M, van de Putte G, Flørenes VA (2001)
Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications
Gynecol Oncol, 83 (2), 249-56
DOI 10.1006/gyno.2001.6388, PubMed 11606079

Davidson B, Risberg B, Goldberg I, Nesland JM, Berner A, Tropé CG, Kristensen GB, Bryne M, Reich R (2001)
Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome
Am J Surg Pathol, 25 (12), 1493-500
DOI 10.1097/00000478-200112000-00004, PubMed 11717538

Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL (2001)
Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions
Am J Pathol, 159 (1), 237-43
DOI 10.1016/s0002-9440(10)61689-6, PubMed 11438470

Flørenes VA, Maelandsmo GM, Faye R, Nesland JM, Holm R (2001)
Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome
J Pathol, 195 (5), 530-6
DOI 10.1002/path.1007, PubMed 11745687

Forus A, D'Angelo A, Henriksen J, Merla G, Maelandsmo GM, Flørenes VA, Olivieri S, Bjerkehagen B, Meza-Zepeda LA, del Vecchio Blanco F, Müller C, Sanvito F, Kononen J, Nesland JM, Fodstad Ø, Reymond A, Kallioniemi OP, Arrigoni G, Ballabio A, Myklebost O, Zollo M (2001)
Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity
Oncogene, 20 (47), 6881-90
DOI 10.1038/sj.onc.1204874, PubMed 11687967

Germeshausen M, Ballmaier M, Schulze H, Welte K, Flohr T, Beiske K, Storm-Mathisen I, Abrahamsen TG (2001)
Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia
Blood, 97 (3), 829-30
DOI 10.1182/blood.v97.3.829, PubMed 11227095

Goldberg I, Davidson B, Reich R, Gotlieb WH, Ben-Baruch G, Bryne M, Berner A, Nesland JM, Kopolovic J (2001)
Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma
Clin Cancer Res, 7 (12), 4073-9
PubMed 11751504

Gotlieb WH, Goldberg I, Weisz B, Davidson B, Novikov I, Kopolovic J, Ben-Baruch G (2001)
Topoisomerase II immunostaining as a prognostic marker for survival in ovarian cancer
Gynecol Oncol, 82 (1), 99-104
DOI 10.1006/gyno.2001.6208, PubMed 11426969

Holm R, Skovlund E, Skomedal H, Flørenes VA, Tanum G (2001)
Reduced expression of p21WAF1 is an indicator of malignant behaviour in anal carcinomas
Histopathology, 39 (1), 43-9
DOI 10.1046/j.1365-2559.2001.01161.x, PubMed 11454043

Risberg B, Davidson B, Nielsen S, Dong HP, Christensen J, Johansen P, Asschenfeldt P, Berner A (2001)
Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry
Diagn Cytopathol, 25 (4), 214-9
DOI 10.1002/dc.2041, PubMed 11599103

Publications 2000

Berner HS, Davidson B, Berner A, Risberg B, Kristensen GB, Trope CG, Van de Putte G, Nesland JM (2000)
Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications
Clin Exp Metastasis, 18 (2), 197-202
DOI 10.1023/a:1006711320107, PubMed 11235996

Berner HS, Davidson B, Berner A, Risberg B, Nesland JM (2000)
Differential expression of CD44s and CD44v3-10 in adenocarcinoma cells and reactive mesothelial cells in effusions
Virchows Arch, 436 (4), 330-5
DOI 10.1007/s004280050455, PubMed 10834535

Cohen ZR, Knoller N, Hadani M, Davidson B, Nass D, Ram Z (2000)
Traumatic intratumoral hemorrhage as the presenting symptom of a spinal neurinoma. Case report
J Neurosurg, 93 (2 Suppl), 327-9
DOI 10.3171/spi.2000.93.2.0327, PubMed 11012070

Davidson B, Berner A (2000)
[Serous effusions]
Tidsskr Nor Laegeforen, 120 (3), 367-72
PubMed 10827531

Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Tropè CG, Kristensen GB, Bryne M, Ann Florenes V (2000)
E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions
J Pathol, 192 (4), 460-9
DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH726>3.0.CO;2-M, PubMed 11113863

Davidson B, Berner A, Nesland JM, Risberg B, Kristensen GB, Tropé CG, Bryne M (2000)
Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions
Hum Pathol, 31 (9), 1081-7
DOI 10.1053/hupa.2000.9776, PubMed 11014575

Davidson B, Goldberg I, Kopolovic J, Gotlieb WH, Givant-Horwitz V, Nesland JM, Berner A, Ben-Baruch G, Bryne M, Reich R (2000)
Expression of angiogenesis-related genes in ovarian carcinoma--a clinicopathologic study
Clin Exp Metastasis, 18 (6), 501-7
DOI 10.1023/a:1011858225144, PubMed 11592307

Davidson B, Goldberg I, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, Novikov I, Kopolovic J (2000)
Expression of topoisomerase II and Ki-67 in cervical carcinoma--clinicopathological study using immunohistochemistry
APMIS, 108 (3), 209-15
DOI 10.1034/j.1600-0463.2000.d01-46.x, PubMed 10752690

Davidson B, Gotlieb WH, Ben-Baruch G, Kopolovic J, Goldberg I, Nesland JM, Berner A, Bjåmer A, Bryne M (2000)
Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study
Gynecol Oncol, 77 (1), 35-43
DOI 10.1006/gyno.1999.5708, PubMed 10739688

Davidson B, Gotlieb WH, Ben-Baruch G, Nesland JM, Bryne M, Goldberg I, Kopolovic J, Berner A (2000)
E-Cadherin complex protein expression and survival in ovarian carcinoma
Gynecol Oncol, 79 (3), 362-71
DOI 10.1006/gyno.2000.5964, PubMed 11104606

Ertesvåg A, Blomhoff HK, Beiske K, Naderi S (2000)
Co-induction of Mad1 and c-Myc in activated normal B lymphocytes
Scand J Immunol, 51 (6), 565-70
DOI 10.1046/j.1365-3083.2000.00726.x, PubMed 10849366

Flørenes VA, Faye RS, Maelandsmo GM, Nesland JM, Holm R (2000)
Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma
Clin Cancer Res, 6 (9), 3614-20
PubMed 10999753

Gotlieb WH, Soriano D, Achiron R, Zalel Y, Davidson B, Kopolovic J, Novikov I, Ben-Baruch G (2000)
CA 125 measurement and ultrasonography in borderline tumors of the ovary
Am J Obstet Gynecol, 183 (3), 541-6
DOI 10.1067/mob.2000.105940, PubMed 10992171

Risberg B, Davidson B, Dong HP, Nesland JM, Berner A (2000)
Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings
J Clin Pathol, 53 (7), 513-7
DOI 10.1136/jcp.53.7.513, PubMed 10961174

Teixeira R, Pastacaldi S, Davies S, Dhillon AP, Emery VC, Rolles K, Davidson B, Patch D, Burroughs AK (2000)
The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation
Transplantation, 70 (10), 1454-8
DOI 10.1097/00007890-200011270-00010, PubMed 11118089

Aasheim HC, Munthe E, Funderud S, Smeland EB, Beiske K, Logtenberg T (2000)
A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes
Blood, 95 (1), 221-30
DOI 10.1182/blood.V95.1.221.001k01_221_230, PubMed 10607706

Publications 1999

Blystad A, Kvalheim G, Torlakovic E, Holte H, Jacobsen E, Beiske K, Vâlerhaugen H, Lenschow E, Kvaloy S (1999)
High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma
Bone Marrow Transplant, 24 (8), 865-72
DOI 10.1038/sj.bmt.1701990, PubMed 10516698

Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad O, Diel I, Solomayer EF, Theocharous P, Coombes RC, Smith BM, Wunder E, Marolleau JP, Garcia J, Pantel K (1999)
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
Cytotherapy, 1 (5), 377-88
DOI 10.1080/0032472031000141283, PubMed 20426539

Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM, Berner A, Bryne M, Reich R (1999)
High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma
Clin Exp Metastasis, 17 (10), 799-808
DOI 10.1023/a:1006723011835, PubMed 11089877

Davidson B, Goldberg I, Gotlieb WH, Lerner-Geva L, Ben-Baruch G, Agulansky L, Novikov I, Kopolovic J (1999)
Macrophage infiltration and angiogenesis in cervical squamous cell carcinoma--clinicopathologic correlation
Acta Obstet Gynecol Scand, 78 (3), 240-4
PubMed 10078587

Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, Reich R (1999)
MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization
Gynecol Oncol, 73 (3), 372-82
DOI 10.1006/gyno.1999.5381, PubMed 10366463

Davidson B, Goldberg I, Kopolovic J, Lerner-Geva L, Gotlieb WH, Weis B, Ben-Baruch G, Reich R (1999)
Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization
Gynecol Oncol, 72 (3), 380-6
DOI 10.1006/gyno.1998.5285, PubMed 10053110

Davidson B, Risberg B, Berner A, Smeland EB, Torlakovic E (1999)
Evaluation of lymphoid cell populations in cytology specimens using flow cytometry and polymerase chain reaction
Diagn Mol Pathol, 8 (4), 183-8
DOI 10.1097/00019606-199912000-00003, PubMed 10617274

Davidson B, Risberg B, Kristensen G, Kvalheim G, Emilsen E, Bjåmer A, Berner A (1999)
Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers
Virchows Arch, 435 (1), 43-9
DOI 10.1007/s004280050393, PubMed 10431845

Easty DJ, Hill SP, Hsu MY, Fallowfield ME, Florenes VA, Herlyn M, Bennett DC (1999)
Up-regulation of ephrin-A1 during melanoma progression
Int J Cancer, 84 (5), 494-501
DOI 10.1002/(sici)1097-0215(19991022)84:5<494::aid-ijc8>3.0.co;2-o, PubMed 10502726

Flørenes VA, Lu C, Bhattacharya N, Rak J, Sheehan C, Slingerland JM, Kerbel RS (1999)
Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma
Oncogene, 18 (4), 1023-32
DOI 10.1038/sj.onc.1202382, PubMed 10023678

Liokumovich P, Goldberg I, Davidson B, Gotlieb WH, Zahavi T, Ben-Baruch G, Reder I, Kopolovic J (1999)
Expression of metalloproteinases endometrial stromal sarcoma: immunohistochemical study using image analysis
J Clin Pathol, 52 (3), 198-202
DOI 10.1136/jcp.52.3.198, PubMed 10450179

Rak J, Mitsuhashi Y, Sheehan C, Krestow JK, Florenes VA, Filmus J, Kerbel RS (1999)
Collateral expression of proangiogenic and tumorigenic properties in intestinal epithelial cell variants selected for resistance to anoikis
Neoplasia, 1 (1), 23-30
DOI 10.1038/sj.neo.7900001, PubMed 10935467

Stratton R, Bryce K, Beynon H, Tibballs J, Watkinson A, Davidson B (1999)
Systemic vasculitis with multiple aneurysms complicating systemic lupus erythematosus
J R Soc Med, 92 (12), 636-7
DOI 10.1177/014107689909201209, PubMed 10692887

Warwick RJ, Davidson B, Watkinson A (1999)
Successful use of a covered nitinol self-expanding stent to seal a malignant fistula of the common bile duct
Clin Radiol, 54 (6), 410-2
DOI 10.1053/crad.1999.0050, PubMed 10406346

Publications 1998

Barshack I, Goldberg I, Davidson B, Ravid A, Schiby G, Kopolovic J, Leviav A, Friedman E (1998)
Expression of rasGTPase activating protein in basal cell carcinoma of the skin
Mod Pathol, 11 (3), 271-5
PubMed 9521474

Borgen E, Beiske K, Trachsel S, Nesland JM, Kvalheim G, Herstad TK, Schlichting E, Qvist H, Naume B (1998)
Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase
J Pathol, 185 (4), 427-34
DOI 10.1002/(SICI)1096-9896(199808)185:4<427::AID-PATH127>3.0.CO;2-7, PubMed 9828843

Davidson B, Agulansky L, Goldberg I, Friedman E, Ramon J, Barshack I, Kopolovic J (1998)
Immunohistochemical analysis of rasGTPase activating protein (rasGAP) in prostate cancer
Pathol Res Pract, 194 (6), 399-404
DOI 10.1016/S0344-0338(98)80030-7, PubMed 9689648

Davidson B, Goldberg I, Gotlieb WH, Ben-Baruch G, Kopolovic J (1998)
CD44 expression in uterine cervical intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study
Eur J Gynaecol Oncol, 19 (1), 46-9
PubMed 9476059

Davidson B, Goldberg I, Gotlieb WH, Ben-Baruch G, Kopolovic J (1998)
Expression of matrix proteins in uterine cervical neoplasia using immunohistochemistry
Eur J Obstet Gynecol Reprod Biol, 76 (1), 109-14
DOI 10.1016/s0301-2115(97)00161-9, PubMed 9481557

Davidson B, Goldberg I, Gotlieb WH, Lerner-Geva L, Ben-Baruch G, Kopolovic J (1998)
Ulex Europaeus lectin and anti-CD31 staining in squamous cell carcinoma of the uterine cervix: potential prognostic markers
Int J Gynecol Pathol, 17 (3), 205-10
DOI 10.1097/00004347-199807000-00003, PubMed 9656115

Davidson B, Goldberg I, Liokumovich P, Kopolovic J, Gotlieb WH, Lerner-Geva L, Reder I, Ben-Baruch G, Reich R (1998)
Expression of metalloproteinases and their inhibitors in adenocarcinoma of the uterine cervix
Int J Gynecol Pathol, 17 (4), 295-301
DOI 10.1097/00004347-199810000-00002, PubMed 9785129

Flørenes VA, Maelandsmo GM, Kerbel RS, Slingerland JM, Nesland JM, Holm R (1998)
Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival
Am J Pathol, 153 (1), 305-12
DOI 10.1016/S0002-9440(10)65572-1, PubMed 9665492

Goldberg I, Davidson B, Lerner-Geva L, Gotlieb WH, Ben-Baruch G, Novikov I, Kopolovic J (1998)
Expression of extracellular matrix proteins in cervical squamous cell carcinoma--a clinicopathological study
J Clin Pathol, 51 (10), 781-5
DOI 10.1136/jcp.51.10.781, PubMed 10023343

Gotlieb WH, Flikker S, Davidson B, Korach Y, Kopolovic J, Ben-Baruch G (1998)
Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome
Cancer, 82 (1), 141-6
PubMed 9428490

Gotlieb WH, Friedman E, Bar-Sade RB, Kruglikova A, Hirsh-Yechezkel G, Modan B, Inbar M, Davidson B, Kopolovic J, Novikov I, Ben-Baruch G (1998)
Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors
J Natl Cancer Inst, 90 (13), 995-1000
DOI 10.1093/jnci/90.13.995, PubMed 9665148

Naume B, Borgen E, Nesland JM, Beiske K, Gilen E, Renolen A, Ravnås G, Qvist H, Kåresen R, Kvalheim G (1998)
Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation
Int J Cancer, 78 (5), 556-60
DOI 10.1002/(sici)1097-0215(19981123)78:5<556::aid-ijc5>3.0.co;2-g, PubMed 9808522

St Croix B, Sheehan C, Rak JW, Flørenes VA, Slingerland JM, Kerbel RS (1998)
E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)
J Cell Biol, 142 (2), 557-71
DOI 10.1083/jcb.142.2.557, PubMed 9679152

Publications 1997

Davidson B, Goldberg I, Kopolovic J (1997)
Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix
Pathol Res Pract, 193 (7), 491-5
DOI 10.1016/s0344-0338(97)80102-1, PubMed 9342755

Davidson B, Goldberg I, Kopolovic J (1997)
Angiogenesis in uterine cervical intraepithelial neoplasia and squamous cell carcinoma: an immunohistochemical study
Int J Gynecol Pathol, 16 (4), 335-8
DOI 10.1097/00004347-199710000-00007, PubMed 9421072

Davidson B, Nass D (1997)
[Genetic defects in neurodegenerative diseases]
Harefuah, 132 (7), 481-5
PubMed 9153920

Easty DJ, Mitchell PJ, Patel K, Flørenes VA, Spritz RA, Bennett DC (1997)
Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma
Int J Cancer, 71 (6), 1061-5
DOI 10.1002/(sici)1097-0215(19970611)71:6<1061::aid-ijc24>3.0.co;2-f, PubMed 9185712

Holm R, Flørenes VA, Erikstein B, Nesland JM (1997)
Expression of stromelysin-3 in medullary carcinoma of the breast
Anticancer Res, 17 (5B), 3725-7
PubMed 9427769

Maelandsmo GM, Flørenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O (1997)
Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma
Int J Cancer, 74 (4), 464-9
DOI 10.1002/(sici)1097-0215(19970822)74:4<464::aid-ijc19>3.0.co;2-9, PubMed 9291441

Naume B, Borgen E, Beiske K, Herstad TK, Ravnås G, Renolen A, Trachsel S, Thrane-Steen K, Funderud S, Kvalheim G (1997)
Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood
J Hematother, 6 (2), 103-14
DOI 10.1089/scd.1.1997.6.103, PubMed 9131439

Rasmussen AM, Horejsí V, Levy FO, Blomhoff HK, Smeland EB, Beiske K, Michaelsen TE, Gaudernack G, Funderud S (1997)
CDw78--a determinant on a major histocompatibility complex class II subpopulation that can be induced to associate with the cytoskeleton
Eur J Immunol, 27 (12), 3206-13
DOI 10.1002/eji.1830271218, PubMed 9464807

Ree AH, Florenes VA, Berg JP, Maelandsmo GM, Nesland JM, Fodstad O (1997)
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases
Clin Cancer Res, 3 (9), 1623-8
PubMed 9815852

Salai M, Zemmer D, Segal E, Corat A, Heyman Z, Davidson B, Langevitz P, Livneh A (1997)
Chronic massive knee effusion in familial Mediterranean fever
Semin Arthritis Rheum, 27 (3), 169-72
DOI 10.1016/s0049-0172(97)80016-9, PubMed 9431588

Publications 1996

Flørenes VA, Bhattacharya N, Bani MR, Ben-David Y, Kerbel RS, Slingerland JM (1996)
TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1
Oncogene, 13 (11), 2447-57
PubMed 8957087

Gjersten MK, Saeterdal I, Beiske K, Gaudernack G (1996)
Antigen-presenting function of human peritoneum mesothelial cells isolated from a pancreatic carcinoma patient after mutant Ras peptide vaccination
Cancer Immunol Immunother, 43 (5), 262-8
DOI 10.1007/s002620050332, PubMed 9024502

Kerbel RS, St Croix B, Florenes VA, Rak J (1996)
Induction and reversal of cell adhesion-dependent multicellular drug resistance in solid breast tumors
Hum Cell, 9 (4), 257-64
PubMed 9183656

Kvalheim G, Pharo A, Holte H, Jakobsen E, Erikstein B, Kvaløy S, Beiske K, Nesland JM, Smeland EB (1996)
[High-dose therapy of cancer with CD34 positive cells as stem cell support]
Tidsskr Nor Laegeforen, 116 (21), 2542-6
PubMed 8928121

Kvalheim G, Wang MY, Pharo A, Holte H, Jacobsen E, Beiske K, Kvaløy S, Smeland E, Funderud S, Fodstad O (1996)
Purging of tumor cells from leukapheresis products: experimental and clinical aspects
J Hematother, 5 (4), 427-36
DOI 10.1089/scd.1.1996.5.427, PubMed 8877718

Loraas A, Lote K, Samdal HH, Beiske K, Langholm R (1996)
[Human T-cell lymphotrophic virus type I and T-cell lymphoma]
Tidsskr Nor Laegeforen, 116 (2), 238-41
PubMed 8633332

Maelandsmo GM, Flørenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Børresen AL, Fodstad O (1996)
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas
Br J Cancer, 73 (8), 909-16
DOI 10.1038/bjc.1996.181, PubMed 8611425

Maelandsmo GM, Holm R, Fodstad O, Kerbel RS, Flørenes VA (1996)
Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions
Am J Pathol, 149 (6), 1813-22
PubMed 8952518

Maelandsmo GM, Hovig E, Skrede M, Engebraaten O, Flørenes VA, Myklebost O, Grigorian M, Lukanidin E, Scanlon KJ, Fodstad O (1996)
Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme
Cancer Res, 56 (23), 5490-8
PubMed 8968106

St Croix B, Flørenes VA, Rak JW, Flanagan M, Bhattacharya N, Slingerland JM, Kerbel RS (1996)
Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents
Nat Med, 2 (11), 1204-10
DOI 10.1038/nm1196-1204, PubMed 8898746

Publications 1995

Davidson B, Kopolovic J (1995)
[Molecular biology of human papilloma virus infection of the female genital tract]
Harefuah, 129 (10), 417-20
PubMed 8647548

Flørenes VA, Holm R, Fodstad O (1995)
Accumulation of p53 protein in human malignant melanoma. Relationship to clinical outcome
Melanoma Res, 5 (3), 183-7
DOI 10.1097/00008390-199506000-00007, PubMed 7640520

Lømo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB (1995)
TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes
J Immunol, 154 (4), 1634-43
PubMed 7836748

Maelandsmo GM, Berner JM, Flørenes VA, Forus A, Hovig E, Fodstad O, Myklebost O (1995)
Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1
Br J Cancer, 72 (2), 393-8
DOI 10.1038/bjc.1995.344, PubMed 7640224

Wen DY, Hall WA, Conrad J, Godal A, Flørenes VA, Fodstad O (1995)
In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line
Neurosurgery, 36 (6), 1158-63; discussion 1163-4
DOI 10.1227/00006123-199506000-00015, PubMed 7643997

Publications 1994

Flørenes VA, Holm R, Myklebost O, Lendahl U, Fodstad O (1994)
Expression of the neuroectodermal intermediate filament nestin in human melanomas
Cancer Res, 54 (2), 354-6
PubMed 8275467

Flørenes VA, Maelandsmo GM, Forus A, Andreassen A, Myklebost O, Fodstad O (1994)
MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status
J Natl Cancer Inst, 86 (17), 1297-302
DOI 10.1093/jnci/86.17.1297, PubMed 8064888

Flørenes VA, Oyjord T, Holm R, Skrede M, Børresen AL, Nesland JM, Fodstad O (1994)
TP53 allele loss, mutations and expression in malignant melanoma
Br J Cancer, 69 (2), 253-9
DOI 10.1038/bjc.1994.48, PubMed 7905277

Forus A, Flørenes VA, Maelandsmo GM, Fodstad O, Myklebost O (1994)
The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas
Cancer Genet Cytogenet, 78 (2), 165-71
DOI 10.1016/0165-4608(94)90085-x, PubMed 7828148

Kashani-Sabet M, Funato T, Florenes VA, Fodstad O, Scanlon KJ (1994)
Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme
Cancer Res, 54 (4), 900-2
PubMed 8313379

Kvalheim G, Jakobsen E, Holte H, Beiske K, Langholm R, Høiby A, Wang MY, Funderund S, Fodstad O, Smeland E (1994)
Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged using immunomagnetic beads
Prog Clin Biol Res, 389, 133-8
PubMed 7700895

Publications 1993

Andreassen A, Oyjord T, Hovig E, Holm R, Flørenes VA, Nesland JM, Myklebost O, Høie J, Bruland OS, Børresen AL (1993)
p53 abnormalities in different subtypes of human sarcomas
Cancer Res, 53 (3), 468-71
PubMed 8425179

Forus A, Flørenes VA, Maelandsmo GM, Meltzer PS, Fodstad O, Myklebost O (1993)
Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2
Cell Growth Differ, 4 (12), 1065-70
PubMed 8117620

Publications 1992

Beiske K, Myklebust AT, Aamdal S, Langholm R, Jakobsen E, Fodstad O (1992)
Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods
Am J Pathol, 141 (3), 531-8
PubMed 1381558

Erikstein BK, Funderud S, Beiske K, Aas-Eng A, De Lange Davies C, Blomhoff HK, Smeland EB (1992)
Cell cycle-dependent regulation of CDw75 (beta-galactoside alpha-2,6-sialyltransferase) on human B lymphocytes
Eur J Immunol, 22 (5), 1149-55
DOI 10.1002/eji.1830220507, PubMed 1577059

Flørenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O (1992)
Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression
Cancer Res, 52 (21), 6088-91
PubMed 1356624

Smeland EB, Beiske K (1992)
[Immunophenotyping of leukemias]
Tidsskr Nor Laegeforen, 112 (18), 2373-4
PubMed 1412241

Wang MY, Kvalheim G, Kvaløy S, Beiske K, Jakobsen E, Wijdenes J, Pihl A, Fodstad O (1992)
An effective immunomagnetic method for bone marrow purging in T cell malignancies
Bone Marrow Transplant, 9 (5), 319-23
PubMed 1617315

Publications 1991

Alfsen GC, Beiske K, Holte H, Hovig E, Deggerdal A, Sandlie I, Widing E, Slørdahl S, Klepper LK, Sizoo W (1991)
T-cell receptor tau delta +/CD3+4-8-T- cell acute lymphoblastic leukemias: a distinct subgroup of leukemias in children. A report of five cases
Blood, 77 (9), 2023-30
PubMed 1826854

Myklebust AT, Beiske K, Pharo A, Davies CD, Aamdal S, Fodstad O (1991)
Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis
Br J Cancer Suppl, 14, 49-53
PubMed 1645572

MYKLEBUST AT, BEISKE K, PHARO A, DAVIES CD, AAMDAL S, FODSTAD O (1991)
SELECTION OF ANTI-SCLC ANTIBODIES FOR DIAGNOSIS OF BONE-MARROW METASTASIS
Br. J. Cancer, 63 14, 49-53

Skjønsberg C, Erikstein BK, Smeland EB, Lie SO, Funderud S, Beiske K, Blomhoff HK (1991)
Interleukin-7 differentiates a subgroup of acute lymphoblastic leukemias
Blood, 77 (11), 2445-50
PubMed 2039826

Thomas JO, Beiske K, Hann I, Koo C, Mason DY (1991)
Immunohistological diagnosis of "plasmacytoid T cell lymphoma" in paraffin wax sections
J Clin Pathol, 44 (8), 632-5
DOI 10.1136/jcp.44.8.632, PubMed 1890195

Publications 1990

Skjønsberg C, Kiil Blomhoff H, Gaudernack G, Funderud S, Beiske K, Smeland EB (1990)
Immunological typing of acute leukaemias by rosetting with immunomagnetic beads: comparison with immunofluorescence staining
Scand J Immunol, 31 (5), 567-73
DOI 10.1111/j.1365-3083.1990.tb02807.x, PubMed 2189214

Publications 1989

Alfsen GC, Beiske K, Bell H, Marton PF (1989)
Low-grade intestinal lymphoma of intraepithelial T lymphocytes with concomitant enteropathy-associated T cell lymphoma: case report suggesting a possible histogenetic relationship
Hum Pathol, 20 (9), 909-13
DOI 10.1016/0046-8177(89)90105-6, PubMed 2789173

Gravdahl HK, Beiske K, Langholm R, Kvaløy S, Marton PF (1989)
[Giant cell anaplastic anemia]
Tidsskr Nor Laegeforen, 109 (23), 2289-94
PubMed 2772896

Holte H, Blomhoff HK, Beiske K, Funderud S, Torjesen P, Gaudernack G, Stokke T, Smeland EB (1989)
Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens
Eur J Immunol, 19 (7), 1221-5
DOI 10.1002/eji.1830190711, PubMed 2547623

Holte H, de Lange Davies C, Beiske K, Stokke T, Marton PF, Smeland EB, Høie J, Kvaløy S (1989)
Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma
Int J Cancer, 44 (6), 975-80
DOI 10.1002/ijc.2910440605, PubMed 2606582

Publications 1988

Alfsen GC, Beiske K, Marton P, Bell H, Qvigstad T (1988)
[Non-Hodgkin's lymphoma of T cell type in the intestine in a patient with celiac disease and ulcerative jejunitis. An example of the diagnostic value of DNA probes]
Tidsskr Nor Laegeforen, 108 (12), 937-9
PubMed 3260045

Beiske K, Clark EA, Holte H, Ledbetter JA, Smeland EB, Godal T (1988)
Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets
Int J Cancer, 42 (4), 521-8
DOI 10.1002/ijc.2910420409, PubMed 2459071

Kvalheim G, Funderud S, Kvaløy S, Gaudernack G, Beiske K, Jakobsen E, Jacobsen AB, Pihl A, Fodstad O (1988)
Successful clinical use of an anti-HLA-DR monoclonal antibody for autologous bone marrow transplantation
J Natl Cancer Inst, 80 (16), 1322-5
DOI 10.1093/jnci/80.16.1322, PubMed 3050139

Ly B, Beiske K, Larsen N (1988)
Immunological typing of acute leukemias: immunoenzymatic staining of fixed cells compared with immunofluorescence staining of unfixed cells in suspension
Eur J Haematol, 41 (2), 147-55
DOI 10.1111/j.1600-0609.1988.tb00884.x, PubMed 2457510

Publications 1987

Beiske K, Munthe-Kaas A, Davies CD, Marton PF, Godal T (1987)
Single cell studies on the immunological marker profile of plasmacytoid T-zone cells
Lab Invest, 56 (4), 381-93
PubMed 3104684

Blomhoff HK, Smeland EB, Beiske K, Blomhoff R, Ruud E, Bjøro T, Pfeifer-Ohlsson S, Watt R, Funderud S, Godal T (1987)
Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes
J Cell Physiol, 131 (3), 426-33
DOI 10.1002/jcp.1041310315, PubMed 3036888

Smeland EB, Beiske K, Ek B, Watt R, Pfeifer-Ohlsson S, Blomhoff HK, Godal T, Ohlsson R (1987)
Regulation of c-myc transcription and protein expression during activation of normal human B cells
Exp Cell Res, 172 (1), 101-9
DOI 10.1016/0014-4827(87)90097-8, PubMed 3308492

Smeland EB, Beiske K, Ohlsson R, Holte H, Ruud E, Blomhoff HK, Jefferis R, Godal T (1987)
Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells
J Immunol, 138 (10), 3179-84
PubMed 3553323

Smeland EB, Blomhoff HK, Holte H, Ruud E, Beiske K, Funderud S, Godal T, Ohlsson R (1987)
Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes
Exp Cell Res, 171 (1), 213-22
DOI 10.1016/0014-4827(87)90264-3, PubMed 2442015

Publications 1986

Beiske K, Langholm R, Godal T, Marton PF (1986)
T-zone lymphoma with predominance of 'plasmacytoid T-cells' associated with myelomonocytic leukaemia--a distinct clinicopathological entity
J Pathol, 150 (4), 247-55
DOI 10.1002/path.1711500404, PubMed 3543277

Lea T, Smeland E, Funderud S, Vartdal F, Davies C, Beiske K, Ugelstad J (1986)
Characterization of human mononuclear cells after positive selection with immunomagnetic particles
Scand J Immunol, 23 (4), 509-19
DOI 10.1111/j.1365-3083.1986.tb03083.x, PubMed 2422741

Smeland EB, Godal T, Beiske K, Watt R, Pfeifer-Ohlsson S, Ohlsson R (1986)
Regulation of c-myc mRNA and protein levels during activation of normal human B cells
Curr Top Microbiol Immunol, 132, 290-6
DOI 10.1007/978-3-642-71562-4_43, PubMed 3539537

Publications 1985

Melsom H, Kvaløy S, Beiske K, Funderud S, Marton PF, Godal T, Lie SO (1985)
[Monoclonal antibodies. A new tool in the diagnosis of leukemia and lymphoma]
Tidsskr Nor Laegeforen, 105 (22), 1379-82
PubMed 4049331

Smeland E, Godal T, Ruud E, Beiske K, Funderud S, Clark EA, Pfeifer-Ohlsson S, Ohlsson R (1985)
The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate
Proc Natl Acad Sci U S A, 82 (18), 6255-9
DOI 10.1073/pnas.82.18.6255, PubMed 3929253

Publications 1984

Beiske K, Ruud E, Drack A, Marton PF, Godal T (1984)
Induction of maturation of human B-cell lymphomas in vitro. Morphologic changes in relation to immunoglobulin and DNA synthesis
Am J Pathol, 115 (3), 362-74
PubMed 6375389

Beiske K, Ruud E, Marton PF, Godal T (1984)
Induction of maturation in different types of B-cell lymphomas in vitro with TPA and antibodies to surface immunoglobulin
Scand J Immunol, 20 (3), 199-208
DOI 10.1111/j.1365-3083.1984.tb00993.x, PubMed 6333716

Ruud E, Beiske K, Drack A, Steen HB, Godal T (1984)
Different fate of antibodies to surface IgM and IgD in germinal centre cell-associated lymphomas
Scand J Immunol, 19 (5), 447-55
DOI 10.1111/j.1365-3083.1984.tb00953.x, PubMed 6427920

Publications 1983

Ruud E, Steen HB, Beiske K, Godal T (1983)
Different responses elicited in vitro by antibodies to IgM and IgD in cells from a surface IgM + D-positive human follicular lymphoma
Scand J Immunol, 17 (2), 155-60
DOI 10.1111/j.1365-3083.1983.tb00778.x, PubMed 6340180

Publications 1982

Beiske K, Lindtjorn B, Olafsson J (1982)
Rhinosporidiosis affecting the palpebral conjunctiva: a case report
Ethiop Med J, 20 (3), 135-9
PubMed 7106098

Publications 1981

Beiske K (1981)
[Ulcerative herpes esophagitis]
Tidsskr Nor Laegeforen, 101 (13), 795-8
PubMed 7268717

Olafsson J, Lindtjorn B, Beiske K (1981)
Chromomycosis: a report of three cases from Ethiopia
Ethiop Med J, 19 (3), 91-6
PubMed 7285897